Document:

<PAGE>

                                                                    EXHIBIT 10.3

--------------------------------------------------------------------------------

                      NOTE AND EQUITY PURCHASE AGREEMENT
                      ----------------------------------

                                 by and between

                           ENCORE MEDICAL CORPORATION,

                           ITS SUBSIDIARIES LISTED ON
                           THE SIGNATURE PAGES HERETO,

                                       and

                           CAPITALSOURCE FINANCE LLC,
                             AS AGENT AND PURCHASER

                                February 8, 2002

--------------------------------------------------------------------------------

<PAGE>

                                TABLE OF CONTENTS
                                -----------------

<TABLE>
<S>                                                                                                   <C>
ARTICLE 1 DEFINITIONS................................................................................  1

   1.1   CERTAIN DEFINITIONS.:.......................................................................  1
   1.2   ACCOUNTING PRINCIPLES....................................................................... 18
   1.3   OTHER DEFINITIONAL PROVISIONS; CONSTRUCTION................................................. 18

ARTICLE 2 ISSUE AND SALE OF SECURITIES............................................................... 18

   2.1   AUTHORIZATION AND ISSUANCE OF THE NOTE...................................................... 18
   2.2   AUTHORIZATION AND ISSUANCE OF WARRANT....................................................... 19
   2.3   SALE AND PURCHASE........................................................................... 19
   2.4   THE CLOSING................................................................................. 19

ARTICLE 3 REPAYMENT OF THE NOTE...................................................................... 20

   3.1   INTEREST RATES AND INTEREST PAYMENTS........................................................ 20
   3.2   REPAYMENT OF THE NOTES...................................................................... 20
   3.3   OPTIONAL PREPAYMENT OF NOTE................................................................. 21
   3.4   NOTICE OF OPTIONAL PREPAYMENT............................................................... 22
   3.5   MANDATORY PREPAYMENT........................................................................ 22
   3.6   HOME OFFICE PAYMENT......................................................................... 23
   3.7   TAXES....................................................................................... 23
   3.8   MAXIMUM LAWFUL RATE......................................................................... 24
   3.9   CAPITAL ADEQUACY............................................................................ 24
   3.10     CERTAIN WAIVERS.......................................................................... 25

ARTICLE 4 CONDITIONS................................................................................. 25

   4.1   CONDITIONS TO PURCHASE OF SECURITIES........................................................ 25
   4.2   WAIVER...................................................................................... 29

ARTICLE 5 REPRESENTATIONS AND WARRANTIES OF THE LOAN PARTIES......................................... 29

   5.1   REPRESENTATIONS AND WARRANTIES OF LOAN PARTIES.............................................. 29

ARTICLE 6 TRANSFER OF SECURITIES..................................................................... 40

   6.1   RESTRICTED SECURITIES....................................................................... 40
   6.2   LEGENDS; PURCHASER'S REPRESENTATIONS........................................................ 40
   6.3   TRANSFER OF NOTES........................................................................... 41
   6.4   REPLACEMENT OF LOST SECURITIES.............................................................. 41
   6.5   NO OTHER REPRESENTATIONS AFFECTED........................................................... 41

ARTICLE 7 COVENANTS.................................................................................. 41

   7.1   AFFIRMATIVE COVENANTS....................................................................... 41
   7.2   NEGATIVE COVENANTS.......................................................................... 49
   7.3   FINANCIAL COVENANTS......................................................................... 56

ARTICLE 8 EVENTS OF DEFAULT.......................................................................... 57

   8.1   EVENTS OF DEFAULT.:......................................................................... 57
   8.2   CONSEQUENCES OF EVENT OF DEFAULT............................................................ 60
   8.3   SECURITY.................................................................................... 61
   8.4   SET-OFF..................................................................................... 61

ARTICLE 9 AGENCY PROVISIONS.......................................................................... 61

   9.1   THE AGENT................................................................................... 61
   9.2   CONSENTS.................................................................................... 66
   9.3   DISSEMINATION OF INFORMATION................................................................ 66
</TABLE>

<PAGE>

<TABLE>
<S>                                                                                                    <C>
ARTICLE 10 MISCELLANEOUS.............................................................................. 67

   10.1     SUCCESSORS AND ASSIGNS; PARTICIPANTS...................................................... 67
   10.2     MODIFICATIONS AND AMENDMENTS.............................................................. 68
   10.3     NO IMPLIED WAIVERS; WRITING REQUIRED; WAIVERS............................................. 68
   10.4     REIMBURSEMENT OF EXPENSES................................................................. 68
   10.5     HOLIDAYS.................................................................................. 69
   10.6     NOTICES................................................................................... 69
   10.7     EFFECTIVENESS AND SURVIVAL................................................................ 70
   10.8     GOVERNING LAW............................................................................. 71
   10.9     COOPERATION IN DISCOVERY AND LITIGATION................................................... 71
   10.10    JURY TRIAL WAIVER......................................................................... 71
   10.11    SEVERABILITY.............................................................................. 71
   10.12    HEADINGS.................................................................................. 72
   10.13    GENERAL INDEMNITY......................................................................... 72
   10.14    ENVIRONMENTAL INDEMNITY................................................................... 72
   10.15    COUNTERPARTS.............................................................................. 73
   10.16    INTEGRATION............................................................................... 73
   10.17    SUBORDINATION............................................................................. 73
   10.18    LENDER APPROVALS.......................................................................... 73
   10.19    LENDER DUTIES............................................................................. 74
   10.20    APPLICATION OF PAYMENTS................................................................... 74
   10.21    CONFIDENTIALITY AND PUBLICITY............................................................. 74
   10.22    ACKNOWLEDGEMENT........................................................................... 75
   10.23    RELEASE OF COLLATERAL..................................................................... 75
   10.24    RIGHTS AND REMEDIES....................................................................... 76
   10.25    RIGHTS AND REMEDIES NOT EXCLUSIVE......................................................... 76
   10.26    WAIVER OF CONSEQUENTIAL AND PUNITIVE DAMAGES.............................................. 76
   10.27    SUBROGATION............................................................................... 76
   10.28    POWER OF ATTORNEY......................................................................... 77
   10.29    ACKNOWLEDGEMENT OF JOINT AND SEVERAL LIABILITY............................................ 77
   10.30    SEAL AND EFFECTIVE DATE. ................................................................. 77
</TABLE>

<PAGE>

                       NOTE AND EQUITY PURCHASE AGREEMENT
                       ----------------------------------

               $24,000,000 Senior Subordinated Notes of Borrowers
                              Due February 8, 2007

                               Warrant to Purchase
                up to 2,198,614 Shares of Common Stock of Parent

         THIS NOTE AND EQUITY PURCHASE AGREEMENT (this "Agreement"), dated as of
February 8, 2002, is by and between ENCORE MEDICAL CORPORATION (the "Parent"),
the subsidiaries of Parent listed on the signature pages attached hereto
(together with the Parent, collectively, the "Loan Parties"), and CAPITALSOURCE
FINANCE LLC, a Delaware limited liability company ("CapitalSource"), as Agent
and Purchaser (each as defined herein). Capitalized terms used and not defined
elsewhere in this Agreement are defined in Article 1.
                                           ---------

                                    RECITALS

         A.   The Loan Parties have proposed selling Senior  Subordinated
Notes to the Purchaser in the aggregate principal amount of $24,000,000 for the
financing of the Acquisition.

         B.   In order to induce the Purchaser to purchase the Notes to be
issued pursuant to this Agreement, the Parent has agreed to issue and sell to
the Purchaser or Holder, in connection with the purchase of such Notes, a
warrant exercisable for up to an aggregate of 2,198,614 shares of Common Stock
of the Parent, subject to the terms and conditions set forth in this Agreement
and the Warrant.

         NOW, THEREFORE, the parties hereto, in consideration of the premises
and their mutual covenants and agreements herein set forth and intending to be
legally bound hereby, covenant and agree as follows:

                                    ARTICLE 1
                                   DEFINITIONS

         1.1  Certain Definitions. In addition to other words and terms defined
              -------------------
elsewhere in this Agreement, the following words and terms have the meanings set
forth below (and such meanings shall be equally applicable to both the singular
and plural form of the terms defined, as the context may require):

         "Account" and "Accounts" have the meanings specified in the Security
Agreements.

         "Acquisition" shall mean the purchase by Parent of all of the
outstanding Capital Stock of Chattanooga Group, Inc.

         "Acquisition Agreement" shall mean that certain Stock Purchase
Agreement dated as of November 28, 2001, as amended, by and among Parent,
Richard T. Niner and Robert W.

<PAGE>

Cruickshank, as Trustees of, and on behalf of, the Robert L. McNeil, Jr. 1983
Trust, under Trust Agreement dated November 30, 1983, Chatt Investment L.P.,
Paul D. Chapman, Scott A. Klosterman, Charles M. Thomas, David C. Linville and
certain other shareholders of Chattanooga Group, Inc., in form and substance
acceptable to the Agent.

         "Affiliate" means with respect to any Person, any other Person that is
directly or indirectly controlling, controlled by or under common control with
such Person or entity or any of its Subsidiaries, and the term "control"
(including the terms "controlled by" and "under common control with") means
having, directly or indirectly, the power to direct or cause the direction of
the management and policies of a Person, whether through ownership of voting
securities or by contract or otherwise. Without limiting the foregoing, the
ownership of ten percent (10%) or more of the voting securities of a Person
shall be deemed to constitute control and, notwithstanding anything to the
contrary herein, neither the Agent, the Purchaser nor the Holder nor any of
their respective Affiliates shall be deemed to be Affiliates of the Loan Parties
by virtue of the transactions contemplated in this Agreement.

         "Agent" means CapitalSource, in its capacity as administrative agent
and collateral agent for the Purchasers, and any successor administrative agent.

         "Agreement" means this Note and Equity Purchase Agreement, as the same
may be amended, restated, supplemented or otherwise modified from time to time.

         "Business" means the principal business of the Loan Parties as set
forth in Section 5.1(c) herein and as such shall continue to be conducted
following the purchase and sale of the Securities.

         "Business Day" means any day other than a Saturday, Sunday or other day
on which banking institutions in New York are authorized or required by law to
close.

         "By-laws" means the by-laws, partnership agreement, operating agreement
or analogous instrument governing the operations of each of the Loan Parties, as
applicable, including all amendments and supplements thereto.

         "Capital Expenditures" means, for any period of determination, the sum
(without duplication) of capital expenditures and payments under Capitalized
Leases and other expenditures that are or should be treated as capital
expenditures under GAAP, in each case of the Loan Parties for such period
determined and consolidated in accordance with GAAP.

         "Capital Stock" means any and all corporate stock, units, shares,
partnership interests, membership interests, equity interests, rights,
securities, or other equivalent evidences of ownership (howsoever designated)
issued by any Person.

         "Capitalized Leases" means, with respect to any Person, leases of (or
other agreements conveying the right to use) any property (whether real,
personal or mixed) by such Person as lessee that, in accordance with GAAP (as
defined in Section 1.2 hereof), either would be required to be classified and
accounted for as capital leases on a balance sheet of such Person or otherwise
be disclosed as such in a note to such balance sheet.

                                       -2-

<PAGE>

          "CERCLA" means the  Comprehensive  Environmental  Response,
Compensation and Liability Act (42 U.S.C. (S) 9604, et seq.), as amended, and
                                                    -- ---
rules, regulations, standards guidelines and publications issued thereunder.

          "Change of Control" means the occurrence of any of the following:

               (a) except as otherwise expressly permitted by this Agreement,
          the adoption of a plan relating to the liquidation, dissolution or
          winding-up of any Loan Party;

               (b) any transaction or series of related transactions resulting
          in the sale or issuance of securities or any rights to securities of
          the Parent by the Parent representing in the aggregate more than 50%
          of its issued and outstanding voting securities, on a fully diluted
          basis, or any transaction or series of related transactions resulting
          in the sale, transfer, assignment or other conveyance or disposition
          of any securities or any rights to securities of the Parent by any
          holder or holders thereof representing in the aggregate more than 50%
          of the issued and outstanding voting securities of the Parent on a
          fully diluted basis and the receipt of any consideration in connection
          therewith;

               (c) a merger, consolidation, reorganization, recapitalization or
          share exchange in which the stockholders of the Parent immediately
          prior to such transaction receive, in exchange for securities of the
          Parent owned by them, cash, property or securities of the resulting or
          surviving entity and as a result thereof Persons who were holders of
          voting securities of the Parent hold less than 50% of the Capital
          Stock, calculated on a fully diluted basis, of the resulting
          corporation entitled to vote in the election of directors;

               (d) a sale, transfer or other disposition of 30% or more of the
          assets of the Loan Parties, on a consolidated basis, other than in the
          ordinary course of business;

               (e) any sale or issuance or series of sales or issuances of the
          Common Stock or any other voting security (or security convertible
          into, exchangeable for, or exercisable for any other voting security)
          of the Parent within a 12-month period that results in a transfer of
          more than 50% of the issued and outstanding shares of voting stock of
          the Parent or a transfer of more than 50% of the voting power of the
          Parent;

               (f) the initial public offer of securities by any Loan Party
          (other than the Parent) other than an offering of securities for an
          employee benefit plan on SEC Form S-8 or a successor form;

               (g) any Loan Party ceases to directly own and control 100% of the
          outstanding Capital Stock of each of its Subsidiaries (other than as a
          result of the merger of two Loan Parties);

               (h) a majority of the members of the Parent's Board of Directors
          do not constitute Continuing Directors;

               (i) Galen Associates at any time ceases to be the record owner of
          at least 66 2/3% of the voting stock, securities and other equity or
          ownership interests of the Parent owned by Galen Associates as of the
          date hereof; and/or

                                       -3-

<PAGE>

               (j) any "change in/of control" or "sale" or "disposition" or
          similar event as defined in any document governing Indebtedness of any
          Loan Party which gives the holder of such indebtedness the right to
          accelerate or otherwise require payment of such Indebtedness prior to
          the maturity date thereof.

         "Charter Documents" means the Articles of Incorporation, Certificate of
Incorporation, certificate of limited partnership, certificate of limited
liability company, charter or analogous organic instrument filed with the
appropriate Governmental Authorities of each of the Loan Parties, as applicable,
including all amendments and supplements thereto.

         "Closing" means the closing of the purchase and sale of the Securities
pursuant to this Agreement.

         "Closing Date" means the date and time for delivery and payment of the
Securities as finally determined pursuant to Section 2.4 hereof.

         "Code" means the Internal Revenue Code of 1986, as amended.

         "Collateral" means, collectively and individually, all collateral
and/or security granted, and/or securities pledged, to the Agent, for the
benefit of the Agent and the Purchasers, by the Loan Parties pursuant to the
Purchase Documents and Security Documents.

         "Commitment Fee" means a fee in an amount equal to $540,000 payable by
the Loan Parties to the Purchaser in consideration of the structuring of the
financing contemplated hereby.

         "Common Stock" means the common stock, $0.001 par value, of the Parent.

         "Condition" means any condition that results in or otherwise relates to
any Environmental Liabilities.

         "Continuing  Director"  means any member of the Board of Director of
the Parent who is a director of the Parent on the Closing Date.

         "Convertible Notes" has the meaning set forth in Section 2.1 hereof.

         "Copyright Security Agreement" means any Copyright Security Agreement,
dated as of any subsequent date, executed and delivered by a Loan Party to the
Agent, for the benefit of the Agent and the Purchasers, to evidence and perfect
the Agent's security interest in such Loan Party's present and future copyrights
and related licenses and rights, as such agreement may be amended, restated, or
otherwise modified from time to time.

         "Corporate Restructuring" means (a) the creation of Encore GP and
Encore Asset Corporation as Wholly-Owned Subsidiaries of the Parent, (b) the
transfer of (i) ninety-nine percent (99%) of the Capital Stock of Encore
Orthopedics, Inc. owned by the Parent to Encore Asset Corporation and (ii) one
percent (1%) of the Capital Stock of Encore Orthopedics, Inc. owned by the
Parent to Encore GP, and (c) the conversion of Encore Orthopedics, Inc., a
Delaware corporation, to Encore Limited.

                                       -4-

<PAGE>

         "Covered Financing" means the issuance of any Indebtedness of any Loan
Party for borrowed money. "Covered Financing" shall exclude any financing the
sole purpose of which is to refinance, repay or redeem the Notes, any financing
provided by the seller as part of an acquisition permitted hereby, any
Capitalized Leases permitted hereby and any loans from one Loan Party to another
Loan Party.

         "Debt to EBITDA Ratio" means, at any date of determination, for the
Loan Parties on a consolidated basis, the ratio of (i) Total Debt on such date,
to (ii) the EBITDA for the Measurement Period ending on such date (taken as one
accounting period).

         "Default" means any event or condition that, but for the giving of
notice or the lapse of time, or both, would constitute an Event of Default.

         "Disqualified Stock" means, with respect to any Person, any Capital
Stock which by its terms (or by the terms of any security into which it is
convertible or for which it is exchangeable) or upon the happening of any event
(i) matures or is mandatorily redeemable pursuant to a sinking fund obligation
or otherwise, (ii) is convertible or exchangeable for Indebtedness or
Disqualified Stock or (iii) is redeemable at the option of the holder thereof,
in whole or in part, in each case on or prior to the first anniversary of the
stated maturity of the Notes.

         "Distribution" has the meaning assigned to such term in Section 7.2(h)
hereof.

         "EBITDA" means for any period, without duplication, the total of the
following for the Loan Parties on a consolidated basis, each calculated for such
period: Net Income plus (i) Interest Expense, (ii) taxes on income, (iii)
depreciation expense, (iv) amortization expense, (v) in each case as acceptable
to the Agent, all other non-cash, non-recurring charges and expenses excluding
accruals for cash expenses made in the ordinary course of business, and (vi)
gain or loss from any sale of assets other than sales in the ordinary course of
business, all of the foregoing determined in accordance with GAAP; provided,
that, for purposes of determining compliance with Section 7.3 for each fiscal
quarter ending prior to the expiration of four fiscal quarters after the Closing
Date, EBITDA for each fiscal quarter ending prior to the Closing Date shall be
the amount as set forth on Schedule 1.2 hereto. For purposes of calculating
                           ------------
EBITDA with respect to any Measurement Period, (A) acquisitions that have been
made by such Person and its Subsidiaries, including through mergers or
consolidations and including any related financing transactions, during the
Measurement Period shall be deemed to have occurred on the first day of the
Measurement Period; provided, however, that only the actual historical results
of operations of the Persons so acquired, without adjustment for pro forma
expense savings or revenue increases, shall be used for such calculation; and
(B) for purposes of calculating Debt to EBITDA Ratio and Minimum EBITDA Ratio
only, the EBITDA of such Person and its Subsidiaries attributable to
discontinued operations, as determined in accordance with GAAP, and operations
or businesses disposed of prior to the end of such Measurement Period, shall be
excluded.

         "EBITDA to Interest Ratio" means , at any date of determination, for
the Loan Parties on a consolidated basis, the ratio of (i) EBITDA for the
Measurement Period ending on such date, to (ii) the cash Interest Expense paid
during such Measurement Period (but not including the Commitment Fee or the
Arrangement Fee (as defined in the Agent's Letter as defined in the Senior
Credit Agreement) in each case taken as one accounting period.

                                       -5-

<PAGE>

         "Encore GP" means Encore Medical GP, Inc., a Nevada corporation, and
its successors and assigns.

         "Encore Limited" means Encore Medical, L.P., a Delaware limited
partnership, and its successors and assigns.

         "Encore Asset Corporation" means Encore Medical Asset Corporation, a
Nevada corporation, and its successors and assigns.

         "Environmental Laws" means any Laws which address, are related to or
are otherwise concerned with environmental, health or safety issues, including
any Laws relating to any emissions, releases or discharges of Pollutants into
ambient air, surface water, ground water or land, or otherwise relating to the
manufacture, processing, distribution, use, treatment, storage, disposal,
transport, handling, clean-up or control of Pollutants or any exposure or impact
on worker health and safety.

         "Environmental Liabilities" means any costs, obligations or liabilities
(including any claims, suits or other assertions of obligations or liabilities)
that are:

                (a)  related to environmental, health or safety issues
          (including on-site or off-site contamination by Pollutants of surface
          or subsurface soil or water, and occupational safety and health); and

                (b)  based upon or related to (i) any provision of past, present
          or future United States or foreign Environmental Law (including CERCLA
          and RCRA) or common law, or (ii) any judgment, order, writ, decree,
          permit or injunction imposed by any court, administrative agency,
          tribunal or otherwise.

          The term "Environmental Liabilities" includes: (i) fines, penalties,
judgments, awards, settlements, losses, damages (including foreseeable and
unforeseeable consequential damages), costs, fees (including attorneys' and
consultants' fees), expenses and disbursements; (ii) defense, investogatory and
other responses to any action of any Governmental Authorities or any
administrative or judicial action (including claims, notice letters, complaints,
and other assertions of liability); and (iii) financial responsibility for (1)
cleanup costs and injunctive relief, including any Removal, Remedial or other
Response actions, and natural resource damages, and (2) any other compliance or
remedial measures.

         "Environmental Lien" means a Lien in favor of any Governmental
Authority for (a) any liability under Environmental Laws or (b) damages arising
from, or costs incurred by such Governmental Authority in response to, a Release
or threatened Release of a Pollutant into the environment.

         "EPA" means the United States Environmental Protection Agency and any
governmental body or agency succeeding to the functions thereof.

         "Equipment" has the meaning specified in the Security Agreement.

                                       -6-

<PAGE>

         "ERISA" means the Employee Retirement Income Security Act of 1974, as
the same may from time to time be amended, and the rules and regulations of any
governmental agency or authority, as from time to time in effect, promulgated
thereunder.

         "ERISA Affiliate" means any Person required at any relevant time to be
aggregated with the Company or any of its Subsidiaries under Sections 414(b),
(c), (m) or (o) of the Code.

         "ERISA Event" means (a) a Reportable Event with respect to a Pension
Plan, (b) a withdrawal by a Loan Party or any ERISA Affiliate from a Pension
Plan subject to Section 4063 of ERISA during a plan year in which it was a
substantial employer (as defined in Section 4001(a)(2) of ERISA) or a cessation
of operations which is treated as such a withdrawal under Section 4062(e) of
ERISA, (c) a complete or partial withdrawal by a Loan Party or any ERISA
Affiliate from a Multiemployer Plan or notification that a Multiemployer Plan is
in reorganization or insolvent, (d) the filing of a notice of intent to
terminate, the treatment of a Plan amendment as a termination under Section 4041
or 4041A of ERISA, or the commencement of proceedings by the PBGC to terminate a
Pension Plan or the termination, insolvency, or reorganization of a
Multiemployer Plan, (e) the occurrence of an event or condition which might
reasonably be expected to constitute grounds under Section 4042 of ERISA for the
termination of, or the appointment of a trustee to administer, any Pension Plan
or Multiemployer Plan, or (f) the imposition of any liability under Title IV of
ERISA, other than for PBGC premiums due but not delinquent under Section 4007 of
ERISA, upon a Loan Party or any ERISA Affiliate.

         "Event of Default" means any of the events of default described in
Section 8.1 hereof.

         "Excess Cash Flow" shall mean, for any fiscal period of the Loan
Parties, on a consolidated basis, without duplication, the sum of the following
EBITDA for such period, plus (a) to the extent not added to Net Income in
arriving at EBITDA, an amount equal to the amount of depreciation expenses,
amortization expense (including the amortization of goodwill), accrued non-cash
Interest Expense and all other non-cash charges, plus (b) an amount equal to the
aggregate net cash proceeds of the sale, lease, transfer or other disposition of
assets by Loan Parties during such period to the extent not required to be
applied to mandatory prepayments or payments on the Notes, plus (c) an amount
equal to the net loss on the sale, lease, transfer or other disposition of
assets by the Loan Parties during such period to the extent deducted in arriving
at EBITDA, plus (d) other amounts of any tax refunds or credits received by the
Loan Parties during such period, minus (e) the amount equal to permitted Capital
Expenditures of the Loan Parties actually paid in cash incurred during such
period, minus (f) cash Interest Expense for such period, minus (g) an amount
equal to the sum of all regularly scheduled payments and optional and mandatory
prepayments of principal on Indebtedness of the Loan Parties (other than on the
Notes) actually made during such period to the extent permitted hereunder, minus
(h) any dividend or payment permitted under Section 7.2(h), minus (i) an amount
equal to the net gain on the sale, lease, transfer or other disposition of
assets by the Loan Parties during such period to the extent included in arriving
at EBITDA.

         "Fair Valuation" shall mean the determination of the value of the
consolidated assets of a Person on the basis of the amount which may be realized
by a willing seller within a reasonable time through collection or sale of such
assets at market value on a going concern basis to an

                                       -7-

<PAGE>

interested buyer who is willing to purchase under ordinary selling conditions in
an arm's length transaction.

         "FDA Laws" means the laws, rules and regulations of the United States
Food and Drug Administration that are applicable to the Loan Parties.

         "FDA Permits" means all permits, licenses and approvals that are
required under the FDA Laws for the operation of the Loan Parties' business.

         "FEIN" means Federal Employer Identification Number.

         "Financing Statements" means such financing statements and other
instruments as the Agent shall require in order to perfect and maintain the
continued perfection of the security interest created by the Security Documents,
each in form and substance satisfactory to the Agent.

         "Fiscal Quarter" or "fiscal quarter" means one of the four quarters,
consisting of a period of 4 weeks plus 4 weeks plus 5 weeks, in a Fiscal Year,
with the first Fiscal Quarter beginning on the first day of a Fiscal Year and
the last Fiscal Quarter ending on December 31 of such Fiscal Year.

         "Fiscal Year" or "fiscal year" means each twelve month period ending on
December 31 of each year.

         "Fixed Charge Coverage Ratio" shall mean, at any date of determination,
for the Loan Parties on a consolidated basis, the ratio of (i) EBITDA, less (a)
Capital Expenditures, and (b) the cash amount of taxes paid for the Measurement
Period ending on such date taken as one accounting period and (c) the cash
amount of Distributions paid by any Loan Party, to (ii) the sum of (a) the cash
amount of Interest Expense paid and (b) principal payments made or required to
be made on any and all Indebtedness of the Loan Parties (excluding principal
payments on the Revolving Loans (as defined in the Senior Credit Agreement in
effect on the date hereof)).

         "GAAP" has the meaning assigned to such term in Section 1.2 hereof.

         "Galen  Associates"  means,  collectively,  Galen Partners III, L.P.,
Galen Partners International III, L.P., Galen Employee Fund III, L.P., and, in
each case, its successors and assigns.

         "Galen Agreement" means the note purchase agreement among Galen
Associates, the Purchaser and the Holder, in form and substance satisfactory to
the Agent.

         "Governmental Authorities" means any federal, state, foreign or
municipal court or other governmental department, commission, board, bureau,
agency or instrumentality, governmental or quasi-governmental, domestic or
foreign.

         "Guarantor" means each entity that becomes a Guarantor under a Guaranty
Agreement.

         "Guaranty" means any guaranty of the payment or performance of any
Indebtedness or other obligation and any other arrangement whereby credit is
extended to one obligor on the basis

                                       -8-

<PAGE>

of any promise of another Person, whether that promise is expressed in terms of
an obligation to pay the Indebtedness of such obligor, or to purchase an
obligation owed by such obligor, or to purchase goods and services from such
obligor pursuant to a take-or-pay contract, or to maintain the capital, working
capital, solvency or general financial condition of such obligor, whether or not
any such arrangement is reflected on the balance sheet of such other Person,
firm or corporation, or referred to in a footnote thereto, but shall not include
endorsements of items for collection in the ordinary course of business. For the
purpose of all computations made under this Agreement, the amount of a Guaranty
in respect of any obligation shall be deemed to be equal to the maximum
aggregate amount of such obligation or, if the Guaranty is limited to less than
the full amount of such obligation, the maximum aggregate potential liability
under the terms of the Guaranty.

         "Guaranty Agreement(s)" means, collectively and individually (as
applicable), the Parent Guaranty Agreement and the Subsidiary Guaranty
Agreement.

         "Holder" shall mean the Person designated by a Purchaser to hold the
Warrant and to whom and in whose name the Warrant shall be issued at the
Closing.

         "Indebtedness" means, for any Person at the time of any determination,
without duplication, all obligations, contingent or otherwise, of such Person
that, in accordance with GAAP on a consolidated basis, should be classified upon
the balance sheet of such Person as indebtedness, but in any event including:
(i) all obligations for borrowed money, (ii) all obligations arising from
installment purchases of property or representing the deferred purchase price of
property or services in respect of which such Person is liable, contingently or
otherwise, as obligor or otherwise (other than trade payables and other current
liabilities incurred in the ordinary course of business on terms customary in
the trade), (iii) all obligations evidenced by notes, bonds, debentures,
acceptances or instruments, or arising out of letters of credit or bankers'
acceptances issued for such Person's account, (iv) all obligations, whether or
not assumed, secured by any Lien or payable out of the proceeds or production
from any property or assets now or hereafter owned or acquired by such Person in
an amount equal to the lesser of (a) such obligation and (b) the fair market
value of such property if such obligation had not been assumed, (v) all
obligations for which such Person is obligated pursuant to a Guaranty, (vi) the
capitalized portion of lease obligations under Capitalized Leases, (vii) all
obligations for which such Person is obligated pursuant to any Interest Rate
Protection Agreements or derivative agreements or arrangements, (viii) all
obligations of such Person upon which interest charges are customarily paid or
accrued, (ix) all obligations of such Person to purchase, redeem, retire,
defease or otherwise make any payment in respect of any Capital Stock in such
Person or any other Person; (x) all obligations of such Person, actual or
contingent, as an account party in respect of letters of credit or similar
facilities and bankers' acceptances; and (xi) all obligations of any partnership
or joint venture as to which such Person is or may become personally liable to
the extent such obligations are deemed to be liabilities under GAAP.

         "Interest Expense" shall mean, for any period, total interest expense
(including attributable to conditional sales contracts, Capitalized Leases and
other title retention agreements) in accordance with GAAP of the Loan Parties on
a consolidated basis with respect to all outstanding Indebtedness including PIK
Interest and capitalized interest, but excluding

                                       -9-

<PAGE>

commissions, discounts and other fees owed with respect to letters of credit and
bankers' acceptance financing and net costs under Interest Rate Protection
Agreements.

         "Interest Rate Protection Agreement" means any interest rate swap,
interest rate cap, interest rate collar or other interest rate hedging agreement
or arrangement.

         "Inventory" has the meaning specified in the Security Agreement.

         "Investment" as applied to any Person means the amount paid or agreed
to be paid or loaned, advanced or contributed to other Persons, and in any event
shall include (i) any direct or indirect purchase or other acquisition of any
notes, obligations, instruments, stock, securities or ownership interest
(including partnership interests and joint venture interests) and (ii) any
capital contribution, loan or extension of credit to any other Person.

         "Investment Property" has the meaning specified in the Security
Agreements.

         "Investor Rights Agreement" means an Investor Rights Agreement, in form
and substance satisfactory to the Agent, executed by the Holder and the Parent,
as the same may be amended, modified or supplemented from time to time in
accordance with the terms thereof.

         "IRS" means the Internal Revenue Service and any governmental body or
agency succeeding to the functions thereof.

         "Junior Subordination Agreement(s)" means, individually or
collectively, as the case may be, those certain Junior Subordination Agreements
dated as of the date hereof between the Agent and each Junior Lender, as the
same may be amended, restated, supplemented or otherwise modified from time to
time.

          "Junior Lender(s)" means, individually or collectively, as the case
may be, CF Holdings, Ltd., Wright Medical, Kimberly-Clark, Steve C. Roy, John D.
Hodgeman, Michael R. Rutkin, Mark J. Rutkin, David Strode and Ralph Renick, Jr.

         "Junior Notes" means the promissory notes of the Loan Parties to the
Junior Lenders in the aggregate original principal amount of $8,559,864.

         "Key Management" shall mean Jack Cahill, Paul Chapman, Kenneth W.
Davidson, Scott Klosterman and Harry L. Zimmerman.

         "Laws" means all U.S. and foreign federal, state or local statutes,
laws, rules, regulations, ordinances, codes, policies, rules of common law, and
the like of any Governmental Authority, now or hereafter in effect, including
any judicial or administrative interpretations thereof, and any judicial or
administrative orders, consents, decrees or judgments.

         "Lien" means any security interest, lien, pledge, bailment, mortgage,
hypothecation, deed of trust, conditional sales, Capitalized Lease and title
retention agreement (including any lease in the nature thereof), charge,
encumbrance or other similar arrangement or interest in real or personal
property, now owned or hereafter acquired, whether such interest is based on
common

                                       -10-

<PAGE>

law, statute or contract and in the case of any securities, any purchase option,
call or similar right of a third party with respect to such securities.

         "Life Insurance" has the meaning assigned to such term in Section
                                                                   -------
4.1(h) hereof.
------

         "Loan Parties" has the meaning set forth in the Preamble.

         "Manage" and "Management" means generation, production, handling,
distribution, processing, use, storage, treatment, operation, transportation,
recycling, reuse and/or disposal, as those terms are defined in CERCLA, RCRA and
other Environmental Laws (including as those terms are further defined,
construed, or otherwise used in rules, regulations, standards, guidelines and
publications issued pursuant to, or otherwise in implementation of, such
Environmental Laws).

         "Material Adverse Effect" or "Material Adverse Change" shall mean any
event, condition or circumstance or set of events, conditions or circumstances
or any change(s) which (i) has, had or could reasonably be expected to have any
material adverse effect upon or change in the validity or enforceability of any
Purchase Document, (ii) has been or could reasonably be expected to be material
and adverse to the value, condition, use or availability of any of the
Collateral and/or to the business, operations, prospects, properties, assets,
liabilities or condition of the Loan Parties, either individually or taken as a
whole, or (iii) has materially impaired or could reasonably be expected to
materially impair the ability of any Loan Party to perform the Obligations or to
consummate the transactions under the Purchase Documents executed by such Person
or the rights and remedies of Purchaser.

         "Measurement Date" has the meaning assigned to such term in Section 7.3
hereof.

         "Measurement Period" means the twelve month period ending on a
Measurement Date.

         "Mortgage" means and includes any mortgage, deed of trust, deed to
secure debt, assignment, or other instrument executed and delivered by any Loan
Party to or for the benefit of the Agent by which the Agent, for the benefit of
the Agent and the Purchasers, acquires a Lien on any Real Estate or a collateral
assignment of such Loan Party's interest under a lease of Real Estate, and any
amendment, modification, or supplement thereto.

         "Multiemployer Plan" means a multiemployer plan (within the meaning of
Section 3(37) of ERISA) that is maintained for the benefit of the employees of
the Loan Parties or any ERISA Affiliate.

         "Net Income" means, for any period, the net income (or loss) of the
Loan Parties on a consolidated basis for such period taken as a single
accounting period, after deduction of all expenses, taxes and other proper
charges (which charges include, without limitation, (i) the income (or loss) of
any Person in which any other Person (other than any Loan Party) has a joint
interest, except to the extent of the amount of dividends or other distributions
actually paid in cash to a Loan Party by such Person during such period, (ii)
the income (or loss) of any Person accrued prior to the date it becomes a Loan
Party or is merged into or consolidated with a Loan Party or that Person's
assets are acquired by a Loan Party, (iii) the income of any Subsidiary of

                                       -11-

<PAGE>

any Loan Party (that is not a Loan Party itself) to the extent that the
declaration or payment of dividends or similar distributions of that income by
that Subsidiary is not at the time permitted by operation of the terms of the
charter or any agreement, instrument, judgment, decree, order, statute, rule or
governmental regulation applicable to that Subsidiary, (iv) any gain arising
from any write-up on the book value of any asset, and (v) any gain arising from
the acquisition of debt or equity securities of any Loan Party or from
cancellation or forgiveness of Indebtedness of any Loan Party, all as determined
in accordance with GAAP).

         "Notes" has the meaning set forth in Section 2.1 hereof.

         "Obligations" means all loans, advances, debts, principal, interest
(including any interest that, but for the provisions of the Bankruptcy Code
would have accrued), contingent reimbursement obligations with respect to
outstanding letters of credit, premiums, liabilities, obligations, fees,
charges, costs, lease payments, guaranties, covenants, and duties of any kind
and description owing by any of the Loan Parties to the Purchaser pursuant to or
evidenced by the Purchase Documents and irrespective of whether for the payment
of money, whether direct or indirect, absolute or contingent, due or to become
due, now existing or hereafter arising, and including all interest not paid when
due and all expenses (including any fees or expenses that, but for the
provisions of the Bankruptcy Code, would have accrued) that any of the Loan
Parties are required to pay or reimburse by the Purchase Documents, by law, or
otherwise. Any reference in the Purchase Documents to the Obligations shall
include all amendments, changes, extensions, modifications, renewals,
replacements, substitutions, and supplements, thereto and thereof, as
applicable, both prior and subsequent to any insolvency proceeding.

         "Orderly Liquidation Value" means, with respect to Inventory or
Equipment of any Loan Party, the orderly liquidation value thereof as determined
in a manner acceptable to the Agent by an experienced and reputable appraiser
acceptable to the Agent, net of all costs of liquidation thereof.

         "Parent" has the meaning assigned to such term in the Preamble hereto.

         "Parent Guaranty Agreement" means the Guaranty Agreement executed by
the Parent in favor of the Purchasers, in form and substance satisfactory to the
Agent, as the same may be amended, restated, supplemented or otherwise modified
from time to time.

         "Parent Security Agreement" means the Security Agreement of even date
between the Parent and the Agent, for the benefit of the Agent and the
Purchasers, as such agreement may be amended, restated, or otherwise modified
from time to time.

         "Patent Security Agreement" means any Patent Security Agreement of even
date or any subsequent date, executed and delivered by a Loan Party to the
Agent, for the benefit of the Agent and the Purchasers, to evidence and perfect
the Agent's security interest in such Loan Party's present and future patents
and related licenses and rights, as such agreement may be amended, restated, or
otherwise modified from time to time.

                                       -12-

<PAGE>

         "PBGC" means the Pension Benefit Guaranty Corporation established
pursuant to Subtitle A of Title IV of ERISA, or any other governmental agency,
department or instrumentality succeeding to the functions thereof.

         "Pension Plan" means a pension plan (as defined in Section 3(2) of
ERISA) subject to Title IV of ERISA which any Loan Party or any ERISA Affiliate
sponsors, maintains, or to which it makes, is making, or is obligated to make
contributions, or in the case of a Multiemployer Plan has made contributions at
any time during the immediately preceding five (5) plan years.

         "Permit" shall mean collectively all licenses, leases, powers, permits,
franchises, certificates, authorizations, approvals and other rights.

         "Permitted Distribution" means any of the following Distributions,
provided, that no Default or Event of Default exists at the time of, or after
--------
giving effect to, any such Distribution: (a) any Distribution by a Loan Party to
a Loan Party, and (b) any conversion by the holders of the Series A Preferred
Stock issued by the Parent, pursuant to the Certificate of Designations,
Preferences and Limitations of Series A Preferred Stock of Encore Medical
Corporation filed on June 7, 2001, as amended on the date hereof (the
"Certificate of Designation"), to common stock of the Parent in accordance with
the terms of the Certificate of Designation.

         "Permitted Liens" has the meaning assigned to such term in Section
7.2(b) hereof.

         "Person" means any individual, partnership, limited partnership,
corporation, limited liability company, association, joint stock company, trust,
joint venture, unincorporated organization or governmental entity or department,
agency or political subdivision thereof.

         "PIK Interest" has the meaning assigned to such term in Section 3.1(b)
hereof and shall be considered interest for all purposes under the Purchase
Documents.

         "Plan" means any employee benefit plan (within the meaning of Section
3(3) of ERISA), other than a Multiemployer Plan, established or maintained by
any of the Loan Parties or any ERISA Affiliate.

         "Pollutant" shall include any "hazardous substance" and any "pollutant
or contaminant" as those terms are defined in CERCLA; any "hazardous waste" as
that term is defined in RCRA; and any "hazardous material" as that term is
defined in the Hazardous Materials Transportation Act (49 U.S.C.(S) 1801 et
                                                                         --
seq.), as amended (including as those terms are further defined, construed, or
---
otherwise used in rules, regulations, standards, guidelines and publications
issued pursuant to, or otherwise in implementation of, said Environmental Laws);
and including without limitation any petroleum product or byproduct, solvent,
flammable or explosive material, radioactive material, asbestos, polychlorinated
biphenyls (PCBs), dioxins, dibenzofurans, heavy metals, and radon gas; and
including any other substance or material that is reasonably determined to
present a threat, hazard or risk to human health or the environment.

         "Prime Rate" means the annual rate of interest as quoted from time to
time by Citibank, N.A. as its base rate, and if a range of rates is listed, the
highest such rate; provided that such rate is not necessarily the best rate
offered to Citibank's customers; provided further that should such

                                       -13-

<PAGE>

practice change or should the Agent be unable to determine such rate, the "Prime
Rate" shall be such other indication of the prevailing prime rate of interest as
may reasonably be chosen by the Agent; provided further, that each change in the
fluctuating interest rate shall take effect simultaneously with the
corresponding change in the Prime Rate.

         "Properties and Facilities" means all of the material assets and
properties used by or useful to the Loan Parties in the Business.

         "Proprietary Rights" means all patents, trademarks, trade names,
service marks, copyrights, inventions, production methods, licenses, formulas,
know-how and trade secrets, regardless of whether such are registered with any
Governmental Authorities, including applications therefor.

         "Purchase Documents" means this Agreement, the Notes, the Warrant, the
Investor Rights Agreement, the Subordination Agreement, the Junior Subordination
Agreements, the Life Insurance, and the Security Documents and all other
agreements, instruments and documents delivered in connection herewith or
therewith and/or contemplated hereby or thereby, including, without limitation,
each document listed or contemplated on a closing checklist of even date
herewith and all other agreements, instruments, documents and other written
matter now or hereafter executed by any Person in connection with any of the
Obligations, in each case as any or all of the foregoing may be supplemented,
modified or amended from time to time.

         "Purchaser(s)" means CapitalSource and, to the extent provided in
Section 6.2, any successor or assignee of all or any part of the Securities.

         "RCRA" means the Resource  Conservation and Recovery Act (42 U.S.C. (S)
6901 et seq.), as amended, and all rules, regulations, standards, guidelines,
     -- ---
and publications issued thereunder.

         "Real Estate" means, with respect to any Person, all of such Person's
now or hereafter owned or leased estates in real property, including, without
limitation, all fees, leaseholds, and future interests, together with all of
such Person's now or hereafter owned or leased interests in the improvements
thereon, the fixtures attached thereto, and the easements appurtenant thereto.

         "Release" means a release, spill, emission, leaking, pumping,
injection, deposit, disposal, discharge, dispersal, leaching, or migration of a
Pollutant into the indoor or outdoor environment or into or out of any Real
Estate or other property, including the movement of Pollutants through or in the
air, soil, surface water, groundwater, or Real Estate or other property.

         "Removal," "Remedial" and "Response" actions shall include the types of
activities covered by CERCLA, RCRA, and other comparable Environmental Laws, and
whether the activities are those which might be taken by a government entity or
those which a government entity or any other person might seek to require of
waste generators, handlers, distributors, processors, users, storers, treaters,
owners, operators, transporters, recyclers, reusers, disposers, or other persons
under "removal," "remedial," or other "response" actions.

                                       -14-

<PAGE>

         "Reportable Event" means any of the events which are reportable under
Section 4043 of ERISA and the regulations promulgated thereunder, other than an
occurrence for which the thirty (30) day notice contained in 29 C.F.R. (S)
2615.3(a) is waived.

         "Required Purchasers" means the Purchasers holding Notes representing
at least 51% of the aggregate principal amount outstanding under all of the
Notes.

         "SEC" means the Securities and Exchange Commission and any governmental
body or agency succeeding to the functions thereof.

         "Securities" has the meaning assigned to such term in Section 2.3.
                                                               -----------

         "Securities Act" means the Securities Act of 1933, as amended.

         "Securities Exchange Act" means the Securities Exchange Act of 1934, as
amended.

         "Security Agreements" means, collectively or individually (as
appropriate) the Parent Security Agreement and the Subsidiary Security
Agreement.

         "Security Documents" means the Security Agreements, the Mortgages, the
Guaranty Agreements, the Copyright Security Agreement, the Patent Security
Agreement, the Trademark Security Agreement, the Financing Statements, and all
other documents, instruments and other materials necessary to create or perfect
the security interests created or pursuant to this Agreement or any of the
Security Documents, as the same may be amended, restated, supplemented or
otherwise modified from time to time.

         "Senior Agent" means Bank of America, National Association, as agent
under the Senior Credit Agreement.

         "Senior Credit Agreement" means that certain Credit Agreement by and
among the Loan Parties, the Senior Agent and the Senior Lenders of even date, as
such may be amended or modified from time to time but only as and to the extent
permitted hereunder and under the Subordination Agreement.

         "Senior Debt" means any and all of the following, now or hereafter
existing or arising: (a) all principal of, and premium, if any, and interest on,
the Loans (as defined in the Senior Credit Agreement) (including, without
limitation, any interest accruing thereon at the legal rate after the
commencement of any bankruptcy proceeding and any additional interest that would
have accrued thereon but for the commencement of such proceeding), (b) all
reimbursement and other obligations under or in connection with any letter of
credit issued by any Senior Lender or any affiliate of Senior Lender, for the
benefit of the Loan Parties, or any of them (c) all obligations of any Loan
Party under or in respect of any interest rate exchange agreement, interest rate
swap agreement or other similar agreement entered into in respect of all or any
portion of the Senior Debt referred to in clause (a) above, (d) all other
                                          ----------
indebtedness, obligations and liabilities of any Loan Party to the Senior Agent
or any Senior Lender, the issuer of any letter of credit under the Senior Credit
Agreement or any other holder of any such indebtedness or obligations, whether
now existing or hereafter incurred or created, under or with respect to the
Senior Credit Agreement or any agreement executed and delivered in connection
therewith, (including, without

                                       -15-

<PAGE>

limitation, claims for indemnity or damages arising thereunder or with respect
thereto), (e) all indebtedness and obligations arising in connection with any
refinancings, replacements or increases of any of the foregoing, whether with
Senior Lenders, or any of them, and whether in the same, lesser or greater
amount, and (f) any amendments, modifications or refinancings of any of the
foregoing, provided, that: (i) the principal amount of the Senior Debt
           --------
(including the outstanding face amount of letters of credit but excluding "Bank
Products" as defined by the Senior Credit Agreement) may not exceed $33,000,000,
as reduced from time to time by all payments and prepayments of principal on the
Term Loans (as defined in the Senior Credit Agreement); and (ii) such
amendments, modifications or refinancings do not: (A) extend the final maturity
of the Term Loans beyond their maturity in effect on the date hereof, (B) extend
the final maturity of the Senior Debt to a date that is later than the date
which is 120 days prior to the end of the Term or (C) add any new financial
performance covenant.

         "Senior Financing" means, collectively, the secured revolving and term
loans of the Loan Parties made by Senior Lender pursuant to the Senior Credit
Agreement in an aggregate amount not to exceed $33,000,000.

         "Senior Lenders" shall mean the Lenders under and as defined in the
Senior Credit Agreement.

         "Solvent" means, when used with respect to any Person, that at the time
of determination: (a) the assets of such Person, at a fair valuation, are in
excess of the total amount of its debts (including contingent liabilities); (b)
the present fair saleable value of its assets is greater than its probable
liability on its existing debts as such debts become absolute and matured; (c)
it is then able and expects to be able to pay its debts (including contingent
debts and other commitments) as they mature; and (d) it has capital sufficient
to carry on its business as conducted and as proposed to be conducted. For
purposes of determining whether a Person is Solvent, the amount of any
contingent liability shall be computed as the amount that, in light of all the
facts and circumstances existing at such time, represents the amount that can
reasonably be expected to become an actual or matured liability.

         "Stock Pledge Agreement(s)" means, individually or collectively, as the
case may be, the Stock Pledge Agreement of even date, executed and delivered by
each Loan Party to the Agent, for the benefit of the Agent and the Purchasers,
to evidence and perfect the Agent's security interest in the Capital Stock of
certain of Subsidiaries held by the Loan Party.

         "Subordination Agreement" means that certain Intercreditor and
Subordination Agreement dated as of the date hereof between the Senior Agent,
the Loan Parties and the Purchaser, as the same may be amended, restated,
supplemented or otherwise modified from time to time.

         "Subsidiary" of any Person means any other Person of which the
outstanding Capital Stock possessing a majority of voting power in the election
of directors or managers (otherwise than as the result of a default) is owned or
controlled by such first Person directly or indirectly through Subsidiaries.

                                      -16-

<PAGE>

         "Subsidiary Guaranty Agreement" means the Guaranty Agreement executed
by each Subsidiary of the Parent in favor of the Purchasers in form and
substance satisfactory to the Agent, as the same may be amended, restated,
supplemented or otherwise modified from time to time.

         "Subsidiary Security Agreement" means the Security Agreement of even
date between the Loan Parties, other than the Parent, and the Agent, for the
benefit of the Agent and the Purchasers, as such agreement may be amended,
restated, or otherwise modified from time to time.

         "Term" shall mean the period commencing on the Closing Date and ending
on February 8, 2007 (i.e., the five year anniversary of the Closing Date).
                     ----

         "Total Debt" shall mean, at any date of determination, for Loan Parties
on a consolidated basis, the total Indebtedness on such date plus the aggregate
liquidation value of all Disqualified Stock of the Loan Parties.

         "Treasury Stock Method" has the meaning as defined in FAS 128 as
promulgated by the Financial Accounting Standards Board.

         "Trademark Security Agreement" means any Trademark Security Agreement
of even date or any subsequent date, executed and delivered by a Loan Party to
the Agent, for the benefit of the Agent and the Purchasers, to evidence and
perfect the Agent's security interest in such Loan Party's present and future
trademarks and related licenses and rights, as such agreement may be amended,
restated, or otherwise modified from time to time.

         "Transactions" means the incurrence of debt and the issuance of
securities in connection therewith and all other transactions contemplated by
the Purchase Documents, the Galen Agreement, the Acquisition Agreement and/or
the Senior Credit Agreement.

         "UCC" shall mean the Uniform Commercial Code as in effect in the State
of Maryland from time to time.

         "Underlying Securities" means (i) the securities issued or issuable
upon exercise of the Warrant, and (ii) any equity securities issued or issuable
with respect to the securities referred to in clause (i) above by way of stock
dividend or stock split or in connection with a combination of shares,
recapitalization, merger, consolidation or other reorganization.

         "Unfunded Pension Liability" means the excess of a Plan's benefit
liabilities under Section 4001(a)(16) of ERISA, over the current value of that
Plan's assets, determined in accordance with the assumptions used for funding
the Pension Plan pursuant to Section 412 of the Code for the applicable plan
year.

         "UST" means an underground storage tank, including as that term is
defined, construed and otherwise used in RCRA and in rules, regulations,
standards, guidelines and publications issued pursuant to RCRA and comparable
state and local laws.

         "Warrant" has the meaning assigned to such term in Section 2.2.
                                                            -----------

                                       -17-

<PAGE>

     1.2  Accounting Principles. The character or amount of any asset,
          ---------------------
liability, capital account or reserve and of any item of income or expense to be
determined, and any consolidation or other accounting computation to be made,
and the construction of any definition containing a financial term, pursuant to
this Agreement shall be determined or made in accordance with generally accepted
accounting principles in the United States of America consistently applied
("GAAP"), unless such principles are inconsistent with the express requirements
of this Agreement.

     1.3  Other Definitional Provisions; Construction. Whenever the context so
          -------------------------------------------
requires, neuter gender includes the masculine and feminine, the singular number
includes the plural and vice versa. The words "hereof" "herein" and "hereunder"
and words of similar import when used in this Agreement shall refer to this
Agreement as a whole and not in any particular provision of this agreement, and
references to section, article, annex, schedule, exhibit and like references are
references to this Agreement unless otherwise specified. A Default or Event of
Default shall "continue" or be "continuing" until such Default or Event of
Default has been cured or waived by the Agent. References in this Agreement to
any Persons shall include such Person's successors and permitted assigns. Other
terms contained in this Agreement (which are not otherwise specifically defined
herein) shall have meanings provided in Article 9 of the Maryland Uniform
Commercial Code on the date hereof to the extent the same are used or defined
therein.

                                   ARTICLE 2
                          ISSUE AND SALE OF SECURITIES

     2.1  Authorization and Issuance of the Note. Each of the Loan Parties has
          --------------------------------------
duly authorized the issuance and sale to the Purchaser of the Senior
Subordinated Notes of the Loan Parties in an aggregate principal amount of
$24,000,000 due at the end of the Term (unless required to be prepaid before
then pursuant to the terms of this Agreement), in form and substance
satisfactory to the Agent (collectively, including any notes issued in
substitution therefor or upon any division thereof pursuant to this Agreement or
otherwise, the "Notes"). The Loan Parties shall initially issue four Notes in
denominations of $10,000,000, $8,000,000, $3,000,000 and $3,000,000. The Notes
shall be substantially in the form attached hereto as Exhibit A, provided that
                                                      ---------
only the two Notes issued in the original principal amounts of $3,000,000 (the
"Convertible Notes") shall contain the following provision:

          "10. Automatic Conversion. In the event that the Holder sells or
               --------------------
otherwise transfers the portion of this Note equal to the original principal
amount of this Note to Galen Associates pursuant to the terms of the Galen
Agreement, (a) this Note shall automatically be converted into the number of
shares of Series A Preferred Stock of the Parent determined by dividing the
principal amount of this Note so converted by the lesser of (i) $150 and (ii) 50
times the greater of $1 and the average of the closing prices of the Company's
Common Stock as quoted in the Nasdaq National Market or the principal exchange
on which the Common Stock is listed for 10 trading days prior to the date of
conversion, provided, however, that without the approval of the stockholders of
Parent, this Note shall not be convertible into shares of Series A Preferred
Stock representing more than nineteen and ninety-nine one hundredths percent
(19.99%) of the voting power of the Parent or nineteen and ninety-nine one
hundredths percent (19.99%) of the outstanding Common Stock of the Parent, and
(b) the Company shall

                                      -18-

<PAGE>

immediately issue to the Holder a new Note in an original principal amount equal
to all PIK Interest and all accrued and unpaid interest to the date of
conversion that is unpaid on this Note. The conversion of this Note shall be
effective automatically, without any further action by the Holder or Galen
Associates and whether or not this Note is surrendered to the Parent; provided
that the Parent shall not be obligated to issue to Galen Associates certificates
evidencing shares of Series A Preferred Stock issuable upon such conversion
unless this Note is delivered to the Parent. From and after the date of
conversion, this Note shall be deemed to have been paid in full and shall be
canceled."

          The Loan Parties hereby acknowledge the convertible nature of the
Convertible Notes. The Parent has duly authorized the issuance of Series A
Preferred Stock upon conversion of each Convertible Note pursuant to its terms
and shall at all times reserve and keep available out of its authorized but
unissued shares of Series A Preferred Stock, solely for the purpose of issuance
upon the conversion of any Convertible Notes, such number of shares of Series A
Preferred Stock issuable upon the conversion of all outstanding Convertible
Notes.

          2.2  Authorization and Issuance of Warrant. The Parent has duly
               -------------------------------------
authorized the issuance and sale to the Holder of a stock purchase warrant in
form and substance satisfactory to the Agent (collectively, including any
warrant issued in substitution therefor or upon any partial exercise thereof
pursuant to this Agreement, the Warrant or otherwise, the "Warrant") evidencing
Holder's right to acquire up to an aggregate 2,198,614 shares of Common Stock of
Parent.

          2.3  Sale and Purchase. Subject to the terms and conditions and in
               -----------------
reliance upon the representations, warranties and agreements set forth herein,
(i) the Parent shall sell to the Purchaser, and the Purchaser shall purchase
from Parent, the Notes, and (ii) the Parent shall issue the Warrant to the
Holder. The Notes, Warrant and Shares (as defined in the Warrant) are sometimes
referred to herein collectively as the "Securities." Under both GAAP
consistently applied and the regulations of the IRS, the issuance to the
Purchaser and the Holder of the Notes and Warrant, respectively, for an
aggregate purchase price equal to the aggregate principal amount of the Notes
being so purchased results in the creation of "original issue discount" on such
Notes (which original issue discount may also be deemed to constitute the value
of any Warrant issued in connection with the issuance of such Notes), and such
regulations require the determination of the value of any warrant so delivered.
Pursuant to GAAP consistently applied and applicable Treasury Regulations,
Purchaser and the Loan Parties agree to allocate $21,115,500 of the purchase
price to the Notes and the remaining $2,884,500 of the purchase price to the
Warrant and that such allocation reflects the relative fair market values of the
Notes and the Warrant as of their issue date. As a result, the Notes will be
issued with an aggregate original issue discount of $2,884,500. The Purchaser
and the Loan Parties agree to recognize and adhere to the determinations and
allocations of original issue discount and valuation of the Warrant set forth
herein for all federal and state income tax purposes. In the event of any
proposed transfer of a Note by a Purchaser, such Purchaser shall, prior to such
transfer, mark such Note with a legend pertaining to the original issue discount
in the form required by Treasury Regulation Section 1.1275-3(b)(1).

          2.4  The Closing.  Delivery of and payment for the Securities (the
               -----------
"Closing") shall be made at the offices of Piper Marbury Rudnick & Wolfe LLP in
Baltimore, Maryland and on such date as may be mutually agreeable to the Loan
Parties and the Purchaser. The date and time of

                                      -19-

<PAGE>

the Closing as finally determined pursuant to this Section 2.4 are referred to
herein as the "Closing Date." Delivery of the Securities shall be made to the
Purchaser and the Holder, as applicable, against payment of $24,000,000 less the
Commitment Fee and any other amounts payable pursuant to Section 4.1(i) hereof,
by wire transfer of immediately available funds in the manner agreed to by the
Parent and the Purchaser. Each Note shall be issued in the name of the Purchaser
and the Warrant shall be issued in the name of the Holder, or in each case, in
such other name or names and in such permitted denomination or denominations as
the Purchaser may request in writing not less than two (2) Business Days before
the Closing Date.

                                   ARTICLE 3
                              REPAYMENT OF THE NOTE

          3.1  Interest Rates and Interest Payments
               ------------------------------------

                    (a)   Interest. The Loan Parties, jointly and severally,
                          --------
               covenant and agree to make payments to each Purchaser of accrued
               interest on the Note held by such Purchaser on the first Business
               Day of each month commencing on March 1, 2002. The Notes will
               bear interest on the outstanding principal amount thereof at a
               rate equal to the greater of (i) thirteen percent (13%), and (ii)
               the Prime Rate plus four percent (4.0%) subject to a maximum cap
               of fifteen percent (15.0%). Interest on the Notes will be
               computed on the basis of a year of 360 days, composed of twelve
               30-day months, and the actual number of days elapsed.

                    (b)   PIK Interest.  In addition to the interest payable
                          ------------
               pursuant to Section 3.1(a), the Loan Parties, jointly and
                           --------------
               severally, covenant and agree to pay interest payable-in-kind
               ("PIK Interest") on the outstanding balance of each Note at a
               rate equal to two and three-fourths percent (2.75%) per annum.
               Such PIK Interest shall accrue and be added to the principal
               outstanding balance of such Note on a monthly basis and shall be
               due and payable upon the earlier of (i) the Loan Parties' early
               prepayment, redemption or termination of such Note or, (ii) the
               Purchaser's demand or acceleration pursuant hereto upon the
               occurrence of an Event of Default, including (without limitation)
               any Change of Control, or (iii) the end of the Term. PIK Interest
               on each Note will be computed on the basis of a year of 360 days,
               composed of twelve 30-day months, and the actual number of days
               elapsed.

          3.2  Repayment of the Notes. The Loan Parties, jointly and severally,
               ----------------------
covenant and agree to repay to each Purchaser the unpaid principal balance of
the Note held by such Purchaser in full, together with all accrued and unpaid
interest, PIK Interest, fees and other amounts and Obligations due under the
Purchase Documents on the last day of the Term or upon demand or acceleration
pursuant to this Agreement.

          3.3  Optional Prepayment of Note.
               ---------------------------

                    (a)   Notwithstanding any other provision of any Purchase
               Document but subject to Section 3.5 hereof, the Loan Parties may
               not prepay any Note prior to

                                       -20-

<PAGE>

               August 8, 2002. Subject to the terms of this Section 3.3, the
               Loan Parties may prepay to the Purchasers the outstanding
               principal amount of the Notes in full, together with all accrued
               and unpaid interest, PIK Interest, fees and other amounts and
               Obligations due under the Purchase Documents, plus the following
               applicable prepayment fees, expressed as a percentage of any
               principal being prepaid:

<TABLE>
<CAPTION>
      -----------------------------------------------------------------------------------------------
          If Prepaid During the Following Periods:                       Prepayment Fee
          ---------------------------------------                        --------------
      <S>                                                     <C>
      -----------------------------------------------------------------------------------------------
      For any prepayment on or after August 8, 2002                          7.5%
      and before February 8, 2003
      -----------------------------------------------------------------------------------------------
      For any prepayment on or after February 8, 2003                        5.0%
      and before February 8, 2004
      -----------------------------------------------------------------------------------------------
      For any prepayment on or after February 8, 2004                        3.0%
      and before February 8, 2005
      -----------------------------------------------------------------------------------------------
      For any prepayment on or after February 8 2005                         No premium
      -----------------------------------------------------------------------------------------------
</TABLE>

                  (b)  With respect to the Convertible Notes,

                       (i)   In the event that EBITDA for the Measurement Period
               ending on the last day of the first Fiscal Quarter of Fiscal Year
               2003 is less than or equal to $17,500,000 but greater than
               $16,500,000, the Loan Parties may prepay to the Purchasers at any
               time prior to August 15, 2003 up to $3,000,000 of the outstanding
               principal amount of the Convertible Notes, together with all
               accrued and unpaid interest, PIK Interest, fees and other amounts
               and Obligations due under the Purchase Documents.

                       (ii)  In the event that EBITDA for the Measurement Period
               ending on the last day of the first Fiscal Quarter of Fiscal Year
               2003 is less than $16,500,000, the Loan Parties may prepay to the
               Purchasers at any time prior to August 15, 2003 up to $6,000,000
               of the outstanding principal amount of the Convertible Notes,
               together with all accrued and unpaid interest, PIK Interest, fees
               and other amounts and Obligations due under the Purchase
               Documents.

                       (iii) In the event of the occurrence of an Event of
               Default pursuant to Section 8.1(a) or pursuant to Section 8.1(d)
               with respect to a breach of the covenants set forth in Section
               7.3, the Loan Parties may prepay to the Purchasers at any time
               prior to the date 90 days after the date of such Event of Default
               up to $6,000,000 of the outstanding principal amount of the
               Convertible Notes, together with all accrued and unpaid interest,
               PIK Interest, fees and other amounts and Obligations due under
               the Purchase Documents.

                                       -21-

<PAGE>

                        (iv)  For purposes of calculating EBITDA under this
              Section 3.3(b), the last sentence of the definition of "EBITDA"
              under Section 1.1 shall be of no force and effect (except as to
              the Acquisition).

                        (v)   The prepayment fees otherwise calculated pursuant
              to this  Section 3.3 shall not be due and payable upon any
              prepayment permitted by this Section 3.3(b).

                  (c)   All such prepayments shall be applied to the outstanding
              principal in the inverse order of maturity after application of
              such prepayment to any accrued interest and prepayment premium
              payable in connection therewith. Notwithstanding any provision to
              the contrary, the prepayment fees calculated pursuant to this
              Section 3.3 shall be due and payable upon any voluntary or
              mandatory prepayment of the Notes (other than a voluntary
              prepayment under Section 3.3(b) and a mandatory prepayment
              pursuant to Section 3.5(a)) and upon acceleration as set forth in
              Section 8.2 hereof.

        3.4   Notice of Optional Prepayment. If the Loan Parties elect to prepay
              -----------------------------
the Notes pursuant to Section 3.3 hereof, the Loan Parties shall give notice of
such prepayment to the Agent and the Purchasers not less than thirty (30) days
or more than ninety (90) days prior to the date fixed for prepayment, specifying
(a) the date on which such prepayment is to be made, (b) the total amount of the
Obligations to be prepaid on such date, and (c) the premium, if any, and accrued
interest (including PIK Interest) applicable to the prepayment. Such notice
shall be accompanied by a certificate of the Chairman of the Board of Directors,
the President or the Vice President and of the Treasurer of the Parent that such
prepayment is being made in compliance with Section 3.3. Notice of prepayment
having been so given, the aggregate principal amount of the Notes, together with
all accrued interest (including PIK Interest) and premium, if any, thereon and
all other Obligations, shall become due and payable on the prepayment date set
forth in such notice. Any offer made by the Loan Parties pursuant to Section 3.3
shall be irrevocable after delivery of notice as set forth in this Section 3.4.

        3.5   Mandatory Prepayment.
              --------------------

                  (a)    Commencing  for the Fiscal  Year in which the Term
              Loans (as defined in the Senior Credit Agreement) in effect on
              the date hereof are paid in full, the Loan Parties shall prepay
              the Notes in an amount equal to fifty percent (50.0%) of Excess
              Cash Flow (as determined by the Loan Parties' audited annual
              financial statements) for each Fiscal Year payable within ten
              (10) days of the completion of the annual audited financial
              statements referred to in and required by Section 7.1(e)(i) for
              such fiscal year which shall be applied to the outstanding
              principal balance of the Notes on a pro rata basis in the inverse
              order of maturity. In the event that the financial statements are
              not so delivered within one hundred (100) days of the fiscal year
              end, then a calculation based upon estimated amounts shall be
              made by the Agent upon which calculation the Loan Parties shall
              make the prepayment required by this Section 3.5(a) within ten
              (10) days of receipt of such calculation, subject to adjustment
              when such financial statements are delivered to the Agent and the
              Purchasers as required hereby. The calculation made by the

                                       -22-

<PAGE>

               Agent shall not be deemed a waiver of any rights the Agent or the
               Purchasers may have as a result of the failure by the Loan
               Parties to deliver such financial statements. Notwithstanding any
               provision to the contrary, the prepayment fees otherwise
               calculated pursuant to Section 3.3 shall not be due and payable
               upon any prepayment permitted by this Section 3.5(a).

                    (b)   If any Loan Party incurs any Indebtedness except for
               Permitted Indebtedness or receives payments of insurance proceeds
               (other than proceeds used to repair or replace fixed assets of a
               Loan Party as permitted under the Senior Credit Agreement), then
               it shall apply 100% of the proceeds thereof to the prepayment of
               (i) the Senior Debt to the extent provided in the Senior Credit
               Agreement or (ii) the Obligations on a pro rata basis in the
               following order and manner: first, to the payment of any and all
               unpaid charges, expenses and fees under the Purchase Documents,
               then to any unpaid interest (including PIK Interest) on the
               Notes, and then to the unpaid principal balance owed under the
               Purchase Documents, together with all prepayment fees in
               accordance with Section 3.3, such payment to be applied at such
               time as the Agent shall decide in its sole discretion. If any
               Loan Party receives any payment of proceeds under the Life
               Insurance, then it shall apply 100% of the proceeds thereof to
               the prepayment of the Obligations on a pro rata basis in the
               following order and manner: first, to the payment of any and all
               unpaid charges, expenses and fees under the Purchase Documents,
               then to any unpaid interest (including PIK Interest) on the
               Notes, and then to the unpaid principal balance owed under the
               Purchase Documents, such payment to be applied at such time as
               the Agent shall decide in its sole discretion;

        3.6    Home Office Payment. The Loan Parties will pay all sums becoming
               -------------------
due on the Notes for principal, premium, if any, and interest (including PIK
Interest) and all other Obligations to the Purchasers by the method and at the
address specified for such purpose in Annex A, or by such other method or at
such other address as each Purchaser shall have from time to time specified to
the Loan Parties in writing for such purpose, without the presentation or
surrender of such Notes or the making of any notation thereon, except that upon
written request of the Loan Parties made concurrently with or reasonably
promptly after indefeasible payment or prepayment in full of the Notes, the
Purchasers shall surrender such Notes for cancellation, reasonably promptly
after such request, to the Loan Parties at their principal executive office.
Unless indicated otherwise by any Purchaser in writing, all payments made by
Loan Parties shall be made only by wire transfer on the date when due, without
offset or counterclaim, in U.S. Dollars, in immediately available funds to such
account as may be indicated in writing by each Purchaser to the Loan Parties
from time to time. Any such payment received after 2:00 p.m., New York City
Time, on the date when due shall be deemed received on the following Business
Day.

        3.7    Taxes. Any and all payments by the Loan Parties hereunder or
               -----
under the Notes or Warrant or other Purchase Documents that are made to or for
the benefit of the Purchasers or the Holders shall be made free and clear of and
without deduction for any and all present or future taxes, levies, imposts,
deductions, charges or withholdings and penalties, interests and all other
liabilities with respect thereto (collectively, "Taxes"), excluding taxes
imposed on any Purchaser's or Holder's net income or capital and franchise taxes
imposed on any of them by the

                                       -23-

<PAGE>

jurisdiction under the laws of which any of them is organized or any political
subdivision thereof (all such nonexcluded Taxes being hereinafter referred to as
"Covered Taxes"). If any of the Loan Parties shall be required by law to deduct
any Covered Taxes from or in respect of any sum payable hereunder or under any
Note, Warrant or other Purchase Documents to any Purchaser or Holder, the sum
payable shall be increased as may be necessary so that after making all required
deductions of Covered Taxes (including deductions of Covered Taxes applicable to
additional sums payable under this paragraph), such Purchaser or Holder, as
applicable, receives an amount equal to the sum it would have received had no
such deductions been made. The Loan Parties shall make such deductions and the
Loan Parties shall pay the full amount so deducted to the relevant taxation
authority or other authority in accordance with applicable law. In addition, the
Loan Parties agree to pay any present or future stamp, documentary, excise,
privilege, intangible or similar levies that arise at any time or from time to
time from any payment made under any and all Purchase Documents or from the
execution or delivery by the Loan Parties or from the filing or recording or
maintenance of, or otherwise with respect to the exercise by Purchaser or Holder
of their respective rights under any and all Purchase Documents (collectively,
"Other Taxes"). The Loan Parties will indemnify each Purchaser and Holder for
the full amount of Covered Taxes imposed on or with respect to amounts payable
hereunder and Other Taxes, and any liability (including penalties, interest and
expenses) arising therefrom or with respect thereto. Payment of this
indemnification shall be made within thirty (30) days from the date any
Purchaser or Holder provides the Loan Parties with a certificate certifying and
setting forth in reasonable detail the calculation thereof as to the amount and
type of such Taxes. Any such certificates submitted by any Purchaser or Holder
in good faith to the Loan Parties shall, absent manifest error, be final,
conclusive and binding on all parties. The obligation of the Loan Parties under
this Section 3.7 shall survive the payment of the Notes, exercise of the Warrant
and the termination of this Agreement and any other Purchase Documents. Within
thirty (30) days after the Loan Parties having received a receipt for payment of
Covered Taxes and/or Other Taxes, the Loan Parties shall furnish to Purchaser,
the original or certified copy of a receipt evidencing payment thereof.

        3.8     Maximum Lawful Rate. This Agreement, the Notes and the other
                -------------------
Purchase Documents (other than the Warrant) are hereby limited by this Section
3.8. In no event, whether by reason of acceleration of the maturity of the
amounts due hereunder or otherwise, shall interest and fees contracted for,
charged, received, paid or agreed to be paid to the Purchasers under the Notes
and other Purchase Documents (other than the Warrant) exceed the maximum amount
permissible under such applicable law. If, from any circumstance whatsoever,
interest and fees would otherwise be payable to the Purchasers in excess of the
maximum amount permissible under such applicable law, the interest and fees
shall be reduced to the maximum amount permitted under applicable law. If from
any circumstance, any Purchaser shall have received anything of value deemed
interest by applicable law in excess of the maximum lawful amount, an amount
equal to any excess of interest shall be applied to the reduction of the
principal amount of the Notes, in such manner as may be determined by the Agent,
and not to the payment of fees or interest, or if such excessive interest
exceeds the unpaid balance of the principal amount of the Notes, such excess
shall be refunded to the Loan Parties.

        3.9    Capital Adequacy. If, after the date hereof, either the
               ----------------
introduction of or any change of the interpretation of any law or the compliance
by any Purchaser or Holder with any guideline or request from any Governmental
Authority (whether or not having the force of law) has or would have the effect
of reducing the rate of return on the capital or assets of such

                                       -24-

<PAGE>

Purchaser and/or Holder as a consequence of, as determined by such Purchaser or
Holder in its sole discretion, the existence of any Purchaser's or Holder's
obligations under this Agreement or any other Purchase Documents, then, upon
demand by such Purchaser or Holder, the Loan Parties immediately shall pay to
such Purchaser or Holder, as applicable, from the time as specified thereby,
additional amounts sufficient to compensate such Purchaser or Holder, as
applicable, in light of such circumstances. The obligations of the Loan Parties
under this Section 3.9 shall survive the payment of the Notes and other
Obligations, the exercise of the Warrant and the termination of this Agreement
and the other Purchase Documents.

        3.10  Certain Waivers. The Loan Parties unconditionally waive (a) any
              ---------------
rights to presentment, demand, protest or (except as expressly required hereby)
notice of any kind, and (b) any rights of rescission, setoff, counterclaim or
defense to payment under the Notes, Warrant, the Purchase Documents or otherwise
that the Loan Parties may have or claim against any Purchaser or Holder or any
prior Purchaser or Holder.

                                   ARTICLE 4
                                   CONDITIONS

        4.1   Conditions to Purchase of Securities. The obligations of the
              ------------------------------------
Purchaser to purchase and pay for the Securities and to consummate the
Transactions to which it is a party are subject to the satisfaction, prior to or
at the Closing, of the following conditions:

              (a)  Representations and Warranties True. The representations and
                   -----------------------------------
        warranties contained in Article 5 hereof shall be true and correct in
        all material respects at and as of the Closing Date as though then
        made, except to the extent of changes caused by the Transactions
        expressly contemplated herein.

              (b)  Material Adverse Change. There will have been no Material
                   -----------------------
        Adverse Effect or Material Adverse Change since December 31, 2000, and
        there shall be no liabilities or obligations of any nature which,
        individually or in the aggregate, would reasonably be likely to have a
        Material Adverse Effect.

              (c)  Purchase Documents. The Loan Parties shall have delivered to
                   ------------------
        the Agent all Purchase Documents (other than the Junior Subordination
        Agreements) to which they are a party, each duly executed by an
        authorized officer of such Person and the other parties thereto (other
        than the Purchaser), and the Galen Agreement, duly executed by an
        authorized officer of Galen Associates.

              (d)  No Liens. The Agent shall have received reports of filings
                   --------
        with appropriate government agencies showing that there are no Liens
        on the assets or securities of the Loan Parties other than Permitted
        Liens.

              (e)  Environmental Reports.  The Agent shall have received reports
                   ---------------------
        covering the Loan Parties' properties in form and substance satisfactory
        to the Agent regarding the Loan Parties' compliance with Environmental
        Laws.
                                       -25-

<PAGE>

          (f) Bailee and Landlord Waivers; Control Agreements. The Loan Parties
              -----------------------------------------------
     shall have delivered to the Agent, in each case duly executed by the
     appropriate parties and in form and substance satisfactory to the Agent,
     (i) a landlord's waiver and consent agreement for each leased property in
     the United States and Mexico, (ii) any consents and control agreements and
     other documentation the Agent determines in its sole discretion are
     necessary to perfect the Agent's Liens in any Inventory or other Collateral
     in the possession of any warehouseman and (iii) any control agreements and
     other documentation the Agent determines in its sole discretion are
     necessary to perfect the Agent's Liens in Investment Property (as defined
     in the Security Agreements) and any other Collateral.

          (g) Corporate Restructuring. The Corporate Restructuring shall have
              -----------------------
     occurred on terms acceptable to the Purchaser in its sole
     discretion.

          (h) Life Insurance. The Loan Parties shall have delivered to the Agent
              --------------
     a life insurance policy paid annually and issued by a carrier reasonably
     acceptable to the Agent insuring the life of Kenneth W. Davidson in the
     amount of $3,000,000, and, naming the Agent, for the benefit of the Agent
     and the Purchasers, as the sole beneficiary (collectively, the "Life
     Insurance"). As set forth in the Subordination Agreement, the Senior Lender
     shall have no rights in, and shall not be named as beneficiary, loss payee
     or additional insured on, the Life Insurance.

          (i) Closing Documents. The Loan Parties will have delivered or caused
              -----------------
     to be delivered to the Agent all of the following documents in form and
     substance satisfactory to the Agent:

              (i)   (A) one or more Notes (as designated by the Agent pursuant
     to Section 2.1) in aggregate original principal amount as set forth herein,
     and (B) one or more Warrants (as designated by the Agent pursuant to
     Section 2.2) evidencing the right to acquire the number of shares of Common
     Stock of the Parent set forth in Section 2.2, subject to adjustment from
     time to time in accordance with the terms thereof, in each case duly
     completed and executed by the Parent;

              (ii)  certificates of good standing dated not more than 10 days
          prior to the Closing Date for each of the Loan Parties issued by
          their respective jurisdictions of organization and each jurisdiction
          where they are qualified to operate as a foreign corporation, or its
          equivalent;

              (iii) a copy of the Charter Documents of each of the Loan Parties,
          certified by the appropriate governmental official of the
          jurisdiction of its organization as of a date not more than 10 days
          prior to the Closing Date;

              (iv)  a copy of the By-laws of each of the Loan Parties, certified
          as of the Closing Date by the secretary, assistant secretary, manager
          or general partner, as applicable, of each respective Loan Party;

                                       -26-

<PAGE>

                    (v)    a certificate of the secretary, assistant secretary,
               manager or general partner of each of the Loan Parties,
               certifying as to the names and true signatures of the officers or
               other authorized person of the respective Loan Party authorized
               to sign this Agreement and the other Purchase Documents to be
               delivered by the respective Loan Party;

                    (vi)   copies of the resolutions duly adopted by the each of
               the Loan Party's board of directors, general partners, board of
               managers or other governing body, authorizing the execution,
               delivery and performance by the respective Loan Party of this
               Agreement and the other Purchase Documents to which the
               respective Loan Party is a party and the consummation of all the
               Transactions, certified as of the Closing Date by the secretary,
               assistant secretary, manager or general partner of the respective
               Loan Party;

                    (vii)  a certificate dated as of the Closing Date from an
               officer, general partner or manager of each of the Loan Parties
               stating that the conditions specified in this Section 4.1 have
               been fully satisfied or waived by the Agent;

                    (viii) certificates of insurance evidencing the existence of
               all insurance required to be maintained by the Loan Parties
               pursuant to Section 7.1(c), and the Agent shall be satisfied with
               the type and extent of such coverage;

                    (ix)   one or more opinions of Jackson Walker LLP, counsel
               to the Loan Parties, in form and substance satisfactory to the
               Agent;

                    (x)    one or more opinions of Thelen Reid & Priest LLP,
               counsel to Galen Associates, in form and substance satisfactory
               to the Agent;

                    (xi)   copies of all material leases to which any of the
               Loan Parties is a party and all Permits required by each of the
               Loan Parties in the conduct of its business;

                    (xii)  a schedule detailing the sources and uses of the Loan
               Parties with respect to the proceeds of the Notes and the Senior
               Debt as of the Closing Date satisfactory to the Agent;

                    (xiii) such other documents relating to the Transactions
               contemplated by this Agreement as the Agent or its counsel may
               reasonably request.

               (j)  Purchaser's Fees and Expenses.
                    -----------------------------

                    (i)    Commitment  Fee: On the Closing Date,  the Loan
                           ---------------
               Parties shall pay the Commitment Fee to the Purchaser (and the
               Loan Parties hereby authorize the Purchaser to deduct from the
               aggregate proceeds from the sales of the Notes by the Loan
               Parties the unpaid amount of such Commitment Fee); and

                    (ii)   Other Fees and  Expenses.  On the Closing  Date,
                           ------------------------
               the Loan Parties shall have paid all other the fees, charges and
               expenses payable by the Loan

                                       -27-

<PAGE>

               Parties pursuant to the Purchase Documents on or prior to the
               Closing Date, including those payable pursuant to Section 10.4
               (and the Loan Parties hereby authorize the Purchaser to deduct
               from the aggregate proceeds of the sale of the Note all such
               amounts).

               (k)  Legal Investment. On the Closing Date, the issuance of
                    ----------------
          the Securities to the Purchaser and the Holder shall not be prohibited
          by any applicable Law of any Governmental Authority (including,
          without limitation, Regulations T, U or X of the Board of Governors of
          the Federal Reserve System) as a result of the promulgation or
          enactment thereof or any changes therein, or change in the
          interpretation thereof by any Governmental Authority, subsequent to
          the date of this Agreement.

               (l)  Proceedings. All proceedings taken or required to be taken
                    -----------
          in connection with the transactions contemplated hereby to be
          consummated at or prior to the Closing and all documents incident
          thereto will be satisfactory in form and substance to the Agent and
          its counsel.

               (m)  Audit. The Agent shall be satisfied, as determined in its
                    -----
          sole and absolute discretion, with the results of its background
          investigations of Key Management, financial and operational audit and
          its other diligence and examination of the Collateral and the books,
          records, business, obligations, financial condition and operational
          state of each Loan Party, and each Loan Party shall have demonstrated
          to the Agent's satisfaction that (i) its operations comply in all
          material respects with all applicable Laws, (ii) its operations are
          not the subject of any governmental investigation, evaluation or any
          remedial action which could result in any material expenditure or
          liability, and (iii) it has no material liability (whether contingent
          or otherwise);

               (n)  No Default. Each of the representations and warranties made
                    ----------
          by the Loan Parties in or pursuant to this Agreement and/or any other
          Purchase Document shall be accurate, no Default or Event of Default
          shall have occurred or be continuing or exist or result from the
          consummation of the Transactions.

               (o)  Availability. The Loan Parties shall have Availability (as
                    ------------
          defined in the Senior Credit Agreement) in an amount equal to or
          greater than $2,000,000 on the Closing Date after giving affect to the
          payment of (a) prior Indebtedness, (b) all fees payable to Purchaser
          under the terms of this Agreement and (c) all costs and expenses
          arising as a result of the Transactions contemplated by this
          Agreement, the Acquisition Agreement, the Galen Agreement, the Senior
          Credit Agreement and any other Purchase Document to which the Loan
          Parties are party, and the Agent shall have received satisfactory
          evidence thereof.

               (p)  Consents. All in form and substance satisfactory to the
                    --------
          Agent in its sole discretion, the Agent shall have received such
          consents, approvals and agreements from such third parties as are
          necessary or desirable with respect to (i) the Purchase Documents
          and/or the Transactions, and/or (ii) claims against any Loan Party or
          the Collateral. All corporate and other proceedings, documents,
          instruments and other legal matters in

                                       -28-

<PAGE>

          connection with the Transactions (including, but not limited to, those
          relating to corporate and capital structures of Loan Parties) shall be
          reasonably satisfactory to the Agent.

               (q)  Refinancings. The Agent shall have received evidence of (i)
                    ------------
          repayment in full and termination of Loan Parties' indebtedness to
          Wells Fargo Bank (Texas), National Association and Wachovia Bank, N.A.
          and all related documents, agreements and instruments and of all Liens
          and UCC financing statements relating thereto, including, without
          limitation, any Liens and/or UCC financing statements covering or
          relating to any assets or properties of any shareholder of any Loan
          Party, and (ii) release and termination of any and all Liens and/or
          the authority to file UCC termination statements in, on, against or
          with respect to any of the collateral securing the Obligations (other
          than Permitted Liens).

               (r)  Consummation of the Acquisition and Senior Financing. The
                    ----------------------------------------------------
          Acquisition and Senior Financing shall have been consummated
          simultaneously with the Transactions contemplated hereby, all in form
          and substance satisfactory to the Agent, in the Agent's sole
          discretion, by the execution, delivery, performance and recordation of
          the Acquisition Agreement and Senior Credit Agreement, respectively,
          and other definitive agreements, instruments, and documents related to
          the Acquisition Agreement and Senior Credit Agreement, respectively,
          and the Agent shall have been provided copies of all such agreements,
          instruments and documents delivered in connection therewith.

          4.2   Waiver. Any condition specified in Section 4.1 may be waived
                ------
by the Agent; provided that no such waiver will be effective against the Agent
or the Purchaser unless it is set forth in a writing executed by the Agent.

                                   ARTICLE 5
               REPRESENTATIONS AND WARRANTIES OF THE LOAN PARTIES

          5.1   Representations and Warranties of Loan Parties. As a material
                ----------------------------------------------
inducement to the Purchasers to enter into this Agreement and consummate the
Transactions, the Loan Parties, jointly and severally, hereby represent and
warrant to the Agent and the Purchasers as follows:

                (a)   Authorization, Validity, and Enforceability of this
                      ---------------------------------------------------
          Agreement and the other Loan Documents; No Conflicts. Each Loan Party
          ----------------------------------------------------
          has the power and authority to execute, deliver, and perform this
          Agreement and the other Purchase Documents to which it is a party, to
          incur the Obligations, and to grant to the Agent Liens upon the
          Collateral. Each Loan Party has taken all necessary action (including
          obtaining approval of its stockholders, partners, general partner(s),
          members, or other applicable equity owners, if necessary) to authorize
          its execution, delivery, and performance of this Agreement and the
          other Purchase Documents to which it is a party. This Agreement and
          the other Purchase Documents have been duly executed and delivered by
          each Loan Party, and constitute the legal, valid, and binding
          obligations of each Loan Party, enforceable against it in accordance
          with their respective terms without defense, setoff, or counterclaim,
          except as limited by applicable bankruptcy, insolvency,
          reorganization, moratorium, or similar laws at the time in effect
          affecting the rights of creditors generally and to the effect of
          general

                                       -29-

<PAGE>

          principles of equity whether applied by a court of law or equity. No
          Loan Party is a party to any judgment, order or decree or any
          agreement, document or instrument, or subject to any restriction,
          which would materially adversely affect its ability to execute and
          deliver, or perform under, any Purchase Document or to pay the
          Obligations. Each Loan Party's execution, delivery, and performance of
          this Agreement and the other Purchase Documents to which it is a party
          do not and will not conflict with, or constitute a violation or breach
          of, or constitute a default under, or result in or require the
          creation or imposition of any Lien upon the property of any Loan Party
          by reason of the terms of (a) any contract, mortgage, Lien, lease,
          agreement, indenture, document, or instrument (including, without
          limitation, the Senior Credit Agreement, the Acquisition Agreement, or
          any agreements entered into in connection therewith) to which such
          Loan Party is a party or which is binding upon it, (b) any requirement
          of the Laws applicable to such Loan Party, or (c) the Charter
          Documents of such Loan Party. The Loan Parties' entering into this
          Agreement and incurrence of the Obligations is not prohibited under
          the Senior Credit Agreement. The Corporate Restructuring has been
          consummated on or prior to the date hereof.

                (b)    Validity and Priority of Security Interest. The
                       ------------------------------------------
          provisions of this Agreement, the Mortgages, and the other Purchase
          Documents create legal and valid Liens on all the Collateral in favor
          of the Agent, for the benefit of the Agent and the Purchaser, and such
          Liens constitute perfected and continuing Liens on the Collateral,
          securing the Obligations, enforceable against the applicable Loan
          Party and all third parties, and having priority over all other Liens
          on the Collateral (a) except in the case of Liens described in Section
          7.2(b)(i), (b)(ii) and (b)(v) of the definition of Permitted Liens to
          the extent any such Liens would have priority over the Agent's Liens
          pursuant to any requirement of the Laws and (b) except for Liens in
          certificated vehicles, and Liens perfected only by possession to the
          extent the Agent have not obtained or do not maintain possession of
          such Collateral.

                (c)    Business; Corporate Name; Prior Transactions. The Loan
                       --------------------------------------------
          Parties are primarily engaged in the business of designing,
          manufacturing and marketing orthopedic implants, orthopedic soft
          goods, patient safety devices, pressure care products, joint and limb
          supports, braces and other orthopedic and rehabiliation products (the
          "Business"). Except as set forth on Schedule 5.1(c), no Loan Party
                                              ---------------
          has, during the past five (5) years, been known by or used any other
          corporate or fictitious name, or been a party to any merger or
          consolidation, or acquired all or substantially all of the assets of
          any Person, or acquired any of its property outside of the ordinary
          course of business. No Loan Party has ever been known by or used any
          of the following names: Encore Medical Products, Inc., Encore Medical
          Supply, Encore Medical, Inc. a Michigan corporation, Encore Medical
          Staffing, Encore Medical Systems, Inc., Encore Medical Systems, Ltd.,
          Encore Medical Technologies, Inc. and Encore Med Corp d/b/a Encore Med
          on Swan.

                (d)    Capitalization; Subsidiaries.
                       ----------------------------

                   (i)    Schedule 5.1(d) is a correct and  complete  list of
                          ---------------
the name and relationship to the Parent of each and all of the Parent's
Subsidiaries. Schedule 5.1(d) sets forth, as of the Closing Date, a true and
              ---------------
complete listing of each class of authorized Capital Stock of

                                       -30-

<PAGE>

each Subsidiary of the Parent, of which all of such issued shares are validly
issued, outstanding, fully paid and non-assessable, and (y) in the case of the
Capital Stock of each such Subsidiary, is owned beneficially and of record by
the Persons identified on Schedule 5.1(d) and (z) in the case of the Capital
                          ---------------
Stock of the Parent, each of the Persons owning, directly or indirectly,
beneficially and of record, five percent (5.0%) or more of the outstanding
Capital Stock of the Parent. The Capitalization Table included as part of
Schedule 5.1(d) is true and correct in all material respects.
---------------

                (ii)    The Parent and each of its Subsidiaries is duly
incorporated, formed, or organized and validly existing in good standing under
the laws of its state or other jurisdiction of incorporation, formation, or
organization set forth on Schedule 5.1(d). The location of the chief executive
                          ---------------
office of the Parent and each of its Subsidiaries is at the address set forth
with respect to each such Person on Schedule 5.1(d). The Parent and each of its
                                    ---------------
Subsidiaries is qualified to do business and in good standing (as applicable) in
each of the jurisdictions set forth on Schedule 5.1(d), as applicable, which are
                                       ---------------
the only jurisdictions in which qualification is necessary for it to own or
lease its property and conduct its business. The Parent and each of its
Subsidiaries has all requisite power and authority to conduct its business and
own its property.

                (iii)   As of the date hereof, the Warrant Shares constitute
eight and one-fourth percent (8.25%) of issued and outstanding Common Stock of
the Parent as calculated on an as-converted, fully diluted basis calculated
using the Treasury Stock Method. Except as set forth on Schedule 5.1(d), (A) as
                                                        ---------------
of the Closing Date, other than the Warrant, none of the Loan Parties will have
outstanding (y) any Capital Stock or other equity securities or securities
convertible or exchangeable for any shares of its Capital Stock or other equity
securities, or (z) any rights or options to subscribe for or to purchase its
Capital Stock or other equity securities or any stock or securities convertible
into or exchangeable for its Capital Sock or other equity securities; and (B) as
of the Closing Date, none of the Loan Parties will be subject to any obligation
(contingent or otherwise) to repurchase or otherwise acquire or retire any
shares of its Capital Stock, except as set forth herein or in the Warrant. All
of the outstanding shares of each Loan Party's Capital Stock are and will be
validly issued, fully paid and nonassessable. Upon issuance pursuant to the
terms of the Warrant, the Warrant Shares will be validly issued, fully paid and
nonassessable. None of the Loan Parties has violated any applicable federal or
state securities laws in connection with the offer, sale or issuance of any of
its Capital Stock, and the offer, sale and issuance of the Securities and the
Underlying Securities hereunder and under the Warrant do not require or are
exempt from registration under the Securities Act or any applicable state
securities Laws. Except as set forth on Schedule 5.1(d), there are no agreements
                                        ---------------
among any Loan Party's stockholders with respect to the voting or transfer of
Parent's Capital Stock. There are no statutory or contractual preemptive or
similar rights with respect to the issuance of the Warrant or the Warrant
Shares.

                (iv)    Except as set forth on Schedule 5.1(d), the Loan Parties
                                               ---------------
do not own, or hold any rights to acquire, any shares of stock or any other
security or interest in any other Person.

           (e)      Financial Statements and Projections.
                    ------------------------------------

                                       -31-

<PAGE>

                    (i)    The Parent has delivered to the Agent and the
Purchaser the audited balance sheet and related statements of income, retained
earnings, cash flow, and changes in stockholders' equity for the Parent and its
Subsidiaries as of December 31, 2000, and for the Fiscal Year then ended,
accompanied by the report thereon of the Parent's independent certified public
accountants, PriceWaterhouseCoopers, LLP and the unaudited balance sheet and
related statements of income and cash flow for the Parent and its Subsidiaries
as of December 31, 2001. The Parent has also delivered to the Agent and the
Purchaser the audited balance sheet and related statements of income, retained
earnings, cash flow, and changes in stockholders' equity for Chattanooga Group,
Inc. ("Chattanooga") and its Subsidiaries as of June 30, 2001, and for the
Fiscal Year then ended, accompanied by the report thereon of Chattanooga's
independent certified public accountants, Arthur Andersen LLP and the unaudited
balance sheet and related statements of income and cash flow for Chattanooga and
its Subsidiaries as of December 31, 2001 (as the case may be). All such
financial statements have been prepared in accordance with GAAP and fairly
present the financial position of the Parent and its Subsidiaries and
Chattanooga and its Subsidiaries, as applicable, as at the dates thereof and
their results of operations for the periods then ended (except with respect to
the financial statements dated December 31, 2001, for the absence of applicable
footnotes and subject to normal year-end adjustments).

                    (ii)   The projections of the Loan Parties' financial
condition, results of operations, and cash flows, in each case for the period
commencing on January 1, 2002 and ending on December 31, 2002, delivered to the
Agent prior to the Closing Date represent the Loan Parties' good faith estimate
of the future financial performance of the Loan Parties for the periods set
forth therein. Such projections have been prepared on the basis of the
assumptions set forth therein, which the Loan Parties believe are fair and
reasonable in light of current and reasonably foreseeable business conditions at
the time submitted to the Agent and the Purchaser.

                    (iii)  The pro forma balance sheet of the Parent dated
December 31, 2001, provided to the Agent and the Purchaser, fairly presents the
Parent's financial condition as at such date after giving effect to Transactions
as if such Transactions had occurred on such date and the Closing Date had been
such date, and has been prepared in accordance with GAAP.

                    (iv)   Accuracy of Financial Statements. The Loan Parties do
                           --------------------------------
not have any liabilities, contingent or otherwise, or forward or long-term
commitments that are not disclosed in the financial statements or in the notes
thereto, and except as disclosed therein there are no unrealized or anticipated
losses from any commitments of the Loan Parties which may cause a Material
Adverse Effect.

               (f)      Solvency. Each Loan Party is Solvent prior to and after
                        --------
          giving effect to the Transactions and shall remain Solvent during the
          term of this Agreement.

               (g)      Indebtedness. After giving effect to the Transactions,
                        ------------
          the Loan Parties have no Indebtedness, except (a) the Obligations, (b)
          Indebtedness described on Schedule 5.1(g), and (c) the Senior Debt.
                                    ---------------
          There has occurred no breach, default or event of default under any
          document evidencing any such Indebtedness or any fact, circumstance,
          condition or event which, with the giving of notice or passage of time
          or both, would constitute or result in a breach, default or event of
          default thereunder. Except to the extent set forth in the
          Subordination Agreement or as set forth on Schedule 5.1(g),
                                                     ---------------

                                       -32-

<PAGE>

          the Obligations are not subordinated in any way to any other
          obligations of any Loan Party or to the rights of any other Person.

               (h)  Distributions. As of the Closing Date, since December 31,
                    -------------
          2000, no Distribution has been declared, paid, or made upon or in
          respect of any Capital Stock of the Parent.

               (i)  Real Estate; Leases. As of the Closing Date, Schedule 5.1(i)
                    -------------------                          ---------------
          sets forth a correct and complete list of all Real Estate owned by
          each Loan Party, all leases and subleases of real or personal property
          by each Loan Party as lessee or sublessee (other than leases of
          personal property as to which it is lessee or sublessee for which the
          value of such personal property in the aggregate is less than
          $150,000), and all leases and subleases of real or personal property
          by each Loan Party as lessor, or sublessor. Each of such leases and
          subleases is valid and enforceable in accordance with its terms and is
          in full force and effect, and no material default by any party to any
          such lease or sublease exists. Each Loan Party has good and marketable
          title in fee simple to the Real Estate identified on Schedule 5.1(i)
                                                               ---------------
          as owned by such Loan Party, or valid leasehold interests in all Real
          Estate designated therein as "leased" by such Loan Party, and each
          Loan Party has good, indefeasible, and merchantable title to all of
          its other property reflected on the December 31, 2001 Financial
          Statements delivered to the Agent and the Purchaser, except as
          disposed of in the ordinary course of business since the date thereof,
          free of all Liens except Permitted Liens.

               (j)  Proprietary Rights. Schedule 5.1(j) sets forth a correct
                    ------------------  ---------------
          and complete list of all of each Loan Party's Proprietary Rights. None
          of the Proprietary Rights listed in Schedule 5.1(j) is subject to any
                                              ---------------
          licensing agreement or similar arrangement except as set forth on
          Schedule 5.1(j). The Proprietary Rights described on Schedule 5.1(j)
          ---------------                                      ---------------
          constitute all of the property of such type necessary to the current
          and anticipated future conduct of the Loan Parties' business. To the
          best of each Loan Party's knowledge, no slogan or other advertising
          device, product, process, method, substance, part, or other material
          now employed, or now contemplated to be employed, by any Loan Party
          infringes in any material respect upon any rights held by any other
          Person. No claim or litigation regarding any of the foregoing is, to
          the knowledge of any Loan Party, pending or threatened, and no patent,
          invention, device, application, principle or any statute, law, rule,
          regulation, standard, or code is pending or, to the knowledge of any
          Loan Party, proposed, which, in either case, could reasonably be
          expected to have a Material Adverse Effect.

               (k)  Trade Names. All trade names or styles under which any Loan
                    -----------
          Party will sell Inventory or create Accounts, or to which instruments
          in payment of Accounts may be made payable, are listed on Schedule
                                                                    --------
          5.1(k).
          ------

               (l)  Litigation. There is no pending, or to the best of any Loan
                    ----------
          Party's knowledge threatened, action, suit, proceeding, or
          counterclaim by any Person, or investigation by any Governmental
          Authority, or any basis for any of the foregoing, which could
          reasonably be expected to have a Material Adverse Effect.

                                       -33-

<PAGE>
               (m)      Labor Disputes. As of the Closing Date, (a) there is no
                        --------------
          collective bargaining agreement or other labor contract covering
          employees of any Loan Party, (b) no such collective bargaining
          agreement or other labor contract is scheduled to expire during the
          term of this Agreement, (c) no union or other labor organization is
          seeking to organize, or to be recognized as, a collective bargaining
          unit of employees of any Loan Party or for any similar purpose, and
          (d) there is no pending or (to the best of any Loan Party's knowledge)
          threatened, strike, work stoppage, material unfair labor practice
          claim, or other material labor dispute against or affecting any Loan
          Party or its employees.

               (n)      Environmental Laws.
                        ------------------

                   (i)     Each Loan Party has complied in all material respects
with all Environmental Laws and no Loan Party nor any of its presently or
previously owned Real Estate or presently conducted or prior operations, is
subject to any enforcement order from or liability agreement with any
Governmental Authority or private Person respecting (i) compliance with any
Environmental Law or (ii) any potential liabilities and costs or remedial action
arising from the Release or threatened Release of a Pollutant.

                   (ii)    Each Loan Party has obtained all permits necessary
for its current operations under Environmental Laws, and all such permits are in
good standing, and each Loan Party is in compliance with all material terms and
conditions of such permits.

                   (iii)   No Loan Party nor to the best of any Loan Party's
knowledge any of its predecessors in interest has in violation of any
Environmental Law stored, treated, or disposed of any hazardous waste (as
defined pursuant to 40 CFR Part 261 or any equivalent Environmental Law).

                   (iv)    No Loan Party has received any summons, complaint,
order, or similar written notice indicating that it is not currently in
compliance with, or that any Governmental Authority is investigating its
compliance with, any Environmental Laws or that it is or may be liable to any
other Person as a result of a Release or threatened Release of a Pollutant.

                   (v)     To the best of each Loan Party's knowledge, none of
the present or past operations of any Loan Party is the subject of any
investigation by any Governmental Authority evaluating whether any remedial
action is needed to respond to a Release or threatened Release of a Pollutant.

                   (vi)    There is not now, nor to the best of any Loan Party's
knowledge has there ever been, on or in the Real Estate of any Loan Party in
violation of Environmental Laws:

                           (a)     any underground storage tanks or surface
impoundments,

                           (b)     any asbestos-containing material, or

                                       -34-

<PAGE>

                               (c)   any polychlorinated biphenyls (PCBs) used
in hydraulic oils, electrical transformers, or other equipment.

                    (vii)      No Loan Party has filed any notice under any
requirement of Environmental Law reporting a spill or accidental and unpermitted
Release or discharge of a Pollutant into the environment.

                    (viii)     No Loan Party has entered into any negotiations
or settlement agreements with any Person (including the prior owner of its
property) imposing material obligations or liabilities on any Loan Party with
respect to any remedial action in response to the Release of a Pollutant or
environmentally related claim.

                    (ix)       None of the products manufactured, distributed,
or sold by any Loan Party contains asbestos containing material.

                    (x)        No Environmental Lien has attached to the Real
Estate of any Loan Party.

               (o)     No Violation of Law. No Loan Party is in violation of any
                       -------------------
          Law, statute, regulation, ordinance, judgment, order, or decree
          applicable to it, including which violation could reasonably be
          expected to have a Material Adverse Effect.

               (p)     No Default. No default, breach or noncompliance exists
                       ----------
          under or with respect to the Senior Credit Agreement or the
          Acquisition Agreement or any of the documents entered into in
          connection therewith. No Loan Party is in default with respect to any
          other note, indenture, loan agreement, mortgage, lease, deed, or other
          agreement to which such Loan Party is a party or by which it is bound,
          which default could reasonably be expected to have a Material Adverse
          Effect.

               (q)     ERISA Compliance.
                       ----------------

                    (i)   Each Plan is in compliance in all material respects
with the applicable provisions of ERISA, the Code, and other federal or state
law. Each Plan which is intended to qualify under Section 401(a) of the Code has
received a favorable determination letter from the IRS and to the best knowledge
of each Loan Party, nothing has occurred which would cause the loss of such
qualification. Each Loan Party and each ERISA Affiliate has made all required
contributions to any Plan subject to Section 412 of the Code, and no application
for a funding waiver or an extension of any amortization period pursuant to
Section 412 of the Code has been made with respect to any Plan.

                    (ii)  There are no pending or, to the best knowledge of any
Loan Party, threatened claims, actions, or lawsuits, or action by any
Governmental Authority, with respect to any Plan which has resulted or could
reasonably be expected to result in a Material Adverse Effect. There has been no
prohibited transaction or violation of the fiduciary responsibility rules with
respect to any Plan which has resulted or could reasonably be expected to result
in a Material Adverse Effect.

                                       -35-

<PAGE>

     (iii) Except for instances, if any, which together do not give rise to
liability in excess of $1,000,000 in the aggregate, (i) no ERISA Event has
occurred or is reasonably expected to occur, (ii) no Pension Plan has any
Unfunded Pension Liability, (iii) no Loan Party nor any ERISA Affiliate has
incurred, or reasonably expects to incur, any liability under Title IV of ERISA
with respect to any Pension Plan (other than premiums due and not delinquent
under Section 4007 of ERISA), (iv) no Loan Party nor any ERISA Affiliate has
incurred, or reasonably expects to incur, any liability (and no event has
occurred which, with the giving of notice under Section 4219 of ERISA, would
result in such liability) under Section 4201 or 4243 of ERISA with respect to a
Multiemployer Plan, and (v) no Loan Party nor any ERISA Affiliate has engaged in
a transaction that could be subject to Section 4069 or 4212(c) of ERISA.

          (r) Taxes. Each Loan Party has filed all federal and other tax returns
              -----
     and reports required to be filed (or appropriate extensions have been
     timely filed), and has paid all federal and other taxes, assessments, fees,
     and other governmental charges levied or imposed upon it or its properties,
     income, or assets otherwise due and payable unless such unpaid taxes and
     assessments would constitute a Permitted Lien.

          (s) Regulated Entities. No Loan Party nor any Person controlling any
              ------------------
     Loan Party is an "investment company" or a company "controlled" by an
     "investment company" within the meaning of the Investment Company Act of
     1940. No Loan Party is a "holding company" or a "subsidiary company" of a
     "holding company" or an "affiliate" of a "holding company" or a "public
     utility" within the meaning of the Public Utility Holding Company Act of
     1935, or a regulated entity under the Federal Power Act, the Interstate
     Commerce Act, any state public utilities code or law, or any other federal
     or state statute or regulation limiting its ability to incur indebtedness.

          (t) Use of Proceeds; Margin Regulations. The Loan Parties will use the
              -----------------------------------
     proceeds from the sale of the Securities to finance the Acquisition and to
     refinance in part certain outstanding Indebtedness of the Loan Parties,
     including Indebtedness to Wells Fargo Bank (Texas), National Association
     and Wachovia Bank, N.A No Loan Party is engaged in the business of buying
     or selling margin stock as such term is defined in Regulation T, U, or X of
     the Federal Reserve Board ("Margin Stock") or extending credit for the
     purpose of buying or carrying Margin Stock.

          (u) No Material Adverse Change. No Material Adverse Effect has
              --------------------------
     occurred since the latest date of the Financial Statements delivered to the
     Purchaser referenced in Section 5.1(e).
                             --------------

          (v) Full Disclosure. None of the representations or warranties made by
              ---------------
     any Loan Party in the Purchase Documents as of the date such
     representations and warranties are made or deemed made, and none of the
     statements contained in any exhibit, report, statement, or certificate
     furnished by or on behalf of any Loan Party in connection with the Purchase
     Documents (including the offering and disclosure materials delivered by or
     on behalf of any Loan Party to the Purchaser prior to the Closing Date),
     contains any untrue statement of a material fact or omits any material fact
     required to be stated therein or necessary to make the statements made
     therein, in light of the circumstances under which they are made, not
     misleading as of the time when made or delivered.

                                       -36-

<PAGE>

          (w) Material Agreements. As of the Closing Date, Schedule 5.1(w) sets
              -------------------                          ---------------
     forth all material agreements and contracts (other than the Purchase
     Documents) of any Loan Party which are required to be publicly disclosed
     pursuant to any requirement of the Laws since the date of the Parent's
     quarterly report for the fiscal quarter ended September 29, 2001. No Loan
     Party is in default in the performance, observance or fulfillment of any
     material obligation, covenant or condition contained in any agreement,
     document or instrument to which it is a party or to which any of its
     properties or assets are subject, which default, if not remedied within any
     applicable grace or cure period could reasonably be expected to have a
     Material Adverse Effect, nor is there any event, fact, condition or
     circumstance which, with notice or passage of time or both, would
     constitute or result in a conflict, breach, default or event of default
     under, any of the foregoing which, if not remedied within any applicable
     grace or cure period could reasonably be expected to have a Material
     Adverse Effect.

          (x) Bank Accounts. As of the Closing Date, Schedule 5.1(x) contains a
              -------------                          ---------------
     complete and accurate list of all bank accounts maintained by each Loan
     Party with any bank or other financial institution.

          (y) Governmental Authorization. No approval, consent, exemption,
              --------------------------
     authorization, or other action by, or notice to, or filing with, any
     Governmental Authority or other Person is necessary or required in
     connection with the execution, delivery, or performance by, or enforcement
     against, any Loan Party of this Agreement or any other Purchase Document
     except for those which have been duly obtained by the Loan Parties, copies
     of which have been provided to the Agent, and for filing of financing
     statements and the Mortgages.

          (z) Investment Property.
              -------------------

              (i) Schedule 5.1(z) sets forth a correct and complete list of all
                  ---------------
Investment Property owned by each Loan Party. Each Loan Party is the legal and
beneficial owner of such Investment Property, as so reflected, free and clear of
any Lien (other than Permitted Liens), and has not sold, granted any option with
respect to, assigned or transferred, or otherwise disposed of any of its rights
or interest therein.

              (ii) To the extent any Loan Party is the owner of or becomes the
issuer of any Investment Property that is Collateral (each such Person which
issues any such Investment Property being referred to herein as an "Issuer"):
                                                                    ------
(i) the Issuer's shareholders that are Loan Parties and the ownership interest
of each such shareholder are as set forth on Schedule 5.1(d), and each such
                                             ---------------
shareholder is the registered owner thereof on the books of the Issuer; (ii) the
Issuer acknowledges the Agent' Lien; (iii) to the extent required to perfect the
Agent' Liens, such security interest, collateral assignment, lien, and pledge in
favor of the Agent has been registered on the books of the Issuer for such
purpose as of the date hereof; and (iv) the Issuer is not aware of any liens,
restrictions, or adverse claims which exist on any such Investment Property
other than the Agent's Lien.

              (aa) Common Enterprise. The successful operation and condition of
                   -----------------
each Loan Party is dependent on the continued successful performance of the
functions of the

                                       -37-

<PAGE>

group of Loan Parties as a whole and the successful operation of each Loan Party
is dependent on the successful performance and operation of each other Loan
Party. Each Loan Party expects to derive benefit (and its board of directors or
other governing body has determined that it may reasonably be expected to derive
benefit), directly and indirectly, from successful operations of the Parent and
each of the other Loan Parties. Each Loan Party expects to derive benefit (and
the boards of directors or other governing body of each such Loan Party have
determined that it may reasonably be expected to derive benefit), directly and
indirectly, from the credit extended by the Purchaser to the Loan Parties
hereunder, both in their separate capacities and as members of the group of
companies. Each Loan Party has determined that execution, delivery, and
performance of this Agreement and any other Purchase Documents to be executed by
such Loan Party is within its purpose, will be of direct and indirect benefit to
such Loan Party, and is in its best interest.

     (bb) Senior Financing. The Senior Credit Agreement has been duly executed
          ----------------
and delivered by each party thereto and the transactions contemplated thereby
have been consummated to the extent contemplated thereunder pursuant to the
terms thereof, and the terms and conditions of the Senior Credit Agreement
constitute the valid and binding obligations of each party thereto, enforceable
in accordance with their terms.

     (cc) Acquisition Agreement. The Parent has delivered to the Agent true,
          ---------------------
complete and correct copies of the Acquisition Agreement and the other documents
related thereto. The Acquisition Agreement has not been amended, supplemented or
modified except as previously disclosed in writing to the Agent and, together
with the other documents related thereto, constitutes the complete understanding
between the Parent and the sellers thereunder in respect of the transactions
contemplated thereby. The Acquisition Agreement has been duly executed and
delivered by, and is a valid, legal and binding obligation of, the sellers
thereunder. The representations and warranties of the Parent contained in the
Acquisition Agreement are true and correct in all material respects on the
Closing Date as if made on and as of such date (except any thereof that are
specifically limited to a prior date). On and as of the Closing Date, the Parent
knows of no reason to believe that the representations and warranties of the
sellers under the Acquisition Agreement are not true and correct in all material
respects. The aggregate acquisition price (being total equity purchase price
plus total existing debt acquired less cash and cash equivalents acquired) paid
by the Parent pursuant to the terms of the Acquisition Agreement is not more
than $42,000,000. With the application of the proceeds of the Notes, together
with other funds of the Loan Parties, in accordance with the terms hereof, the
Acquisition has been consummated on the date hereof in accordance with the terms
of the Acquisition Agreement

     (dd) Side Agreements. Other than the Galen Agreement, neither the Loan
          ----------------
Parties nor any Affiliate of the Loan Parties nor any director, officer or
employee of the Loan Parties or any of their Affiliates, respectively, has
entered into, as of the date hereof, any side agreement, either oral or written,
with any individual or business, pursuant to which the director, officer,
employee, Loan Parties or Affiliate agreed to do anything beyond the
requirements of the formal, written contracts executed by the Loan Parties and
disclosed to Purchaser herein.

                                       -38-

<PAGE>

     (ee) Broker's or Finder's Commissions. Except as set forth on Schedule
          --------------------------------
5.1(ee), no broker's or finder's or placement fee or commission will be payable
to any broker or agent engaged by the Loan Parties or any of its officers,
directors or agents with respect to any of the Transactions, except for fees
payable to Purchaser. The Loan Parties agree to indemnify Purchaser and hold
Purchaser harmless from against any claim, demand or liability for broker's or
finder's or placement fees or similar commissions, whether or not payable by the
Loan Parties, alleged to have been incurred in connection with such
transactions, other than any broker's or finder's fees payable to Persons
engaged by Purchaser without the knowledge of the Loan Parties.

     (ff) Affiliate Transactions. Except as set forth on Schedule 5.1(ff), There
          ----------------------
are no existing or proposed agreements, arrangements, understandings or
transactions between any Loan Party and any of the officers, members, managers,
directors, stockholders, partners, other interest holders, employees or
Affiliates of any Loan Party or any members of their respective immediate
families, and none of the foregoing Persons are directly or indirectly, indebted
to or have any direct or indirect ownership, partnership or voting interest in,
any Affiliate of any Loan Party or any Person with which any Loan Party has a
business relationship or which competes with any Borrower (except that any such
Persons may own stock in (but not exceeding two (2%) percent of the outstanding
capital stock of) any publicly traded company that may compete with a Loan
Party.

     (gg) Insurance. Each Loan Party has in full force and effect such insurance
          ---------
policies as are customary in its industry and as may be required pursuant to
this Agreement, including (without limitation) adequate product liability
insurance.

     (hh) Food and Drug. Set forth on Schedule 5.1(hh) is a correct and complete
          -------------               ---------------
list of (i) all permits, licenses and approvals that are required under the FDA
Laws for the operation of the Loan Parties' business (collectively, the "FDA
Permits"). Each Loan Party has all applicable FDA Permits, all of which (A) are
valid and in full force and effect, (B) have not been reversed, stayed, set
aside, annulled or suspended, (C) are not subject to any conditions or
requirements that are not generally imposed on the holders thereof, and (iii)
constitute the only licenses, permits, authorizations, consents and approvals
required from FDA for the operation of the Loan Party's business as currently
conducted and as contemplated in the Purchase Documents. Without limitation on
the foregoing representations and warranties in this Section 5.1(hh):

          (i) Each Loan Party is in material compliance with all applicable FDA
     Laws, including (without limitation) current good manufacturing practice
     requirements;

          (ii) Each Loan Party is registered with the FDA, to the extent such
     registration is required by any FDA regulations, and each Loan Party's
     products, to the extent required by the FDA Laws, have been approved by the
     FDA or are the subject of a premarket notification to FDA and order from
     FDA declaring such product to be substantially equivalent to a legally
     marketed predicate device, to the extent such approval or premarket
     notification is required by FDA regulations;

                                       -39-

<PAGE>
               (iii) Each Loan Party has investigational exemptions for all
          products requiring such exemptions, and such products have not been
          and are not being sold or distributed outside the terms of such
          investigational exemptions;

               (iv) Except as set forth on Schedule 5.1(hh), there have been no
                                           ----------------
          "recalls," "product corrections," "removals," "corrections," "market
          withdrawals" or "stock recoveries" as such terms are defined in the
          regulations promulgated under the Federal Food, Drug and Cosmetic Act
          with respect to the products during the five-year period preceding the
          date hereof;

               (v) There are currently no adverse regulatory compliance issues
          or actions pending with the FDA and no FDA GMP audits conducted at any
          of the Loan Parties' facilities have resulted in any material adverse
          compliance enforcement actions; and

               (vi) Schedule 5.1(hh) contains a list of each Loan Party that has
                    ----------------
          received an ISO 9001 certification and "CE" certification.

               (vii) Except as set forth on Schedule 5.1(hh), there are no
                                            ----------------
          product liability claims pending, nor to the best knowledge of the
          Loan Parties, threatened against any of the Loan Parties.

               (viii) No Loan Party is required to obtain any Permits that are
          required by any Governmental Authority of the State of Tennessee
          having similar authority to or purview of FDA.

                                   ARTICLE 6
                             TRANSFER OF SECURITIES

     6.1 Restricted Securities. The Purchaser acknowledges that the Securities
         ---------------------
have not been registered under the Securities Act and may be resold only if
registered pursuant to the provisions of the Securities Act or if an exemption
from registration is available, and that the Loan Parties are not required to
register the Securities except as set forth in the Warrant.

     6.2 Legends; Purchaser's Representations. The Purchaser represents and
         ------------------------------------
warrants, for itself and for the Holder, to the Loan Parties that each of
Purchaser and the Holder is an "accredited investor" within the meaning of Rule
501(a) under the Securities Act and is acquiring the Securities for investment
for its own account, with no present intention of dividing its participation
with others (except for a potential transfer or transfers of the Securities to
an Affiliate or Affiliates of Purchaser) or reselling or otherwise distributing
the same in violation of the Securities Act or any applicable state securities
laws. The Loan Parties may place an appropriate legend on the Securities owned
by the Purchaser or the Holder concerning the restrictions set forth in this
Article 6. Upon the assignment or transfer by any Purchaser or Holder or any of
their successors or assignees of all or any part of the Securities, the term
"Purchaser" or "Holder" as used herein shall thereafter mean, to the extent
thereof, the then holder or holders of such Securities, or portion thereof.

                                       -40-

<PAGE>

     6.3 Transfer of Notes. Subject to Section 6.2 hereof, a holder of a
         -----------------
Security may transfer such Security to a new holder, or may exchange such
Security for Securities of different denominations (but, with respect to the
Note, in no event of denominations of less than $100,000 in original principal
amount), by surrendering such Security to the Loan Parties duly endorsed for
transfer or accompanied by a duly executed instrument of transfer naming the new
holder (or the current holder if submitted for exchange only), together with
written instructions for the issuance of one or more new Securities specifying
the respective principal amounts of each new Security, the name of each new
holder and each address therefor and the federal tax identification number of
each new holder. The Loan Parties shall simultaneously deliver to such holder or
its designee such new Securities, shall mark the surrendered Securities as
canceled and shall provide notice of such transfer to the Agent. In lieu of the
foregoing procedures, a holder may assign a Security (in whole but not in part)
to a new holder by sending written notice to the Loan Parties and the Agent of
such assignment specifying the new holder's name and address; in such case, the
Loan Parties shall promptly acknowledge such assignment in writing to both the
old and new holder. The Loan Parties shall not be required to recognize any
subsequent holder of a Security unless and until the Loan Parties have received
reasonable assurance that all applicable transfer taxes have been paid.

     6.4 Replacement of Lost Securities. Upon receipt of evidence reasonably
         ------------------------------
satisfactory to the Loan Parties of the mutilation, destruction, loss or theft
of any Securities and the ownership thereof, the Loan Parties shall, upon the
written request of the holder of such Securities, execute and deliver in
replacement thereof new Securities in the same form, in the same original
principal amount and dated the same date as the Securities so mutilated,
destroyed, lost or stolen; and such Securities so mutilated, destroyed, lost or
stolen shall then be deemed no longer outstanding hereunder. If the Securities
being replaced have been mutilated, they shall be surrendered to the Loan
Parties; and if such replaced Securities have been destroyed, lost or stolen,
such holder shall furnish the Loan Parties with an indemnity in writing to save
it harmless in respect of such replaced Security.

     6.5 No Other Representations Affected. Nothing contained in this Article 6
         ---------------------------------
shall limit the full force or effect of any representation, agreement or
warranty made in any Purchase Document or in connection therewith to the Agent
or to any Purchaser or Holder.

                                   ARTICLE 7
                                   COVENANTS

     7.1 Affirmative Covenants. The Loan Parties, jointly and severally,
         ---------------------
covenant that, so long as all or any of the Obligations or any interest thereon
shall remain outstanding, the Loan Parties shall:

          (a) Existence. Do or cause to be done all things necessary to
              ---------
     preserve, renew and keep in full force and effect its legal existence and
     to maintain its qualification and good standing in all jurisdictions where
     the failure to do so might reasonably be expected to have a Material
     Adverse Effect.

                                       -41-

<PAGE>
          (b) Businesses and Properties; Compliance with Laws. At all times (i)
              -----------------------------------------------
     do or cause to be done all things necessary to preserve, renew and keep in
     full force and effect the rights, licenses, registrations, Permits,
     certifications, approvals, consents, franchises, patents, copyrights,
     trademarks, Proprietary Rights and trade names, and any other trade names
     which may be material to the conduct of their businesses; (ii) comply in
     all material respects with all Laws and regulations applicable to the
     operation of such business, including but not limited to, all Environmental
     Laws and all closure and post-closure obligations and financing and bonding
     obligations thereunder, whether now in effect or hereafter enacted and with
     all other applicable Laws, (iii) take all action which may be required to
     obtain, preserve, renew and extend all rights, patents, copyrights,
     trademarks, tradenames, franchises, registrations, certifications,
     approvals, consents, licenses, Permits, Proprietary Rights and any other
     authorizations which may be material to the operation of such business,
     (iv) maintain, preserve and protect all property material to the conduct of
     such business, and (v) except for obsolete or worn out equipment, keep
     their property in good repair, working order and condition and from time to
     time make, or cause to be made, all needful and proper repairs, renewals,
     additions, improvements and replacements thereto necessary in order that
     the business carried on in connection therewith may be properly conducted
     at all times.

          (c) Insurance. Maintain insurance required by the Purchase Documents,
              ---------
     the Senior Credit Agreement, the Acquisition Agreement and/or any other
     agreement to which any Loan Party is a party or is otherwise bound,
     including but not limited to: (i) the Life Insurance until the Obligations
     have been indefeasibly repaid in full; (ii) coverage on their insurable
     properties (including all inventory, equipment and real property) against
     the perils of fire, theft and burglary; (iii) public liability; (iv)
     workers' compensation; (v) business interruption; (vi) product liability
     and environmental; and (vii) such other risks as are customary with
     companies similarly situated and in the same or similar business as that of
     the Loan Parties or are otherwise required by applicable law or any
     agreements to which any of the Loan Parties is a party or subject, in all
     cases under policies issued by financially sound and reputable insurers
     acceptable to the Agent in such amounts either as are customary with
     companies similarly situated and in the same or similar business or as are
     required under such laws or agreements. Each of the Loan Parties shall pay
     all insurance premiums payable by it and shall deliver the policy or
     policies of such insurance (or certificates of insurance with copies of
     such policies) to the Agent. All insurance policies of the Loan Parties
     shall contain endorsements, in form and substance reasonably satisfactory
     to the Agent, providing that the insurance shall not be cancelable except
     upon thirty (30) days' prior written notice to the Agent and the
     Purchasers. The Agent, for the benefit of the Agent and the Purchasers,
     shall be shown as a loss payee and an additional named insured party under
     all such insurance policies, subordinate to the rights of the Senior Agent
     as provided in the Subordination Agreement. The Agent, for the benefit of
     the Agent and the Purchasers, shall be shown as a loss payee and an
     additional named insured party under all such insurance policies and as
     sole beneficiary on the Life Insurance.

          (d) Obligations and Taxes. Pay and discharge promptly when due all
              ---------------------
     taxes, assessments and governmental charges or levies imposed upon them or
     upon their income or profits or in respect of their properties before the
     same shall become delinquent or in

                                       -42-

<PAGE>

default, as well as all lawful claims for labor, materials and supplies or
otherwise, which, if unpaid, might give rise to Liens or charges upon such
properties or any part thereof; provided, however, that the Loan Parties shall
not be required to pay and discharge or to cause to be paid and discharged any
such tax, assessment, charge, levy or claim so long as the validity or amount
thereof shall be contested in good faith by appropriate proceedings, and the
Loan Parties shall have set aside on their books adequate reserves with respect
thereto and such contest operates to suspend collection of the contested tax,
assessment, charge levy or claim and enforcement of a Lien.

     (e)   Financial Statements; Reports. Furnish to the Agent and the
           -----------------------------
Purchasers:

           (i)   Annual Statements. Within 90 days after the end of each fiscal
                 -----------------
     year, a balance sheet and statements of operations, stockholders' equity
     and cash flows of the Loan Parties on a consolidated and consolidating
     basis showing the financial condition of the Loan Parties as of the close
     of such year and the results of operations during such year, all the
     foregoing financial statements (other than the consolidating statements) to
     be audited by a firm of independent certified public accountants of
     recognized national standing acceptable to the Agent and accompanied by an
     opinion of such accountants without material exceptions or qualifications.

           (ii)  Quarterly and Monthly Statements. Within 30 calendar days after
                 --------------------------------
     the end of each calendar month (45 days in the case of a month that is the
     end of one of the first three fiscal quarters in a fiscal year), financial
     statements (including a balance sheet and cash flow and income statements)
     showing the financial condition and results of operations of the Loan
     Parties on a consolidated and consolidating basis as of the end of each
     such fiscal quarter and/or month, as applicable, and for the then elapsed
     portion of the current fiscal year, together with comparisons to the
     corresponding periods in the preceding year and the budget for such
     periods, accompanied by a certificate of an officer that such financial
     statements have been prepared in accordance with GAAP, consistently
     applied, and setting forth in comparative form the respective financial
     statements for the corresponding date and period in the previous fiscal
     year.

           (iii) Format; Management Report; Certificate of Compliance: Each
                 ----------------------------------------------------
     balance sheet, operations statement and cash flow statement furnished
     pursuant to subsections (i) and (ii) of this 7.1(e) shall be accompanied by
     (A) a written narrative report by the management of the Loan Parties
     explaining material developments and trends in the Business and such
     financial statements, and (B) a written certificate signed by the Loan
     Parties' chief financial officer to the effect that no Default or Event of
     Default has occurred during the period(s) covered by such statements or, if
     any such Default or Event of Default has occurred during such period(s),
     setting forth a description of such Default or Event of Default and
     specifying the action, if any, taken by the Loan Parties to remedy the
     same, and a compliance certificate showing the Loan Parties' compliance
     with the covenants set forth in Section 7.3.

                                      -43-

<PAGE>

         (iv)   Accountant Reports. Promptly upon the receipt thereof, copies
                ------------------
     of all reports, if any, submitted to the Loan Parties by their independent
     certified public accountants in connection with each annual, interim or
     special audit or review of the financial statements of the Loan Parties
     made by such accountants, including but not limited to, any comment letter
     submitted by such accountants to management in connection with any annual
     review.

         (v)    Projections. As soon as available, but in no event later than
                -----------
     thirty (30) days prior to the beginning of each fiscal year of the Loan
     Parties, a projection of the Loan Parties' balance sheet, and income,
     retained earnings, stockholders' equity and cash flow statements,
     respectively, for the following one (1) fiscal year and comparable actual
     and budgeted figures for the current fiscal year; and within ten (10) days
     after any material update or amendment of any such plan or forecast, a copy
     of such update or amendment, including a description of and reasons for
     such update or amendment. Each such projection, update or amendment shall
     be accompanied by a written certificate signed by the Loan Parties' chief
     financial officer to the effect that it has been prepared on the basis of
     the Loan Parties' historical financial statements and records, together
     with the assumptions set forth in such projection and that it reflects
     expectations, after reasonable analysis, of the Loan Parties' management as
     to the matters set forth therein.

         (vi)   Filings. (A) any and all filings made by any Loan Party with
                -------
     the SEC or otherwise pursuant to the Securities Act and/or Securities
     Exchange Act, (B) copies of the Loan Parties' federal income tax returns
     and any amendments thereto filed with the IRS, and (C) any other
     information that is provided by any Loan Party to its stockholders
     generally.

         (vii)  Other Financings. (i) A copy of any borrowing certificate
                ----------------
     submitted or received pursuant to the Senior Credit Agreement immediately
     following any audit or appraisal conducted by or on behalf of Senior
     Lenders and (ii) copies of all statements, reports and notices furnished to
     any other Person pursuant to the terms of any indenture, loan or creditor
     or similar agreement (including, without limitation, the Senior Credit
     Agreement and other documents evidencing the Senior Financing) and not
     otherwise required to be furnished to the Agent and the Purchasers pursuant
     to this Agreement.

         (viii) Additional Information. Promptly, from time to time, such other
                ----------------------
     information regarding the compliance by the Loan Parties with the terms of
     the Purchase Documents or the affairs, operations or condition (financial
     or otherwise) of the Loan Parties as the Agent may reasonably request and
     that is capable of being obtained, produced or generated by the Loan
     Parties or of which the Loan Parties have knowledge.

     (f) Litigation and Other Notices. Give the Agent and the Purchasers prompt
         ----------------------------
written notice of the following:

                                      -44-

<PAGE>

          (i)   Orders; Injunctions. The issuance by any court or Governmental
                -------------------
     Authority of any injunction, order, decision or other restraint
     prohibiting, or having the effect of prohibiting, the making of any loan or
     the initiation of any litigation or similar proceeding seeking any such
     injunction, order or other restraint.

          (ii)  Litigation. The notice, filing or commencement of any action,
                ----------
     suit or proceeding against any of the Loan Parties whether at law or in
     equity or by or before any court or any Federal, state, municipal or other
     Governmental Authority and that, if adversely determined against any of the
     Loan Parties, could result in uninsured liability in excess of $100,000 in
     the aggregate.

          (iii) Environmental Matters. (i) Any release or threatened release of
                ---------------------
     any Pollutant required to be reported to any Federal, state or local
     governmental or regulatory agency under any applicable Environmental Laws,
     (ii) any Removal, Remedial or Response action taken by any of the Loan
     Parties or any other Person in response to any Pollutant in, at, on or
     under, a part of or about any of the Loan Parties' properties or any other
     property, (iii) any violation by any of the Loan Parties of any
     Environmental Law, in each case, that could result in a Material Adverse
     Effect, or (iv) any notice, claim or other information that any of the Loan
     Parties might be subject to an Environmental Liability.

          (iv)  Default; Collateral. Any Default or Event of Default, specifying
                -------------------
     the nature and extent thereof and the action (if any) that is proposed to
     be taken with respect thereto. Any matter(s) affecting the value,
     enforceability or collectability of any of the Collateral, including,
     without limitation, claims or disputes in the amount of $150,000 or more,
     singly or in the aggregate, in existence at any one time. Any notice given
     by any Loan Party to or received from any other lender of any Loan Party
     accompanied by a copy of such notice Any filing, recording or assessment of
     any material federal, state, local or foreign tax lien against the
     Collateral or any Borrower.

          (v)   Material Adverse Effect. Any Material Adverse Change or any
                -----------------------
     development in the business or affairs of any of the Loan Parties that
     could have a Material Adverse Effect.

          (vi)  Put Rights. The exercise of any "put" right by any shareholder
                ----------
     or holder of any equity security of any Loan Party representing more than
     2% of the outstanding Capital Stock of such Loan Party or any warrant or
     option or security convertible into any equity security of any Loan Party
     representing more than 2% of the outstanding Capital Stock of such Loan
     Party.

          (vii) Board Materials. Written notice of each regular meeting of each
                ---------------
     Loan Party's Board of Directors at least 30 days in advance of such meeting
     and prior written notice of each special meeting of each of the Loan
     Party's Board of Directors on the date on which the members of the Board of
     Directors are notified of such meeting. In addition, the Loan Parties will
     send the Agent copies of all

                                      -45-

<PAGE>

     reports and materials provided to members of the Board of Directors at
     meetings or otherwise.

         (viii) Change of Control. At least 20 days prior written notice of any
                -----------------
     plan to institute a Change of Control.

     (g) Board Rights. The Parent shall permit one authorized representative of
         ------------
the Purchasers to attend and participate (without the right to vote) in all
meetings of its board of directors and any committee thereof, whether in person,
by telephone or otherwise, and shall provide such representative with such
notice and other information with respect to such meetings as are delivered to
the directors of the Parent. The Parent shall pay such representatives'
reasonable travel expenses (including, without limitation, the cost of airfare,
meals and lodging) in connection with the attendance of such meetings.

     (h) ERISA. Comply in all material respects with the applicable provisions
         -----
of ERISA and the provisions of the Code relating thereto and furnish to the
Agent and the Purchasers if requested (i) as soon as possible, and in any event
within thirty (30) days after the Loan Parties know or have reason to know
thereof, notice of (A) the establishment by the Loan Parties of any Plan, (B)
the commencement by the Loan Parties of contributions to a Multiemployer Plan,
(C) any failure by the Loan Parties or any of their ERISA Affiliates to make
contributions required by Section 302 of ERISA (whether or not such requirement
is waived pursuant to Section 303 of ERISA), (D) the occurrence of any
Reportable Event with respect to any Plan or Multiemployer Plan for which the
reporting requirement is not waived, together with a statement of an officer
setting forth details as to such Reportable Event and the action which the Loan
Parties propose to take with respect thereto, together with a copy of the notice
of such Reportable Event given to the PBGC if any such notice was provided by
the Loan Parties, or (E) the occurrence of any ERISA Event, and (ii) promptly
after receipt thereof, a copy of any notice the Loan Parties may receive from
the PBGC relating to the intention of the PBGC to terminate any Plan or
Multiemployer Plan, or to appoint a trustee to administer any Plan or
Multiemployer Plan, and (iii) promptly after receipt thereof, a copy of any
notice of withdrawal liability from any Multiemployer Plan.

     (i) Maintaining Records; Access to Premises and Inspections. Maintain
         -------------------------------------------------------
financial records in accordance with generally accepted practices and, upon
reasonable notice, at all reasonable times and as often as the Agent or a
Purchaser may reasonably request (and at any time after the occurrence and
during the continuation of a Default or Event of Default), permit any authorized
representative designated by the Agent or a Purchaser to visit and inspect the
properties and financial records of the Loan Parties and to make extracts from
such financial records, all at the Loan Parties' reasonable expense, and permit
any authorized representative designated by the Agent or a Purchaser to discuss
the affairs, finances and conditions of the Loan Parties with the Loan Parties'
chief financial officer and such other officers as the Loan Parties shall deem
appropriate, and the Loan Parties' independent public accountants.

                                      -46-

<PAGE>

     (j) Future Financings. If any Loan Party desires to undertake any Covered
         -----------------
Financing, then, prior to doing so, such Loan Party shall be obligated to first
comply with following requirements:

          (i) Such Loan Party shall provide written notice to the Agent and the
     Purchasers of its intention to pursue a Covered Financing, together with
     such information concerning the Covered Financing as the Agent may
     reasonably request to enable to the Purchasers to propose the material
     terms and conditions under which the Purchasers would offer to provide such
     Covered Financing (the "Material Terms and Conditions").

          (ii) For a period of 15 Business Days after receipt of such notice and
     information, the Purchasers shall have the exclusive option, but not the
     obligation, to propose Material Terms and Conditions under which the
     Purchasers would offer to provide such Covered Financing by delivering
     written notice to the Loan Party, setting forth the Material Terms and
     Conditions. Failure by the Purchasers to make an offer within such time
     period shall be deemed an election by the Purchasers not to provide the
     Covered Financing.

          (iii) If the Loan Party agrees to accept an offer of the Purchasers to
     provide the Covered Financing by delivering written notice of such
     acceptance to the Agent and the Purchasers within 15 Business Days after
     receipt of the Material Terms and Conditions, then the Loan Party and the
     Purchasers agree to use their best efforts to negotiate and execute
     definitive agreements within 45 days of such acceptance. Failure by the
     Loan Party to accept such offer within such 15 day period shall be deemed
     an election by the Loan Party not to accept the offer. If more than one
     Purchaser desires to provide such financing, the Purchasers shall
     participate therein on a pro rata basis. A Purchaser's pro rata share, for
     purposes of this subsection (iii), shall equal a fraction, the numerator of
     which is the amount outstanding under the Purchaser's Note and the
     denominator of which is the aggregate amount outstanding under all of the
     Notes held by all Purchasers exercising their rights to participate in the
     Covered Financing under this subsection (iii).

          (iv) If the Loan Party does not accept the offer of the Purchasers,
     the Loan Party shall thereafter be free for a period of 120 days to obtain
     the Covered Financing from a third party offeror, pursuant to terms and
     conditions that are not substantially similar to or more adverse to the
     Loan Party than the Material Terms and Conditions, without any further
     obligations hereunder in connection with such Covered Financing.

     (k) Consents. The Loan Parties shall obtain and deliver to the Agent and
         --------
the Purchasers from time to time all required consents, approvals and agreements
from such third parties as the Agent or a Purchaser shall determine are
necessary or desirable and that are satisfactory to the Agent or Purchaser with
respect to (i) the Purchase Documents and the Transactions, (ii) claims against
any Loan Party or the Collateral, and/or (iii) any agreements, consents,
documents or instruments to which any Loan Party is a party or by

                                      -47-

<PAGE>

which any properties or assets of any Loan Party or any of the Collateral is or
are bound or subject (except where the failure to obtain such consent, approval
or agreement could not reasonably be expected to result in a Material Adverse
Effect).

     (l) Payment of Obligations; Other Obligations. The Loan Parties shall make
         -----------------------------------------
full and timely indefeasible payment in cash of the principal of and interest on
the Notes and all other Obligations when due. Each Loan Party shall (i) except
as limited pursuant to the Purchase Documents, materially perform in accordance
with its terms each contract, agreement or other arrangement to which it is a
party or by which it or any of its properties or assets is bound, except where
the failure to comply, pay or perform could not reasonably be expected to have a
Material Adverse Effect, (ii) except as limited pursuant to the Purchase
Documents, pay, discharge or otherwise satisfy at or before maturity (subject to
applicable grace periods and, in the case of trade payables, to ordinary course
payment practices) all of its material obligations and liabilities, except when
the amount or validity thereof is being contested in good faith by appropriate
proceedings and such reserves as the Agent may deem proper and necessary shall
have been made, and (iii) to the extent not inconsistent with the Security
Documents, (A) if Liens other than Permitted Liens exist, take, execute and
deliver all actions, documents and instruments necessary to release and
terminate such Liens, (B) execute, obtain, deliver, file, register and/or record
any and all financing statements, continuation statements, stock powers,
instruments and other documents, or cause the execution, filing, registration,
recording or delivery of any and all of the foregoing, that are necessary or
required under Law or otherwise or reasonably requested by the Agent to be
executed, filed, registered, obtained, delivered or recorded to create,
maintain, perfect, preserve, validate or otherwise protect the pledge of the
Collateral to the Agent and the Agent's perfected Lien thereon (and each Loan
Party irrevocably grants the Agent the right, at the Agent's option, to file any
or all of the foregoing), (C) maintain, or cause to be maintained, at all times,
the pledge of the Collateral to the Agent and the Agent's perfected Lien
thereon, and (D) defend the Collateral and the Agent's perfected Lien thereon
against all claims and demands of all Persons (other than Persons with Permitted
Liens) at any time claiming the same or any interest therein adverse to the
Agent or the Purchasers, and pay all reasonable costs and expenses (including,
without limitation, in-house documentation and diligence fees and legal expenses
and reasonable attorneys' fees and expenses) in connection with such defense,
which may at the Agent's discretion be added to the Obligations.

     (m) Further Assurances; Post Closing. Each Loan Party shall (i) within five
         --------------------------------
(5) Business Days after the Agent's or Purchaser's demand, take such further
actions, use reasonable efforts to obtain such consents and approvals and duly
execute and deliver such further agreements, assignments, instructions or
documents as the Agent or Purchaser may request with respect to the purposes,
terms and conditions of the Purchase Documents and the consummation of the
Transactions, whether before, at or after the performance and/or consummation of
the Transactions or the occurrence of a Default or Event of Default, (ii) use
best efforts to obtain the approval of the stockholders of the Parent as
contemplated by the Warrant as soon as practicable but in no event later than
July 1, 2002, (iii) without limiting and notwithstanding any other provision of
any Purchase Document, execute and deliver, or cause to be executed and
delivered, such agreements and documents, and take or cause to be taken such
actions, and otherwise

                                      -48-

<PAGE>

     perform, observe and comply with such obligations, as are set forth on the
     "Post Closing Schedule," and (iv) upon the exercise by the Agent, any
     Purchaser or any of its Affiliates of any power, right, privilege or remedy
     pursuant to any Purchase Document or under applicable law or at equity
     which requires any consent, approval, registration, qualification or
     authorization of any Governmental Authority, execute and deliver, or cause
     the execution and delivery of, all applications, certificates, instruments
     and other documents that may be so required for such consent, approval,
     registration, qualification or authorization. Without limiting the
     foregoing, upon the exercise by the Agent, any Purchaser or any of its
     Affiliates of any right or remedy under any Purchase Document in connection
     with which any Person requires any consent, approval or registration with,
     consent, qualification or authorization by, then each Loan Party shall
     execute and deliver, or cause the execution and delivery of, all
     applications, certificates, instruments and other documents that such other
     Person requires the Agent, the Purchaser or its Affiliate to obtain for
     itself or on its behalf for any such consent, approval, registration,
     qualification or authorization.

     7.2 Negative Covenants. The Loan Parties, jointly and severally, covenant
         ------------------
that, so long as all or any of the Obligations or any interest thereon shall
remain outstanding, without the prior written consent of the Agent:

          (a)  Indebtedness. None of the Loan Parties shall create, incur,
               ------------
     assume guarantee or be or remain liable for, contingently or otherwise, or
     suffer to exist any Indebtedness, except the following (collectively,
     "Permitted Indebtedness"):

               (i)   Indebtedness under this Agreement;

               (ii)  Senior Debt;

               (iii) unsecured Indebtedness incurred in the ordinary course of
          business with respect to customer deposits, trade payables and other
          unsecured current liabilities not the result of borrowing and not
          evidenced by any note or other evidence of indebtedness;

               (iv)  Indebtedness as set forth on the Permitted Indebtedness
          Schedule attached hereto as Schedule 7.2(a) and any refundings,
          renewals, or extensions of any such Indebtedness, provided that (i)
          the principal amount thereof is not increased, (ii) the Liens, if any,
          securing such refunded, renewed, or extended Indebtedness do not
          attach to any assets in addition to those assets as of the Closing
          Date, if any, securing the Indebtedness to be refunded, renewed, or
          extended, (iii) no Person that is not an obligor or guarantor of such
          Indebtedness as of the Closing Date shall become an obligor or
          guarantor thereof, and (iv) the terms of such refunding, renewal, or
          extension are, in the Agent's reasonable discretion, no less favorable
          to such Loan Party, the Agent, or the Purchasers than the original
          Indebtedness;

               (v)   intercompany Indebtedness among the Loan Parties, provided
          that any such Indebtedness shall be on terms acceptable to the Agent;
          and

                                      -49-

<PAGE>

               (vi) obligations under Capitalized Leases and purchase money
          Indebtedness for Equipment acquired in the ordinary course of the
          business, provided that (i) the Liens securing such Capitalized Leases
          and purchase money Indebtedness shall attach only to the Equipment
          acquired by the incurrence of such Capitalized Leases and purchase
          money Indebtedness and (ii) the aggregate amount of such Indebtedness
          (including all Capitalized Leases at any time outstanding) outstanding
          does not exceed $2,000,000 at any time.

     Notwithstanding any provision to the contrary, none of the Loan Parties
     shall incur any Indebtedness after the Closing Date that is subordinate or
     junior in right of payment to any Senior Debt unless such Indebtedness by
     its terms is subordinated to the Notes or the guarantee of the Loan
     Parties, in each case in form and substance satisfactory to the Agent.

          (b) Negative Pledge; Liens. None of the Loan Parties shall create,
              ----------------------
     incur, assume or suffer to exist any Lien of any kind on any of their
     properties or assets of any kind, except the following (collectively,
     "Permitted Liens"):

               (i)   Liens created in connection with the Senior Debt and the
          Purchase Documents;

               (ii)  Liens for or priority claims imposed by law that are
          incidental to the conduct of business or the ownership of properties
          and assets (including mechanic's, warehousemen's, attorneys' and
          statutory landlords' liens) and deposits, pledges or liens to secure
          statutory obligations, surety or appeal bonds or other liens of like
          general nature incurred in the ordinary course of business and not in
          connection with the borrowing of money; provided, however, that in
          each case, the obligation secured is not overdue, or, if overdue, is
          being contested in good faith and adequate reserves have been set up
          by the Loan Parties as the case may be; and provided, further, that
          the Lien and security interest provided in the Security Documents or
          any portion thereof created or intended to be created thereby is not,
          in the opinion of the Agent, unreasonably jeopardized thereby;

               (iii) Liens securing the payments of taxes, assessments and
          governmental charges or levies incurred in the ordinary course of
          business that either (a) are not delinquent, or (b) are being
          contested in good faith by appropriate legal or administrative
          proceedings and as to which adequate reserves have been set aside on
          their books, and so long as during the period of any such contest, the
          Loan Parties shall suffer no loss of any privilege of doing business
          or any other right, power or privilege necessary or material to the
          operation of the Business;

               (iv)  Liens listed on the Permitted Encumbrances Schedule
          attached hereto as Schedule 7.2(b);
                            ----------------

               (v)   Liens constituting encumbrances in the nature of
          reservations, exceptions, encroachments, easements, rights of way,
          covenants running with the land, and other similar title exceptions or
          encumbrances affecting any Real Estate,

                                       -50-

<PAGE>

          provided that any such Liens do not in the aggregate materially
          detract from the value of such Real Estate or materially interfere
          with its use in the ordinary conduct of a Loan Party's business;

              (vi)   Liens which secure Capitalized Leases or constitute
          purchase money Liens on Equipment acquired in the ordinary course of
          the business with respect solely to Indebtedness permitted under
          Section 7.2(a)(vi);

              (vii)  Liens arising from judgments and attachments in connection
          with court proceedings, provided that the attachment or enforcement of
          such Liens would not result in an Event of Default hereunder and such
          Liens are being contested in good faith by appropriate proceedings,
          adequate financial reserves have been established on the applicable
          Loan Party's books and records in accordance with GAAP, no material
          property is subject to a material risk of loss or forfeiture, the
          claims in respect of such Liens are fully covered by insurance
          (subject to ordinary and customary deductibles), and a stay of
          execution pending appeal or proceeding for review is in effect; and

              (viii) extensions, renewals and replacements of Liens referred to
          in clauses (i) through (vii) of this Section 7.2(b); provided,
          however, that any such extension, renewal or replacement Lien shall be
          limited to the property or assets covered by the Lien extended,
          renewed or replaced and that the obligations secured by any such
          extension, renewal or replacement Lien shall be in an amount not
          greater than the amount of the obligations secured by the Lien
          extended, renewed or replaced.

          (c) Contingent Liabilities. Except for the Guaranty Agreements and
              ----------------------
     guarantees of the Senior Debt as contemplated by Section 7.2(a)(ii) above,
     none of the Loan Parties shall be or become liable for or subject or party
     to any mortgage, note, indenture, indemnity or Guarantee of, with respect
     to or evidencing any Indebtedness of any other Person other than another
     Loan Party, except for the endorsement of negotiable instruments for
     deposit or collection or similar transactions in the ordinary course of
     business.

          (d) Leases. At no point shall the sum of the aggregate amount of
              ------
     annualized payments on operating leases of the Loan Parties during any
     Fiscal Year exceed $1,200,000.

          (e) Capital Expenditures. The Loan Parties shall not make or commit to
              --------------------
     make any payments in any Fiscal Year on account of the purchase or lease of
     any assets that if purchased would constitute fixed assets or that if
     leased would constitute a Capitalized Lease, that in the aggregate would
     cost more than (i) $3,800,000 for the Fiscal Year ended December 31, 2002
     and (ii) $4,200,000 for each Fiscal Year thereafter.

          (f) Mergers, Purchase of Assets; Sale of Assets, etc. None of the Loan
              ------------------------------------------------
     Parties shall merge into or consolidate or combine with any other Person,
     or purchase, lease or otherwise acquire (in one transaction or a series of
     related transactions) all or any part of

                                       -51-

<PAGE>

          the property or assets of any Person other than purchases or other
          acquisitions of inventory, materials, leases, property and equipment
          in the ordinary course of business; provided that any Loan Party
          (other than the Parent) may merge or consolidate with the Parent or
          another Loan Party (provided that the Parent is the survivor of any
          such merger or consolidation with which it is a party) . None of the
          Loan Parties shall sell, transfer, lease, license or otherwise dispose
          of any of its assets, including the Collateral, provided that, so long
          as no Default or Event of Default exists or would result therefrom, a
          Loan Party may enter into (i) sales or other dispositions of Inventory
          sold in the ordinary course of business and (ii) provided that the
          Parent provides the Agent and the Purchasers with prior written
          notice, sales and other dispositions of Equipment and Real Estate if
          (A) the Orderly Liquidation Value of such Equipment and the appraised
          fair market value of such Real Estate does not exceed $2,000,000 in
          the aggregate (net of the related sales costs, if any, of such
          Equipment and Real Estate) during the term of this Agreement for all
          of the Loan Parties, collectively, (B) the Orderly Liquidation Value
          of such Equipment and the appraised fair market value of such Real
          Estate does not exceed $1,000,000 in the aggregate (net of the related
          sales costs, if any, of such Equipment and Real Estate) for all of the
          Loan Parties, collectively, during any period of four consecutive
          fiscal quarters, (C) the Agent shall have received written notice of
          any such sale or disposition involving Equipment with an Orderly
          Liquidation Value and Real Estate having an appraised fair market
          value in excess of $250,000, and (D) the cash consideration received
          by the applicable Loan Party at the time of any such sale or other
          disposition shall be not less than fifty percent (50%) of the total
          consideration received.

               (g) Affiliate Transactions. Except as provided in Schedule
                   ----------------------                        --------
           5.1(ff), none of the Loan Parties shall make any loan or advance or
           -------
          other payment to any director, officer or employee of the Loan Parties
          or any of their Affiliates, or enter into or be a party to any
          transaction or arrangement with any Affiliate of the Loan Parties,
          including, without limitation, the purchase from, sale to or exchange
          of property with, any merger or consolidation with or into, or the
          rendering of any service by or for, any such Affiliate, except
          pursuant to the reasonable requirements of the Loan Parties' business
          and upon fair and reasonable terms no less favorable to the Loan
          Parties than would be obtained in a comparable arm's-length
          transaction with a Person other than an Affiliate. Notwithstanding any
          provision of any Purchase Document, no Loan Party shall make or suffer
          to exist any payment (other than the payment of salaries to employees
          in the ordinary course of business without any increase after such
          event) or transaction permitted under this Section 7.2(g) if a Default
          or Event of Default has occurred and is continuing or would result
          therefrom. None of the Loan Parties shall pay any management,
          consulting, investment banking or similar fee or compensation to any
          Affiliate of any Loan Party.

               (h) Dividends and Stock Purchases. Except for Permitted
                   -----------------------------
          Distributions, none of the Loan Parties shall directly or indirectly,
          without the consent of the Agent: (i) make, declare or pay any
          dividends (in cash or other property other than a dividend on Capital
          Stock of any shares of Capital Stock (or any options or warrants for,
          or other rights with respect to, such Capital Stock) of the same
          class) on, or purchase, acquire, redeem or retire any Capital Stock of
          any class, whether now or hereafter outstanding, (ii) make any
          distribution of any kind on their outstanding Capital Stock of any
          class, whether now or hereafter outstanding, (iii) make, declare or
          pay any other payment of any kind to any of

                                       -52-

<PAGE>

          their stockholders or Affiliates (including any redemption, purchase
          or acquisition of, whether in cash or in property, securities or a
          combination thereof, any partnership interests or capital accounts or
          warrants, options or any of their other securities), or (iv) set aside
          any sum for any such purpose other than for such dividends,
          distributions or payments paid solely to other Loan Parties (each, a
          "Distribution"); provided, however, that this Section 7.2(h) shall not
                           --------- --------
          apply to any provision of the Warrant or any "put" right thereunder or
          with respect to the Warrant or the Underlying Securities.

               (i) Advances, Investments and Loans. None of the Loan Parties
                   -------------------------------
          shall purchase, or hold beneficially any stock, other securities or
          evidences of Indebtedness of, or make or permit to exist any loan,
          Guaranty or advance to, or make any Investment or acquire any interest
          whatsoever in, any other Person (including, but not limited to, the
          formation or acquisition of any Subsidiaries), except:

                   (i)   securities issued or directly and fully guaranteed or
               insured by the United States of America or any agency or
               instrumentality thereof having maturities of not more than six
               months from the date of acquisition;

                   (ii)  United States dollar-denominated time deposits,
               certificates of deposit and bankers acceptances of any bank or
               any bank whose short-term debt rating from Standard & Poor's
               Ratings Group, a division of The McGraw-Hill Companies, Inc.
               ("S&P"), is at least A-1 or the equivalent or from Moody's
               Investors Service, Inc. ("Moody's") is at least P-1 or the
               equivalent with maturities of not more than one year from the
               date of acquisition;

                   (iii) commercial paper with a rating of at least A-1 or the
               equivalent by S&P or at least P-1 or the equivalent by Moody's
               maturing within six months after the date of acquisition;

                   (iv)  marketable direct obligations issued by any state of
               the United States of America or any political subdivision of any
               such state or any public instrumentality thereof maturing within
               six months from the date of acquisition thereof and, at the time
               of acquisition, having one of the two highest ratings obtainable
               from either S&P or Moody's;

                   (v)   Investments in money market funds substantially all
               the assets of which are comprised of securities of the types
               described in clauses (i) through (iv) above;

                   (vi)  deposit accounts maintained in accordance with any
               loan agreement evidencing the Senior Debt;

                   (vii) Investments (including debt obligations) received in
               connection with the bankruptcy or reorganization of suppliers and
               customers and in settlement of delinquent obligations of, and
               other disputes with, customers and suppliers arising in the
               ordinary course of business;

                                       -53-

<PAGE>

               (viii) receivables owing to the Loan Parties created or acquired
          in the ordinary course of business and payable on customary trade
          terms of the Loan Parties;

               (ix)   deposits made in the ordinary course of business
          consistent with past practices to secure the performance of leases or
          in connection with bidding on government contracts;

               (x)    advances to employees in the ordinary course of business
          for business expenses; provided, however, that the aggregate amount of
          such advances at any time outstanding shall not exceed $20,000;

               (xi)   securities issued by other Loan Parties and Investments
          constituting intercompany loans between Loan Parties;

               (xii)  Investments in respect of Interest Rate Protection
          Agreements entered into in the ordinary course of business and not for
          speculative purposes;

               (xiii) Investments listed on the Permitted Investment Schedule
          attached hereto as Schedule 7.2(i);

               (xiv)  advances to independent sales Persons against commissions
          in an aggregate amount at any time not exceeding $1,250,000; and

               (xv)   other Investments in an aggregate amount at any time not
          exceeding $100,000.

          (j) Use of Proceeds. None of the Loan Parties shall use any proceeds
              ---------------
     from the sale of the Securities hereunder (i) other than as contemplated in
     Section 5.1(t) or (ii) directly or indirectly, for the purposes of
     purchasing or carrying any "margin securities" within the meaning of
     Regulations T, U or X promulgated by the Board of Governors of the Federal
     Reserve Board or for the purpose of arranging for the extension of credit
     secured, directly or indirectly, in whole or in part by collateral that
     includes any "margin securities."

          (k) [Reserved].
              ----------

          (l) Sale and Lease-Back Transactions. No Loan Party shall enter into
              --------------------------------
     any arrangement, directly or indirectly, with any Person whereby it shall
     sell or transfer any property, real or personal, used or useful in its
     business, whether now owned or thereafter acquired, and thereafter in a
     related transaction rent or lease such property or other property that it
     intends to use for substantially the same purpose or purposes as the
     property being sold or transferred.

          (m) Prepayments; Payments to Junior Lenders. Except for the Senior
              ---------------------------------------
     Debt, the Notes or Indebtedness owed to the Parent from another Loan Party,
     no Loan Party shall prepay any Indebtedness for borrowed money. So long as
     an Event of Default has

                                       -54-

<PAGE>

occurred and is continuing, no Loan Party shall make any payment to any Junior
Lender in respect of the Junior Notes.

     (n) Amendment of Charter Documents. None of the Loan Parties shall amend,
         ------------------------------
terminate, modify or waive or agree to the amendment, modification or waiver of
any material term or provision of their respective Charter Documents or Bylaws.

     (o) Subsidiaries. None of the Loan Parties shall establish or acquire any
         ------------
Subsidiary.

     (p) Business. None of the Loan Parties shall engage, directly or
         --------
indirectly, in any business other than the Business.

     (q) Fiscal Year; Accounting. None of the Loan Parties shall change its
         -----------------------
Fiscal Year from ending on December 31 of each year or method of accounting
(other than immaterial changes in methods), except as required by GAAP.

     (r) Establishment of New or Changed Business Locations. None of the Loan
         --------------------------------------------------
Parties shall (i) relocate its principal executive offices or other facilities
without providing not less than thirty (30) days advance written notice to the
Agent or (ii) establish new business locations or store any inventory or other
assets or Collateral at a location not set forth on the "Name and Location
Schedule" (Schedule 7.2(r)) unless such location is established in the ordinary
           ---------------
course of business and is added to the Name and Location Schedule not less than
thirty (30) days thereafter. In no event shall any of the Collateral with a fair
market value in excess of $2,000,000 be located outside the continental United
States. Prior to moving any Collateral to any location not owned by a Loan
Party, the Loan Parties shall obtain and deliver to the Agent an agreement, in
form and substance acceptable to the Agent, pursuant to which the owner of such
location shall subordinate any rights which it may have or thereafter obtain in
any of the Collateral to the rights and Liens of the Agent, for the benefit of
the Agent and the Purchasers, and allow the Agent access to the Collateral in
order to remove the Collateral from such location.

     (s) Changed or Additional Business Names; FEIN. None of the Loan Parties
         ------------------------------------------
shall change its corporate name or FEIN or establish new or additional trade
names without providing not less than thirty (30) days advance written notice to
the Agent and the Purchasers.

     (t) Life Insurance and Other Restrictions. No Loan Party shall (i) amend,
         -------------------------------------
modify, restate or change the Life Insurance in any material respect (including,
without limitation, with respect to amounts of coverage, beneficiaries and/or
loss payees and additional insured), (ii) enter into any agreement or
arrangements which would restrict in any material respect its ability to fulfill
its Obligations under the Purchase Documents, (iii) amend, alter or suspend or
terminate or make provisional in any material way, any Permit, (iv) wind up,
liquidate or dissolve (voluntarily or involuntarily) or commence or suffer any
proceedings seeking or that would result in any of the foregoing (provided that
a Loan Party (other than the Parent) may wind-up, liquidate or dissolve if its
property is transferred to the Parent or another Loan Party), or (v) sell,
lease, transfer, pledge, assign

                                       -55-

<PAGE>

     or otherwise dispose of any Collateral or any interest therein (except as
     permitted under the Purchase Documents).

     7.3 Financial Covenants. The Loan Parties, jointly and severally, covenant
         -------------------
that, so long as all or any part of Obligations or any interest thereon shall
remain outstanding, they shall maintain and comply with the following, on a
consolidated basis at the end of each fiscal quarter (each such date being a
"Measurement Date"):

          (a) Minimum EBITDA. As measured on each Measurement Date for the
              --------------
     Measurement Period ending on such Measurement Date, EBITDA shall not be
     less than:

<TABLE>
<CAPTION>
     Measurement Date                                                        Minimum EBITDA
     ----------------                                                        --------------
<S>                                                                          <C>
     The last day of the 1st Fiscal Quarter of Fiscal Year 2002              $15,682,000
     The last day of the 2nd Fiscal Quarter of Fiscal Year 2002               15,363,000
     The last day of the 3rd Fiscal Quarter of Fiscal Year 2002               14,624,000
     December 31, 2002                                                        14,638,000
     The last day of the 1st Fiscal Quarter of Fiscal Year 2003               15,638,000
     The last day of the 2nd Fiscal Quarter of Fiscal Year 2003               16,542,000
     The last day of the 3rd Fiscal Quarter of Fiscal Year 2003               17,174,000
     December 31, 2003                                                        17,566,000
     The last day of the 1st Fiscal Quarter of Fiscal Year 2004               18,197,000
     The last day of the 2nd Fiscal Quarter of Fiscal Year 2004               18,844,000
     The last day of the 3rd Fiscal Quarter of Fiscal Year 2004               19,510,000
     December 31, 2004                                                        20,200,000
     The last day of the 1st Fiscal Quarter of Fiscal Year 2005               20,694,000
     The last day of the 2nd Fiscal Quarter of Fiscal Year 2005               21,289,000
     The last day of the 3rd Fiscal Quarter of Fiscal Year 2005               21,736,000
     December 31, 2005                                                        22,220,000
     The last day of the 1st Fiscal Quarter of Fiscal Year 2006               22,753,000
     The last day of the 1st Fiscal Quarter of Fiscal Year 2006               23,309,000
     The last day of the 1st Fiscal Quarter of Fiscal Year 2006               23,865,000
     December 31, 2006                                                        24,443,000
</TABLE>

          (b) Debt to EBITDA Ratio (Total Debt/EBITDA). As measured on each
              ----------------------------------------
     Measurement Date for the Measurement Period ending on such Measurement
     Date, the Debt to EBITDA Ratio shall not exceed:

<TABLE>
<CAPTION>
     Measurement Date                                                       Minimum EBITDA
     ----------------                                                       --------------
<S>                                                                         <C>
     The last day of each Fiscal Quarter of Fiscal Year 2002                3.50 to 1.00
     The last day of the 1st Fiscal Quarter of Fiscal Year 2003             3.25 to 1.00
     The last day of the 2nd Fiscal Quarter of Fiscal Year 2003             3.25 to 1.00
     The last day of the 3rd Fiscal Quarter of Fiscal Year 2003             3.00 to 1.00
     December 31, 2003                                                      3.00 to 1.00
     The last day of the 1st Fiscal Quarter of Fiscal Year 2004             2.75 to 1.00
     The last day of the 2nd Fiscal Quarter of Fiscal Year 2004             2.75 to 1.00
</TABLE>

                                       -56-

<PAGE>

     The last day of each Fiscal Quarter thereafter                 2.50 to 1.00

          (c) Fixed Charge Coverage Ratio. As measured on each Measurement Date
              ---------------------------
     for the Measurement Period ending on such Measurement Date, the Fixed
     Charge Coverage Ratio shall not be less than:

<TABLE>
<CAPTION>
     Measurement Date                                                           Ratio
     ----------------                                                           -----
<S>                                                                             <C>
     The last day of each Fiscal Quarter of Fiscal Year 2002                    1.00 to 1.00
     The last day of the 1st Fiscal Quarter of Fiscal Year 2003                 1.05 to 1.00
     The last day of the 2nd Fiscal Quarter of Fiscal Year 2003                 1.05 to 1.00
     The last day of the 3rd Fiscal Quarter of Fiscal Year 2003                 1.10 to 1.00
     December 31, 2003                                                          1.10 to 1.00
     The last day of each Fiscal Quarter thereafter                             1.15 to 1.00
</TABLE>

          (d) Minimum EBITDA to Interest Ratio. As measured on each Measurement
              --------------------------------
     Date for the Measurement Period ending on such Measurement Date, the EBITDA
     to Interest Ratio shall not be less than:

<TABLE>
<CAPTION>
     Measurement Date                                                           Ratio
     ----------------                                                           -----
<S>                                                                             <C>
     The last day of each Fiscal Quarter of Fiscal Year 2002                    2.50 to 1.00
     The last day of each Fiscal Quarter of Fiscal Year 2003                    2.75 to 1.00
     The last day of each Fiscal Quarter thereafter                             3.00 to 1.00
</TABLE>

                                   ARTICLE 8
                                EVENTS OF DEFAULT

     8.1 Events of Default. An Event of Default means the occurrence of one or
         -----------------
more of the following described events:

         (a) any Loan Party shall default in the payment of (i) interest on the
     Note within three (3) days after its due date, or (ii) principal of the
     Note and/or any PIK Interest or other Obligation when due, whether at
     maturity, upon notice of prepayment in accordance with this Agreement, upon
     any scheduled payment date or by acceleration or otherwise;

         (b) (i) any Loan Party shall default under or breach any agreement
     under which any Indebtedness in an aggregate principal amount of $250,000
     or more is created, assumed, secured or guaranteed and such default or
     breach (A) entitles the holder of such Indebtedness to accelerate the
     maturity of such Indebtedness, (B) occurs at the final maturity of the
     obligations thereunder, or (C) results in the other party thereto
     terminating such agreement or refusing to renew such agreement pursuant to
     an automatic renewal right therein, (ii) any default or breach occurs,
     which is not cured or waived, in the performance, observance or fulfillment
     of any provision contained in any material agreement, contract, document or
     instrument to which any Loan Party is a party or to which any of their
     respective properties or assets are subject or bound (as determined by

                                       -57-

<PAGE>

the Agent in its sole discretion) and such default or breach continues for more
than any applicable grace period or permits the other party thereto to terminate
such agreement, setoff any amounts or otherwise reduce or limit any amounts owed
by such other party thereunder or take any action against any Loan Party, or
(iii) any Indebtedness of any Loan Party in excess of $250,000 is declared to be
due and payable or is required to be prepaid (other than by a regularly
scheduled payment) prior to the stated maturity thereof, or any obligation of
such Person for the payment of Indebtedness (other than the Obligations) is not
paid when due or within any applicable grace period, or any such obligation
becomes or is declared to be due and payable before the expressed maturity
thereof, or there occurs an event which, with the giving of notice or lapse of
time, or both, would cause any such obligation to become, or allow any such
obligation to be declared to be, due and payable;

     (c) any representation or warranty in any Purchase Document made by any
Loan Party, or any certificate or financial statement furnished pursuant to the
provisions hereof, shall prove to have been false or misleading in any material
respect as of the time made or furnished or deemed made or furnished (except to
the extent already qualified by materiality, in which case it shall be true and
correct in all respects and shall not be false or misleading in any respect);

     (d) any Loan Party or other party thereto other than Purchaser shall be in
violation, breach or default of, or shall fail to perform, observe or comply
with any covenant, obligation or agreement set forth in, any Purchase Document
and such violation, breach, default or failure shall not be cured within the
applicable period set forth in the applicable Purchase Document; provided that,
                                                                 --------
with respect to the affirmative covenants set forth in Article VII (other than
                                                       -----------
Section 7.1(a) (for which there shall be no cure) there shall be a fifteen (15)
--------------
calendar day cure period commencing from the earlier of (i) Receipt by such
Person of written notice of such breach, default, violation or failure, and (ii)
the time at which such Person or any authorized officer thereof knew or became
aware, or should have known or been aware, of such failure, violation, breach or
default;

     (e) (i) a default or event of default shall occur under any of the other
Purchase Documents beyond any applicable notice or cure periods, or (ii) receipt
by the Agent or any Purchaser of any notice from any Loan Party that it is
attempting to terminate or limit any portion of its obligations under any
Purchase Document;

     (f) a proceeding shall have been instituted in a court having jurisdiction
in the premises seeking a decree or order for relief in respect of any Loan
Party in an involuntary case under any applicable bankruptcy, insolvency or
other similar law now or hereafter in effect, or for the appointment of a
receiver, liquidator, assignee, custodian, trustee, sequestrator (or similar
official) of any Loan Party or for any substantial part of its property, or for
the winding-up or liquidation of their affairs, and such proceeding shall remain
undismissed or unstayed and in effect for a period of 60 days;

     (g) any Loan Party shall commence a voluntary case under any applicable
bankruptcy, insolvency or other similar law now or hereafter in effect, shall
consent to the entry of an order for relief in an involuntary case under any
such law, or shall consent to

                                       -58-

<PAGE>

the appointment of or taking possession by a receiver, liquidator, assignee,
trustee, custodian, sequestrator (or other similar official) of any Loan Party
or for any substantial part of their property, or shall make a general
assignment for the benefit of creditors, or shall fail generally to pay their
debts as they become due, or shall take any action in furtherance of any of the
foregoing;

     (h) both the following events shall occur; (i) a Reportable Event, the
occurrence of which would have a Material Adverse Effect which could cause the
imposition of a Lien under Section 4068 of ERISA, shall have occurred with
respect to any Plan or Plans; and (ii) the aggregate amount of the then "current
liability" (as defined in Section 412(l)(7) of the Internal Revenue Code of
1986, as amended) of all accrued benefits under such Plan or Plans exceeds the
then current value of the assets allocable to such benefits by more than
$500,000 at such time;

     (i) a final judgment which, with other undischarged final judgments against
any and all Loan Parties, exceeds an aggregate of $250,000 (excluding judgments
to the extent the applicable Loan Party is fully insured or the deductible or
retention limit does not exceed $250,000 and with respect to which the insurer
has assumed responsibility in writing), shall have been entered against any Loan
Party if, within thirty (30) days after the entry thereof, such judgment shall
not have been discharged or execution thereof stayed pending appeal, or if,
within thirty (30) days after the expiration of any such stay, such judgment
shall not have been discharged;

     (j) any Purchase Document shall at any time after the Closing Date cease
for any reason to be in full force and effect or shall cease to create perfected
security interests in favor of the Agent, for the benefit of the Agent and the
Purchasers, in the Collateral subject or purported to be subject thereto,
subject to no other Liens other than Permitted Liens, or any Lien created
thereunder ceases to constitute a perfected Lien in accordance with the terms
thereof or the Agent ceases to have a perfected lien in any of the Collateral or
such Collateral shall have been transferred to any Person without the prior
written consent of the Agent;

     (k) (i) any Change of Control occurs or any agreement or commitment to
cause or that may result in any such Change of Control is entered into, (ii) any
Material Adverse Effect or Material Adverse Change occurs or is reasonably
expected to occur, or (iii) any Loan Party ceases any portion of its business
operations as currently conducted;

     (l) The Agent or any Purchaser receives any indication or evidence that any
Loan Party may have directly or indirectly been engaged in any type of activity
which, in the Agent or Purchaser's determination, might result in forfeiture of
all or any material part of the Collateral to any Governmental Authority which
shall have continued unremedied for a period of 10 calendar days after written
notice from the Agent or Purchaser, except where contested in good faith by
proper proceedings diligently pursued where a stay of enforcement is in effect;

                                       -59-

<PAGE>

     (m) any uninsured damage to, or loss, theft or destruction of, any portion
of the Collateral occurs which could reasonably be expected to cause a Material
Adverse Effect and is not adequately covered by insurance;

     (n) any Loan Party or any of their respective directors (other than outside
directors) or senior officers is criminally indicted or convicted of
         any felony under any Law;

     (o) the issuance of any process for levy, attachment or garnishment or
execution upon or prior to any judgment against any Loan Party or any of the
Collateral or the issuance of any injunction against any Loan Party which
enjoins or restrains any of the Loan Parties from continuing to conduct any
material part of such Loan Party's business affairs; or

     (p) any Loan Party does, or enters into or becomes a party to any agreement
or commitment to do, or cause to be done, any of the things described in this
Article VIII or otherwise prohibited by any Purchase Document (subject to any
cure periods set forth therein);

8.2  Consequences of Event of Default.
     --------------------------------

     (a) Bankruptcy. If an Event of Default specified in paragraphs (f) or (g)
         ----------
of Section 8.1 hereof shall occur, the unpaid balance of the Notes, interest
accrued thereon (including PIK Interest) and all other liabilities and
Obligations of the Loan Parties to the Purchasers under the Purchase Documents
shall be immediately due and payable, without presentment, demand, protest or
(except as expressly required hereby) notice of any kind, all of which are
hereby expressly waived.

     (b) Other Defaults. If any other Event of Default shall occur, the Agent
         --------------
may at its option (and shall at the written direction of the Required
Purchasers), by written notice to the Loan Parties, declare the entire unpaid
balance of the Notes, and interest accrued thereon and all other liabilities and
Obligations of the Loan Parties under the Purchase Documents to be forthwith due
and payable, and the same shall thereupon become immediately due and payable,
without presentment, demand, protest or (except as expressly required hereby)
notice of any kind, all of which are hereby expressly waived, anything contained
herein or in any other Purchase Document to the contrary notwithstanding. The
Agent may (and shall at the written direction of the Required Purchasers), by
notice to the Parent, rescind and annual any declaration of an Event of Default
or acceleration of maturity under this paragraph (b) prior to the indefeasible
payment in full of the outstanding Notes.

     (c) Penalty Interest. Following the occurrence and during the continuance
         ----------------
of any Event of Default, the Purchasers shall be entitled to receive, to the
extent permitted by applicable law, interest on the outstanding principal of,
and premium and overdue interest, if any, on, the Notes at a rate per annum
equal to the interest rate thereon (determined as provided in this Agreement)
plus 300 basis points.

                                       -60-

<PAGE>

         (d) Premium. In the event of any acceleration of Notes pursuant to
             -------
     this Section 8.2, the Loan Parties shall also pay to the Purchasers (in
     addition to the then outstanding principal, accrued interest and other
     Obligations pursuant to the terms of the Purchase Documents), as yield
     maintenance for the loss of bargain and not as a penalty, the prepayment
     premium that would otherwise be payable upon any voluntary prepayment of
     the Notes pursuant to Section 3.3 of this Agreement as if the Notes were
     voluntarily prepaid on the date of such Event of Default.

     8.3 Security. Payments of principal of, and premium, if any, and interest
         --------
on, the Notes and all other Obligations of the Loan Parties under the Purchase
Documents are secured pursuant to the terms of the Security Documents.

     8.4 Set-off. Upon the occurrence and during the continuance of any Event of
         -------
Default, each Purchaser is hereby authorized at any time and from time to time
without notice to any Loan Party (any such notice being expressly waived by such
Loan Party) and, to the fullest extent permitted by law, to set off and to apply
any and all balances, credits, deposits (general or special, time or demand,
provisional or final), accounts or moneys at any time held and other
indebtedness or amounts at any time owing by such Purchaser to or for the
account of such Loan Party against any and all of the Obligations of the Loan
Parties now or hereafter existing under this Agreement, any other Purchase
Document or any other agreement or instrument delivered by such Loan Party to
such Purchaser in connection therewith, whether or not such Purchaser shall have
made any demand hereunder or thereunder and although such obligations may be
contingent or unmatured. The rights of the Purchasers under this Section are in
addition to other rights and remedies (including, without limitation, other
rights of set-off) which they may have. A Purchaser shall give the Loan Party
notice of any set-off hereunder after such set-off has occurred.

                                   ARTICLE 9
                                AGENCY PROVISIONS

9.1  The Agent.
     ---------

     (a) Appointment. Each Purchaser hereby designates and appoints
         -----------
CapitalSource as the administrative agent and the collateral agent, under this
Agreement and the other Purchase Documents, and each Purchaser hereby
irrevocably authorizes CapitalSource, as the administrative agent and the
collateral agent for such Purchaser, to take such action or to refrain from
taking such action on its behalf under the provisions of this Agreement and the
other Purchase Documents and to exercise such powers and perform such duties as
are delegated to the Agent by the terms of this Agreement and the other Purchase
Documents, together with such other powers as are reasonably incidental thereto.
The Agent agrees to act as such on the conditions contained in this Article 9.
The provisions of this Article 9 are solely for the benefit of the Agent and the
Purchasers, and no Loan Party shall have rights as a third-party beneficiary of
any of the provisions hereof, except as expressly set forth in this Article 9.
The Agent may perform any of its duties hereunder, or under the Purchase
Documents, by or through its agents or employees.

                                       -61-

<PAGE>

     (b) Nature of Duties. In performing its functions and duties under this
         ----------------
Agreement, the Agent is acting solely on behalf of the Purchasers and its duties
are administrative in nature and does not assume and shall not be deemed to have
assumed any obligation toward or relationship of agency or trust with or for the
Purchasers, other than as expressly set forth herein and in the other Purchase
Documents, or Loan Parties. The Agent shall have no duties, obligations or
responsibilities except those expressly set forth in this Agreement or in the
other Purchase Documents. The Agent shall not have by reason of this Agreement a
fiduciary relationship in respect of any Purchaser. Except for information,
notices, reports, and other documents expressly required to be furnished to the
Purchasers by the Agent hereunder or given to the Agent for the account of or
with copies for the Purchasers, each Purchaser shall make its own independent
investigation of the financial condition and affairs of the Loan Parties in
connection with the extension of credit hereunder and shall make its own
appraisal of the creditworthiness of the Loan Parties, and the Agent shall have
no duty or responsibility, either initially or on a continuing basis, to provide
any Purchaser with any credit or other information with respect thereto, whether
coming into its possession before the Closing Date or at any time or times
thereafter. If the Agent seeks the consent or approval of any Purchasers to the
taking or refraining from taking any action hereunder, then the Agent shall send
prior written notice thereof to each Purchaser. The Agent shall promptly notify
(in writing) each Purchaser any time that the applicable percentage of the
Purchasers have instructed the Agent to act or refrain from acting pursuant
hereto.

     (c) Rights, Exculpation, Etc. Neither the Agent nor any of its officers,
         ------------------------
directors, managers, members, equity owners, employees or agents shall be liable
to any Purchaser for any action lawfully taken or omitted by them hereunder or
under any of the other Purchase Documents, or in connection herewith or
therewith. Notwithstanding the foregoing, the Agent shall be obligated on the
terms set forth herein for performance of its express duties and obligations
hereunder, and the Agent shall be liable with respect to its own gross
negligence or willful misconduct. The Agent shall not be liable for any
apportionment or distribution of payments made by it in good faith, and if any
such apportionment or distribution is subsequently determined to have been made
in error, the sole recourse of any Purchaser to whom payment was due but not
made shall be to recover from other Purchasers any payment in excess of the
amount to which they are determined to be entitled (and such other Purchasers
hereby agree to return to such Purchaser any such erroneous payments received by
them). In performing its functions and duties hereunder, the Agent shall
exercise the same care which it would in dealing with loans for its own account.
The Agent shall not be responsible to any Purchaser for any recitals,
statements, representations or warranties made by Loan Parties herein or for the
execution, effectiveness, genuineness, validity, enforceability, collectability,
or sufficiency of this Agreement or any of the other Purchase Documents or the
transactions contemplated thereby, or for the financial condition of the Loan
Parties. The Agent shall not be required to make any inquiry concerning either
the performance or observance of any of the terms, provisions, or conditions of
this Agreement or any of the Purchase Documents or the financial condition of
the Loan Parties, or the existence or possible existence of any Default or Event
of Default. The Agent may at any time request instructions from the Purchasers
with respect to any actions or approvals which by the

                                       -62-

<PAGE>

terms of this Agreement or of any of the other Purchase Documents the Agent is
permitted or required to take or to grant, and the Agent shall be absolutely
entitled to refrain from taking any action or to withhold any approval and shall
not be under any liability whatsoever to any Person for refraining from taking
any action or withholding any approval under any of the Purchase Documents until
it shall have received such instructions from the applicable percentage of the
Purchasers. Without limiting the foregoing, no Purchaser shall have any right of
action whatsoever against the Agent as a result of the Agent acting or
refraining from acting under this Agreement or any of the other Purchase
Documents in accordance with the instructions of the applicable percentage of
the Purchasers and notwithstanding the instructions of the Purchasers, the Agent
shall have no obligation to take any action if it, in good faith believes that
such action exposes the Agent or any of its officers, directors, managers,
members, equity owners, employees or agents to any personal liability unless the
Agent receives an indemnification reasonably satisfactory to it from the
Purchasers with respect to such action.

     (d) Reliance. The Agent shall be entitled to rely upon any written notices,
         --------
statements, certificates, orders or other documents or any telephone message or
other communication (including any writing, telex, telecopy or telegram)
believed by it in good faith to be genuine and correct and to have been signed,
sent or made by the proper Person, and with respect to all matters pertaining to
this Agreement or any of the other Purchase Documents and its duties hereunder
or thereunder, upon advice of legal counsel, independent accountants, and other
experts selected by the Agent in its sole discretion.

     (e) Indemnification. Each Purchaser, severally and not jointly, agrees to
         ---------------
reimburse and indemnify the Agent and its officers, directors, managers,
members, equity owners, employees and agents (to the extent not reimbursed by
the Loan Parties), ratably according to the principal portion of the Notes held
by such Purchaser in relation to the principal portion of the outstanding Notes,
as in effect on the date on which indemnification is sought under this
subsection, from and against any and all liabilities, obligations, losses,
damages, penalties, actions, judgments, suits, costs, expenses, advances, or
disbursements of any kind or nature whatsoever which may be imposed on, incurred
by, or asserted against the Agent or any of its officers, directors, managers,
members, equity owners, employees or agents in any way relating to or arising
out of this Agreement or any of the other Purchase Documents or any action taken
or omitted by the Agent under this Agreement or any of the other Purchase
Documents; provided, however, that no Purchaser shall be liable for the payment
           --------  -------
of any portion of such liabilities, obligations, losses, damages, penalties,
actions, judgments, suits, costs, expenses, advances or disbursements resulting
from the Agent's gross negligence or willful misconduct. The obligations of the
Purchasers under this Article 9 shall survive the payment in full of the
Obligations and the termination of this Agreement.

     (f) CapitalSource Individually. With respect to the Notes issued to it,
         --------------------------
CapitalSource shall have and may exercise the same rights and powers hereunder
and under the other Purchase Documents and is subject to the same obligations
and liabilities as and to the extent set forth herein and the other Purchase
Documents as any other Purchaser. The terms "the Purchasers" or any similar
terms shall, unless the context

                                       -63-

<PAGE>

     clearly otherwise indicates, include CapitalSource in its individual
     capacity as a Purchaser. CapitalSource may lend money to, and generally
     engage in any kind of banking, trust or other business with the Loan
     Parties or any subsidiary of the Loan Parties as if it were not acting as
     the Agent pursuant hereto.

          (g) Successor the Agent
              -------------------

              (i)   Resignation. The Agent may resign from the performance of
                    -----------
all its functions and duties hereunder at any time by giving at least thirty
(30) days' prior written notice to the Loan Parties and the Purchasers. Such
resignation shall take effect upon the acceptance by a successor the Agent of
appointment pursuant to clause (ii) below or as otherwise provided below.

              (ii)  Appointment of Successor. Upon any such notice of
                    ------------------------
resignation pursuant to paragraph (g)(i) above, the Purchasers shall appoint a
successor Agent. If a successor Agent shall not have been so appointed within
said thirty (30) day period, the retiring Agent, upon notice to Loan Parties,
may, on behalf of the Purchasers, then appoint a successor Agent who shall serve
as the Agent until such time as the Purchasers appoint a successor Agent as
provided above. If no successor Agent has been appointed pursuant to the
foregoing within said thirty (30) day period, the resignation shall become
effective and the Purchasers shall thereafter perform all the duties of the
Agent hereunder, until such time, if any, as the Purchasers appoint a successor
Agent as provided above.

              (iii) Successor Agent. Upon the acceptance of any appointment as
                    ---------------
the Agent under the Purchase Documents by a successor Agent, such successor
Agent shall thereupon succeed to and become vested with all the rights, powers,
privileges and duties of the retiring Agent, and, upon the earlier of such
acceptance or the effective date of the retiring Agent's resignation, the
retiring Agent shall be discharged from its duties and obligations under the
Purchase Documents, except that any indemnity rights or other rights in favor of
such retiring Agent shall continue. After any retiring Agent's resignation as
the Agent under the Purchase Documents, the provisions of this Article 9 shall
inure to its benefit as to any actions taken or omitted to be taken by it while
it was the Agent under the Purchase Documents.

          (h) Collateral Matters.
              ------------------

              (i)   Collateral. Each Purchaser agrees that any action taken by
                    ----------
the Agent or the Purchasers in accordance with the provisions of this Agreement
or of the other Purchase Documents relating to the Collateral, and the exercise
by the Agent or the Purchasers of the powers set forth herein or therein,
together with such other powers as are reasonably incidental thereto, shall be
authorized and binding upon all of the Purchasers and the Agent. Without
limiting the generality of the foregoing, the Agent shall have the sole and
exclusive right and authority to (i) act as the disbursing and collecting agent
for the Purchasers with respect to all payments and collections arising in
connection herewith and with the Purchase Documents in connection with the
Collateral; (ii) execute and deliver each Purchase Document relating to the
Collateral and accept delivery of each such agreement delivered by the Loan
Parties; (iii) act as collateral agent for the Purchasers for purposes of the
perfection of all security interests and Liens created by such agreements and
all other purposes stated therein; (iv) manage, supervise and

                                      -64-

<PAGE>

otherwise deal with the Collateral; (v) take such action as is necessary or
desirable to maintain the perfection and priority of the security interests and
Liens created or purported to be created by the Purchase Documents relating to
the Collateral, and (vi) except as may be otherwise specifically restricted by
the terms hereof or of any other Purchase Document, exercise all remedies given
to such Agent and the Purchasers with respect to the Collateral under the
Purchase Documents relating thereto, applicable law or otherwise.

         (ii)  Release of Collateral. The Purchasers hereby irrevocably
               ---------------------
authorize the Agent, at its option and in its discretion, to release any Lien
granted to or held by the Agent for the benefit of the Purchasers upon any
property covered by this Agreement or the Purchase Documents (A) upon
termination of this Agreement and payment and satisfaction in full of all
Obligations; (B) constituting property being sold or disposed of if the Loan
Parties certify to the Agent that the sale or disposition is made in compliance
with the provisions of this Agreement (and the Agent may rely in good faith
conclusively on any such certificate, without further inquiry); or (C)
constituting property leased to any of the Loan Parties under a lease which has
expired or been terminated in a transaction permitted under this Agreement or is
about to expire and which has not been, and is not intended by the Loan Parties
to be, renewed or extended.

         (iii) Confirmation of Authority; Execution of Releases. Without in any
               ------------------------------------------------
manner limiting the Agent's authority to act without any specific or further
authorization or consent by the Purchasers (as set forth in Section 9.1(h)(i)
and (ii)), each Purchaser agrees to confirm in writing, upon request by the
Parent, the authority to release any property covered by this Agreement or the
Purchase Documents conferred upon the Agent under Section 9.1(h)(ii). So long as
no Event of Default is then continuing, upon receipt by the Agent of
confirmation from the requisite percentage of the Purchasers, of its authority
to release any particular item or types of property covered by this Agreement or
the Purchase Documents, and upon at least five (5) Business Days prior written
request by Loan Parties, the Agent shall (and is hereby irrevocably authorized
by the Purchasers to) execute such documents as may be necessary to evidence the
release of the Liens granted to the Agent for the benefit of the Purchasers
herein or pursuant hereto upon such Collateral; provided, however, that (A) the
                                                --------  -------
Agent shall not be required to execute any such document on terms which, in the
Agent's opinion, would expose the Agent to liability or create any obligation or
entail any consequence other than the release of such Liens without recourse or
warranty, and (B) such release shall not in any manner discharge, affect or
impair the Obligations or any Liens upon (or obligations of the Loan Parties in
respect of), all interests retained by the Loan Parties, including, without
limitation, the proceeds of any sale, all of which shall continue to constitute
part of the property covered by this Agreement or the Purchase Documents.

         (iv)  Absence of Duty. The Agent shall have no obligation whatsoever to
               ---------------
any Purchaser or any other Person to assure that the property covered by this
Agreement or the Purchase Documents exists or is owned by the Loan Parties or is
cared for, protected or insured or has been encumbered or that the Liens granted
to the Agent on behalf of the Purchasers herein or pursuant hereto have been
properly or sufficiently or lawfully created, perfected, protected or enforced
or are entitled to any particular priority, or to exercise at all or in any
particular manner or under any duty of care, disclosure, or fidelity, or to
continue exercising, any of the rights, authorities and powers granted or
available to the Agent in this Section 9.1(h) or in any of the

                                       -65-

<PAGE>

Purchase Documents, it being understood and agreed that in respect of the
property covered by this Agreement or the Purchase Documents or any act,
omission, or event related thereto, the Agent may act in any manner it may deem
appropriate, in its discretion, given the Agent's own interest in property
covered by this Agreement or the Purchase Documents as one of the Purchasers and
that the Agent shall have no duty or liability whatsoever to any of the other
the Purchasers; provided, that the Agent shall exercise the same care which it
                --------
would in dealing with loans for its own account. Notwithstanding the foregoing,
the Agent shall be liable with respect to its own gross negligence or willful
misconduct.

          (i) Agency for Perfection. Each Purchaser hereby appoints the Agent as
              ---------------------
     agent for the purpose of perfecting the Purchasers' security interest in
     Collateral which, in accordance with Article 9 of the UCC in any applicable
     jurisdiction, can be perfected only by possession. Should any Purchaser
     (other than the Agent) obtain possession of any such Collateral, such
     Purchaser shall notify the Agent thereof, and, promptly upon the Agent's
     request therefor, shall deliver such Collateral to the Agent or in
     accordance with the Agent's instructions.

          (j) Exercise of Remedies. Except as set forth in Section 9.3, each
              --------------------
     Purchaser agrees that it will not have any right individually to enforce or
     seek to enforce this Agreement or any Purchase Document or to realize upon
     any Collateral, it being understood and agreed that such rights and
     remedies may be exercised only by the Agent.

     9.2  Consents.
          --------

          (a) In the event the Agent requests the consent of a Purchaser and
     does not receive a written denial thereof within five (5) Business Days
     after such Purchaser's receipt of such request, then such Purchaser will be
     deemed to have given such consent so long as such request contained a
     notice stating that such failure to respond within five (5) business days
     would be deemed to be a consent by such Purchaser.

          (b) In the event the Agent requests the consent of a Purchaser in a
     situation where such Purchaser's consent would be required and such consent
     is denied, then the Agent may, at its option, require such Purchaser to
     assign the Notes held by such Purchaser to Agent for a price equal to the
     then outstanding principal amount thereof plus accrued and unpaid interest
     and fees due such Purchaser, which interest and fees will be paid when
     collected from the Loan Parties. In the event that the Agent elects to
     require any Purchaser to assign its interest to the Agent pursuant to this
     Section 9.2, the Agent will so notify such Purchaser in writing within
     forty-five (45) days following such Purchaser's denial, and such Purchaser
     will assign its interest to the Agent no later than five (5) days following
     receipt of such notice.

     9.3  Dissemination of Information. The Agent will distribute promptly to
          ----------------------------
each Purchaser copies of all notices, schedules, reports, projections, financial
statements, agreements and other material and other information, including, but
not limited to, financial and reporting information received from the Loan
Parties or generated by a third party (and excluding only internal information
generated by CapitalSource for its own use as a Purchaser or as Agent), as
provided for in this Agreement and the other Purchase Documents as received by
the Agent. The

                                       -66-

<PAGE>

Agent shall promptly give notice to the Purchasers of the receipt or sending of
any notice, schedule, report, projection, financial statement or other document
or information pursuant to this Agreement or any of the other Purchase Documents
and shall promptly forward a copy thereof to each Purchaser. The Agent shall
request information from the Loan Parties as the Purchasers may request from
time to time. The Agent shall not be liable to the Purchasers for any failure to
comply with its obligations under this Section 9.3, except to the extent that
such failure is attributable to the Agent's gross negligence or willful
misconduct.

                                   ARTICLE 10
                                  MISCELLANEOUS

     10.1 Successors and Assigns; Participants.
          ------------------------------------

          (a) This Agreement shall be binding upon and inure to the benefit of
     the parties hereto and their respective successors and assigns, except that
     (i) the Loan Parties may not assign or transfer their rights hereunder or
     any interest herein or delegate their duties hereunder, and (ii) each
     Purchaser shall have the right to assign its rights hereunder and under the
     other Purchase Documents and, in accordance with Article 6, under the
     Securities in accordance with Article 6. No rights are intended to be
     created under any Purchase Document for the benefit of any third party
     donee, creditor or incidental beneficiary of any Loan Party. Nothing
     contained in any Purchase Document shall be construed as a delegation to
     Purchaser of any other Person's duty of performance.

          (b) Each Purchaser may at any time sell participations in all or any
     part of its rights and obligations under this Agreement and the other
     Purchase Documents (including the Notes) to one or more Persons (a
     "Participant"). In the event of any such sale by a Purchaser of a
     participation to a Participant, such Purchaser's obligations under this
     Agreement to the other parties to this Agreement shall remain unchanged,
     such Purchaser shall remain solely responsible for the performance thereof,
     such Purchaser shall remain the holder of any such Note for all purposes
     under this Agreement and the other Purchase Documents and the Loan Parties
     and the Agent shall continue to deal solely and directly with such
     Purchaser in connection with such Purchaser's rights and obligations under
     this Agreement and the other Purchase Documents. Notwithstanding any other
     provision set forth in this Agreement, any Purchaser may at any time create
     a security interest in all or any portion of its rights under this
     Agreement, including, without limitation, the Notes held by it. The Loan
     Parties agree to use commercially reasonable efforts to assist any
     Purchaser in assigning or selling participations in all or any part of any
     Notes made by such Purchaser to another Person identified by such
     Purchaser. Each Purchaser may furnish any information concerning the Loan
     Parties in the possession of such Purchaser from time to time to assignees
     and participants (including prospective assignees and participants).

          (c) Notwithstanding anything in this Agreement to the contrary, there
     shall be no limitation or restriction on CapitalSource's ability to assign,
     pledge or otherwise transfer any Purchase Document to any lender or funding
     source of CapitalSource or CapitalSource's affiliates.

                                       -67-

<PAGE>

     10.2 Modifications and Amendments. The provisions of this Agreement may be
          ----------------------------
modified, waived or amended, but only by a written instrument signed by each of
the Loan Parties to be bound thereby, the Agent and the Required Purchasers.

     10.3 No Implied Waivers; Writing Required; Waivers. No delay or failure in
          ---------------------------------------------
exercising any right, power or remedy under the Purchase Documents shall affect
or operate as a waiver thereof; nor shall any single or partial exercise thereof
or any abandonment or discontinuance of steps to enforce such a right, power or
remedy preclude any further exercise thereof or of any other right, power or
remedy. Any waiver, permit, consent or approval of any kind or character of any
breach or default under the Purchase Documents or any such waiver of any
provision or condition of the Purchase Documents must be in writing and shall be
effective only to the extent in such writing specifically set forth. No course
of action or dealing, renewal, release or extension of any provision of any
Purchase Document, or single or partial exercise of any such provision, or
delay, failure or omission on the Agent's or a Purchaser's part in enforcing any
such provision shall affect the liability of any Loan Party or operate as a
waiver of such provision or affect the liability of any Loan Party or preclude
any other or further exercise of such provision. Notwithstanding any other
provision of any Purchase Document, by consummating the Transactions, the Agent
and the Purchasers do not waive any breach of any representation or warranty of
under any Purchase Document, and all of the Agent's and the Purchaser's claims
and rights resulting from any such breach or misrepresentation are specifically
reserved. Except as expressly provided for herein, each Loan Party hereby waives
demand, presentment, protest, all defenses with respect to any and all
instruments and all notices and demands of any description. Each Loan Party
hereby waives any and all defenses and counterclaims it may have or could
interpose in any action or procedure brought by the Agent to obtain an order of
court recognizing the assignment of, or Lien of the Agent, for the benefit of
the Agent and the Purchasers, in and to, any Collateral covered by the Security
Documents.

     10.4 Reimbursement of Expenses; Contingent Fee.
          -----------------------------------------

          (a) The Loan Parties upon demand shall pay or reimburse the Agent and
     any Purchaser for all fees and expenses incurred or payable by the Agent,
     any Purchaser and/or its Affiliates (including, without limitation,
     documentation and diligence fees and expenses, all search, audit,
     appraisal, recording, professional and filing fees and expenses and all
     other out-of-pocket charges and expenses (including, without limitation,
     UCC and judgment and tax lien searches and UCC filings and fees for
     post-Closing UCC and judgment and tax lien searches and wire transfer fees
     and audit expenses and reasonable attorneys' fees and expenses), from time
     to time (i) in any effort to enforce, protect or collect payment of any
     Obligation or to enforce any Purchase Document or any related agreement,
     document or instrument, (ii) in connection with entering into, negotiating,
     preparing, reviewing and executing the Purchase Documents and/or any
     related agreements, documents or instruments, (iii) arising in any way out
     of administration of the Obligations, (iv) in connection with instituting,
     maintaining, preserving, enforcing and/or foreclosing the Purchase
     Documents or on the Agent's Liens in any Collateral or securities pledged
     under the Purchase Documents or in collection of the Notes or Obligations,
     whether through judicial proceedings or otherwise, (v) in defending or
     prosecuting any actions, claims or proceedings arising out of or relating
     to the Agent or any Purchaser's transactions with Loan Parties, (vi) in
     seeking, obtaining or receiving any

                                       -68-

<PAGE>

     advice with respect to its rights and obligations under any Purchase
     Document and any related agreement, document or instrument, and/or (vii) in
     connection with any modification, restatement, supplement, amendment,
     waiver or extension of any Purchase Document and/or any related agreement,
     document or instrument. All of the foregoing shall be part of the
     Obligations. If the Agent, any Purchaser or any of its Affiliates uses
     in-house counsel for any purpose under any Purchase Document for which Loan
     Parties are responsible to pay or indemnify, Loan Parties expressly agree
     that their Obligations include reasonable charges for such work
     commensurate with the fees that would otherwise be charged by outside legal
     counsel selected by the Agent, such Purchaser or such Affiliate in its sole
     discretion for the work performed.

          (b) In the event that the Parent does not receive the consent of its
     stockholders required to comply with NASDAQ Rule 4350(i)(1)(D) prior to
     July 1, 2002 in order to increase the number of shares purchasable under
     Section 1(b) of the Warrant, within three Business Days of such date, the
     Loan Parties shall pay to the Purchaser a fee equal to the greater of (i)
     $324,255.38 and (ii) the product of (i) 48,614 multiplied by the per share
                                                    ----------
     fair market value of the Shares (as determined in accordance with the terms
     of the Warrant) as of July 1, 2002.

     10.5 Holidays. Whenever any payment or action to be made or taken hereunder
          --------
or under the Notes or Warrant or any other Purchase Document shall be stated to
be due on a day which is not a Business Day, such payment or action shall be
made or taken on the next following Business Day, and such extension of time
shall be included in computing interest or fees, if any, in connection with such
payment or action.

     10.6 Notices. All notices and other communications given to or made upon
          -------
any party hereto in connection with any Purchase Document shall be in writing
and shall be given at such party's address set forth below, or at such other
address as such party may hereafter specify in a notice given in the manner
required under this Section 10.6, and shall be given only by, and shall be
deemed to have been received upon (each, a "Receipt"): (i) registered or
certified mail, return receipt requested, on the date on which such received as
indicated in such return receipt, (ii) delivery by a nationally recognized
overnight courier, one (1) Business Day after deposit with such courier, or
(iii) facsimile or electronic transmission, in each case upon telephone or
further electronic communication from the recipient acknowledging receipt
(whether automatic or manual from recipient), as applicable:

     to any of the Loan Parties:

          c/o Encore Medical Corporation
          9800 Metric Blvd.
          Austin, Texas 78758
          Attn:  Harry Zimmerman
          Telephone: (512) 834-6208
          Fax:  (512) 834-6310
          E-Mail: harry_zimmerman@encoremed.com

     with a copy to:

                                       -69-

<PAGE>

          Jackson Walker L.L.P.
          100 Congress Avenue, Suite 110
          Austin, Texas 78701
          Attn:  Lawrence A. Waks, Esq.
          Telephone: (512) 236-2222
          Fax:  (512) 236-2002
          E-Mail: lwaks@jw.com

     to the Purchasers or the Agent:

          c/o CapitalSource Finance LLC
          4445 Willard Avenue, 12/th/ Floor
          Chevy Chase, MD  20815
          Attention:  Corporate Finance Group, Portfolio Manager
          Telephone:  (301) 841-2700
          FAX:  (301) 841-2360
          E-Mail: rdailey@capitalsource.com

     10.7 Effectiveness and Survival. This Agreement shall continue in full
          --------------------------
force and effect until the full performance and indefeasible payment in cash of
all Obligations pursuant to the provisions herein. Notwithstanding any other
provision of any Purchase Document, no termination of this Agreement shall
affect the Agent's or any Purchaser's rights or any of the Obligations existing
as of the effective date of such termination, and the provisions of the Purchase
Documents shall continue to be fully operative until the Obligations have been
fully performed and indefeasibly paid in cash in full. The Liens granted to the
Agent under the Security Documents and the Financing Statements filed pursuant
thereto and the rights and powers of the Agent shall continue in full force and
effect until all of the Obligations have been fully performed and indefeasibly
paid in full in cash. All representations, warranties, covenants and agreements
of the Loan Parties contained herein or made in writing in connection herewith
or in any Purchase Document shall survive the execution and delivery and, if
applicable, termination of this Agreement and the purchase of the Notes and
Warrant and shall continue in full force and effect so long as any Note is
outstanding and until payment in full and performance of all of the Loan
Parties' Obligations hereunder or thereunder. All obligations relating to
indemnification hereunder shall survive any termination of this Agreement and
shall continue for the length of any applicable statute of limitations. The
obligations and provisions of Sections 10.3, 10.4, 10.7, 10.10 and 10.18 shall
survive termination of the Purchase Documents and any payment, in full or in
part, of the Obligations.

     10.8 Governing Law. This Agreement and any other Purchase Document which by
          -------------
its terms does not include a governing law provision shall be governed by and
construed in accordance with the internal laws of the State of Maryland without
giving effect to its choice of law provisions. Any judicial proceeding against
any Loan Party with respect to the Obligations, any Purchase Document or any
related agreement may be brought in any federal or state court of competent
jurisdiction located in the State of Maryland. By execution and delivery of each
Purchase Document to which it is a party, each Loan Party (i) accepts the
non-exclusive

                                       -70-

<PAGE>

jurisdiction of the aforesaid courts and irrevocably agrees to be bound by any
judgment rendered thereby, (ii) waives personal service of process, (iii) agrees
that service of process upon it may be made by certified or registered mail,
return receipt requested, pursuant to Section 10.6 hereof, and (iv) waives any
objection to jurisdiction and venue of any action instituted hereunder and
agrees not to assert any defense based on lack of jurisdiction or venue or forum
non conveniens. Nothing shall affect the right of the Agent or any Purchaser to
serve process in any manner permitted by law or shall limit the right of the
Agent or any Purchaser to bring proceedings against any Loan Party in the courts
of any other jurisdiction having jurisdiction. Any judicial proceedings against
the Agent or any Purchaser involving, directly or indirectly, the Obligations,
any Purchase Document or any related agreement shall be brought only in a
federal or state court located in the State of Maryland. All parties acknowledge
that they participated in the negotiation and drafting of this Agreement and
that, accordingly, no party shall move or petition a court construing this
Agreement to construe it more stringently against one party than against any
other.

     10.9  Cooperation in Discovery and Litigation. In any litigation,
           ---------------------------------------
arbitration or other dispute resolution proceeding relating to any Purchase
Document, each Loan Party waives any and all defenses, objections and
counterclaims it may have or could interpose with respect to (i) any of its and
its affiliates' directors, officers, employees or agents being deemed to be
employees or managing agents of the Loan Parties for purposes of all applicable
law or court rules regarding the production of witnesses by notice for testimony
(whether in a deposition, at trial or otherwise), (ii) the Agent's or any
Purchaser's counsel examining any such individuals as if under cross-examination
and using any discovery deposition of any of them as if it were an evidence
deposition, and/or (iii) using all commercially reasonable efforts to produce in
any such dispute resolution proceeding, at the time and in the manner requested
by the Agent or any Purchaser, all Persons, documents (whether in tangible,
electronic or other form) and/or other things under its control and relating to
the dispute.

     10.10 Jury Trial Waiver. EACH PARTY TO THIS AGREEMENT HEREBY EXPRESSLY
           -----------------
WAIVES ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM OR CAUSE OF ACTION OR PROCEEDING
TO ENFORCE OR DEFEND ANY RIGHTS UNDER OR IN CONNECTION WITH ANY PURCHASE
DOCUMENT OR ARISING UNDER THE PURCHASE DOCUMENTS OR IN ANY WAY CONNECTED WITH OR
INCIDENTAL TO THE DEALINGS OF THE PARTIES WITH RESPECT TO THE PURCHASE DOCUMENTS
OR THE TRANSACTIONS CONTEMPLATED THEREBY, WHETHER NOW EXISTING OR HEREAFTER
ARISING, AND WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE. EACH PARTY HEREBY
AGREES AND CONSENTS THAT ANY SUCH CLAIM OR CAUSE OF ACTION SHALL BE DECIDED BY
COURT TRIAL WITHOUT A JURY, AND THAT ANY PARTY TO THIS AGREEMENT MAY FILE AN
ORIGINAL COUNTERPART OR A COPY OF THIS SECTION WITH ANY COURT AS WRITTEN
EVIDENCE OF THE CONSENTS OF THE PARTIES TO THE WAIVER OF THEIR RESPECTIVE RIGHTS
TO TRIAL BY JURY.

     10.11 Severability. If any provision of any Purchase Document is
           ------------
adjudicated to be invalid under applicable laws or regulations, such provision
shall be inapplicable to the extent of such invalidity without affecting the
validity or enforceability of the remainder of the Purchase Documents which
shall be given effect so far as possible.

                                       -71-

<PAGE>

     10.12 Headings. The captions in the Purchase Documents are intended for
           --------
convenience and reference only and shall not affect the meaning or
interpretation of the Purchase Documents.

     10.13 General Indemnity. The Loan Parties, jointly and severally, hereby
           -----------------
agree to indemnify, defend and hold harmless the Agent and its affiliates, each
Purchaser and its affiliates and each of its and their respective managers,
members, officers, employees, affiliates, agents, representatives, successors,
assigns, accountants and attorneys (collectively, the "Indemnified Persons")
from and against any and all liabilities, obligations, losses, damages,
penalties, actions, judgments, suits, costs, expenses and disbursements of any
kind or nature whatsoever (including, without limitation, reasonable fees and
disbursements of counsel and in-house documentation and diligence fees and legal
expenses) which may be imposed on, incurred by or asserted against any
Indemnified Person with respect to or arising out of, or in any litigation,
proceeding or investigation instituted or conducted by any Person with respect
to any aspect of, or any transaction contemplated by or referred to in, or any
matter related to, any Purchase Document or any agreement, document or
transaction contemplated thereby, or from any act of, or omission by, the Loan
Parties or their Affiliates or any officer, director, employee, agent or
representative of the Loan Parties or their Affiliates with respect to the
Transactions, the Purchase Documents, the Notes, Warrant, Charter Documents, the
Bylaws or any agreements entered into in connection with any such agreements,
instruments or documents, whether or not such Indemnified Person is a party
thereto, except to the extent that any of the foregoing arises out of the gross
negligence or willful misconduct of such Indemnified Person. To the extent that
the foregoing undertakings may be unenforceable for any reason, the Loan Parties
agree to make the maximum contribution to the payment and satisfaction of
indemnified liabilities set forth in this Section 10.13 which is permissible
under applicable law. If any Indemnified Person uses in-house counsel for any
purpose for which any Loan Party is responsible to pay or indemnify, the Loan
Parties expressly agree that their indemnification obligations include
reasonable charges for such work commensurate with the fees that would otherwise
be charged by outside legal counsel selected by such Indemnified Person in its
sole discretion for the work performed.

     10.14 Environmental Indemnity. The Loan Parties, and their successors and
           -----------------------
assigns, jointly and severally, hereby release and discharge, and agree to
defend, indemnify and hold harmless the Indemnified Persons from and against any
and all Environmental Liabilities, whenever and by whomever asserted, to the
extent that such Environmental Liabilities are based upon, or otherwise relate
to: (a) any Condition at any time in, at, on, under, a part of, involving or
otherwise related to the Properties and Facilities (including any of the
properties, materials, articles, products, or other things included in or
otherwise a part of the Properties and Facilities); (b) any action or failure to
act of any Person, including any prior owner or operator of the Properties and
Facilities (including any of the properties, materials, articles, products, or
other things included in or otherwise a part of the Properties and Facilities),
involving or otherwise related to the Properties and Facilities or operations of
the Loan Parties; (c) the Management of any Pollutant, material, article or
product (including Management of any material, article or product containing a
Pollutant) in any physical state and at any time, involving or otherwise related
to the Properties and Facilities or any property covered by clause (d)
(including Management either from the Properties and Facilities or from any
property covered by clause (d), and Management to, at, involving or otherwise
related to the Properties and Facilities or any property covered by clause (d));
(d) Conditions, and actions or failures to act, in, at, on, under, a part of,
involving or otherwise related to any property other than the Properties and
Facilities,

                                       -72-

<PAGE>

which property was, at or prior to the Closing Date, (i) acquired, held, sold,
owned, operated, leased, managed, or divested by, or otherwise associated with,
(A) the Loan Parties, (B) any of the Loan Parties' Affiliates, or (C) any
predecessor or successor organization of those identified in (A) or (B); or (ii)
engaged in any tolling, contract manufacturing or processing, or other similar
activities for, with, or on behalf of the Loan Parties; (e) any violation of or
noncompliance with or the assertion of any Lien under the Environmental Laws,
(f) the presence of any toxic or hazardous substances, wastes or contaminants
on, at or from the past and present properties and facilities, including,
without limitation, human exposure thereto; (g) any spill, release, discharge or
emission affecting the past and present properties and facilities, whether or
not the same originates or emanates from such properties and facilities or any
contiguous real estate, including, without limitation, any loss of value of such
properties and facilities as a result thereof; or (h) a misrepresentation in any
representation or warranty or breach of or failure to perform any covenant made
by the Loan Parties in this Agreement. This indemnity and agreement to defend
and hold harmless shall survive any termination or satisfaction of the Notes
and/or exercise of the Warrant and/or the sale, assignment or foreclosure
thereof or the sale, transfer or conveyance of all or part of the past and
present properties and facilities or any other circumstances which might
otherwise constitute a legal or equitable release or discharge, in whole or in
part, of the Loan Parties under the Notes.

     10.15 Counterparts. The Purchase Documents (other than the Warrant) may be
           ------------
executed in one or more counterparts (which taken together, as applicable, shall
constitute one and the same instrument) and by facsimile transmission, which
facsimile signatures shall be considered original executed counterparts. Each
party to this Agreement agrees that it will be bound by its own facsimile
signature and that it accepts the facsimile signature of each other party.

     10.16 Integration. This Agreement and the other Purchase Documents to which
           -----------
Loan Parties are a party set forth the entire understanding of the parties
hereto with respect to all matters contemplated hereby and thereby and supersede
all previous agreements and understandings among them concerning such matters.
No statements or agreements, oral or written, made prior to or at the signing
hereof, shall vary, waive or modify the written terms hereof. Each party hereto
acknowledges that it has been advised by counsel in connection with the
negotiation and execution of this Agreement and is not relying upon oral
representations or statements inconsistent with the terms and provisions hereof.

     10.17 Subordination. The Note is subordinate in the manner and to the
           -------------
extent set forth in the Subordination Agreement, and each holder of the Note, by
its acceptance thereof, acknowledges and agrees to be bound by the provisions of
the Subordination Agreement.

     10.18 Lender Approvals. Unless expressly provided herein to the contrary,
           ----------------
any approval, consent, waiver or satisfaction of the Agent or the Purchasers
with respect to any matter that is subject of any Purchase Document may be
granted or withheld by the Agent or the Purchasers in their sole and absolute
discretion. Except as expressly provided herein, to the extent that (i) the
terms of this Agreement or any of the other Purchase Documents require the
consent, action or approval of the Purchasers, (ii) the Loan Parties seek an
amendment to or termination of any of the terms of this Agreement or any of the
Purchase Documents, or (iii) the Loan Parties seek a waiver of any right granted
to the Purchasers under this Agreement or any of

                                       -73-

<PAGE>

the Purchase Documents, such consent, approval, action, termination, amendment
or waiver shall be made by the Required Purchasers. Notwithstanding any
provision of this Section 10.18 to the contrary, the Purchasers shall not,
without the prior written consent and approval of all of the affected
Purchasers, amend, modify, terminate or obtain a waiver of any provision of this
Agreement or any of the Purchase Documents, which will have the effect of (i)
reducing the principal amount of any Notes or of any payment required to be made
to the Purchasers hereunder, or modifying the terms of a payment or prepayment
thereof; (ii) reducing the interest rate on the Notes or extending the time for
payment of interest under any Notes; or (iii) releasing any Loan Party or other
obligor from any Obligation under this Agreement or any of the other Purchase
Documents.

     10.19 Lender Duties. Neither the Agent nor any Purchaser shall have any
           -------------
responsibility for or obligation or duty with respect to any of the Collateral
or any matter or proceeding arising out of or relating thereto, including,
without limitation, any obligation or duty to collect any sums due in respect
thereof or to protect or preserve any rights pertaining thereto.

     10.20 Application of Payments. To the extent that any payment made or
           -----------------------
received with respect to the Obligations is subsequently invalidated, determined
to be fraudulent or preferential, set aside or required to be repaid to a
trustee, Loan Party in possession, receiver, custodian or any other Person under
any Law, common law or equitable cause or any other law, then the Obligations
intended to be satisfied by such payment shall be revived and shall continue as
if such payment had not been received by the Purchasers.

     10.21 Confidentiality and Publicity. Except to the extent required by
           -----------------------------
applicable laws or regulations, each Loan Party agrees, and agrees to cause each
of its Affiliates, (i) not to transmit or disclose any provision of any Purchase
Document to any Person (other than to its advisors and officers on a
need-to-know basis) without the Agent's prior written consent and (ii) to inform
all Persons of the confidential nature of the Purchase Documents and to direct
them not to disclose the same to any other Person and to require each of them to
be bound by these provisions; provided that, to any such disclosure required to
the SEC, the Loan Party agrees to request and use its best efforts to obtain
confidential treatment of such information to the extent permitted by applicable
law. The Agent and each Purchaser reserves the right to review and approve all
materials that any Loan Party or any of their Affiliates prepares that contain
such Purchaser's name or describe or refer to any Purchase Document, any of the
terms thereof or any of the transactions contemplated thereby. No Loan Party
shall, or shall permit any of its Affiliates to, use the Agent's or any
Purchaser's name (or the name of any of the Agent's or such Purchaser's
Affiliates) in connection with any of its business operations; provided that the
Loan Parties may disclose the Purchaser's name and the aggregate principal
amount of the Notes outstanding to prospective purchasers of debt or equity
securities of a Loan Party so long as the Loan Party informs such prospective
purchasers of the confidential nature of such information and directs them not
to disclose the same to any other Person. Nothing contained in any Purchase
Document is intended to permit or authorize any Loan Party or any of their
Affiliates to contract on behalf of the Agent or any Purchaser.

                                       -74-

<PAGE>

     10.22 Acknowledgement. Each of Encore GP, Encore Limited, Encore Asset
           ---------------
Corporation and Chattanooga Group, Inc. acknowledges and agrees that as a direct
or indirect subsidiary of Parent, it will benefit from the execution, delivery
and performance by the Purchasers of the Purchase Documents and the purchase of
the Notes by the Purchasers and that the proceeds of the Notes constitute
valuable consideration thereto and irrevocably appoints the Parent as its agent
for all purposes relevant to the Purchase Documents.

     10.23 Release of Collateral. Promptly following full performance and
           ---------------------
satisfaction and indefeasible payment in full in cash of all Obligations and the
termination of this Agreement, the Liens created under the Security Document
shall terminate and the Agent shall execute and deliver such documents, at Loan
Parties' expense, as are necessary to release the Agent's Liens in the
Collateral and shall return the Collateral to Loan Parties. The Agent shall not
be deemed to have made any representation or warranty with respect to any such
Collateral so delivered except that such Collateral is free and clear, on the
date of such delivery, of any and all Liens arising from the Agent's own acts.

     10.24 Rights and Remedies. In addition to the acceleration provisions set
           -------------------
forth in Article 8 above, upon the occurrence and continuation of an Event of
Default, the Agent shall have the right to exercise any and all rights, options
and remedies provided for in any Purchase Document, under the UCC or at law or
in equity, including, without limitation, the right to (i) apply any property of
any Loan Party held by the Agent or any Purchaser to reduce the Obligations,
(ii) foreclose the Liens created under the Purchase Documents, (iii) realize
upon, take possession of and/or sell any Collateral or securities pledged, with
or without judicial process, (iv) exercise all rights and powers with respect to
the Collateral as any Loan Party might exercise, (v) collect and send notices
regarding the Collateral, with or without judicial process, (vi) by its own
means or with judicial assistance, enter any premises at which Collateral and/or
pledged securities are located, or render any of the foregoing unusable or
dispose of the Collateral and/or pledged securities on such premises without any
liability for rent, storage, utilities, or other sums, and no Loan Party shall
resist or interfere with such action, (vii) at Loan Parties' expense, require
that all or any part of the Collateral be assembled and made available to the
Agent at any place designated by the Agent, and/or (viii) relinquish or abandon
any Collateral or securities pledged or any Lien thereon. Notwithstanding any
provision of any Purchase Document, the Purchasers , in their sole discretion,
shall have the right, at any time that any Loan Party fails to do so or fails to
perform any of its agreements or covenants in any Purchase Document (including
those with respect to compliance with applicable Laws), and from time to time,
without prior notice, to: (i) obtain insurance covering any of the Collateral to
the extent required hereunder; (ii) discharge taxes or Liens on any of the
Collateral that are in violation of any Purchase Document unless Loan Parties
are in good faith with due diligence by appropriate proceedings contesting those
items; (iii) pay for the performance of such agreements or covenants and/or (iv)
pay for the maintenance, protection and preservation of the Collateral and the
Agent's perfected, priority security interests and Liens therein. Such expenses
and advances shall be added to the Obligations until reimbursed to the
Purchasers and shall be secured by the Collateral, and such payments by the
Purchasers shall not be construed as a waiver by any Purchaser of any Event of
Default or any other rights or remedies of the Agent or the Purchasers. Each
Loan Party agrees that notice received by it at least ten (10) calendar days
before the time of any intended public sale, or the time after which any private
sale or other disposition of any Collateral is to be made,

                                       -75-

<PAGE>

shall be deemed to be reasonable notice of such sale or other disposition. If
permitted by applicable law, any perishable Collateral which threatens to
speedily decline in value or which is sold on a recognized market may be sold
immediately by Purchaser without prior notice to any Loan Party. At any sale or
disposition of any Collateral or securities pledged, any Purchaser may (to the
extent permitted by applicable law) purchase all or any part thereof free from
any right of redemption by any Loan Party, which right is hereby waived and
released.

     10.25 Rights and Remedies not Exclusive. The Agent shall have the right in
           ---------------------------------
its sole discretion (or at the written direction of the Required Purchasers) to
determine which rights, Liens and/or remedies the Agent may at any time pursue,
relinquish, subordinate or modify, and such determination will not in any way
modify or affect any of the Agent's or Purchaser's rights, Liens or remedies
under any Purchase Document, applicable law or equity. The enumeration of any
rights and remedies in any Purchase Document is not intended to be exhaustive,
and all rights and remedies of the Agent or the Purchasers described in any
Purchase Document are cumulative and are not alternative to or exclusive of any
other rights or remedies which the Agent or the Purchasers otherwise may have.
The partial or complete exercise of any right or remedy shall not preclude any
other further exercise of such or any other right or remedy.

     10.26 Waiver of Consequential and Punitive Damages. Each of the Loan
           --------------------------------------------
Parties, the Agent and the Purchasers hereby waive to the fullest extent
permitted by law all claims to consequential and punitive damages in any lawsuit
or other legal action brought by any of them against any other of them in
respect of any claim among or between any of them arising under this Agreement,
the other Purchase Documents, or any other agreement or agreements between or
among any of them at any time, including any such agreements, whether written or
oral, made or alleged to have been made at any time prior to the Closing Date,
and all agreements made hereafter or otherwise, and any and all claims arising
under common law or under any statute of any state or the United States of
America, including any thereof in contract, tort, strict liability or otherwise,
whether any such claims be now existing or hereafter arising, now known or
unknown. In making this waiver, the Agent, the Purchasers and the Loan Parties
acknowledge and agree that there shall be no claims for consequential or
punitive damages made by the Agent or the Purchasers against any Loan Party and
there shall be no claims for consequential or punitive damages made against the
Agent or the Purchasers by any Loan Party. The Agent, the Purchasers and the
Loan Parties acknowledge and agree that this waiver of claims for consequential
damages and punitive damages is a material element of the consideration for this
Agreement.

     10.27 Subrogation. No payment or prepayment of any amount by any Purchaser
           -----------
or any other Person shall entitle any Person to be subrogated to the rights of
the Purchasers under any Purchase Document unless and until the Obligations have
been fully performed and paid irrevocably in cash and the Notes has been
terminated.

     10.28 Power of Attorney. The Agent is hereby irrevocably made, constituted
           -----------------
and appointed the true and lawful attorney for Loan Parties (without requiring
Loan Parties to act as such) with full power of substitution to do the
following: (i) upon the occurrence and continuation of an Event of Default,
endorse the name of any such Person upon any and all checks, drafts, money
orders and other instruments for the payment of money that are payable to such
Person

                                       -76-

<PAGE>

and constitute collections on such Person's accounts; (ii) execute in the name
of Loan Parties any financing statements, schedules, assignments, instruments,
documents, and statements that they are obligated to give the Agent or the
Purchasers under any of the Purchase Documents; and (iii) do such other and
further acts and deeds in the name of Loan Parties that the Agent may deem
necessary or desirable to enforce, make, create, maintain, continue or perfect
the Agent's security interest or lien or rights in any Collateral.

     10.29 Acknowledgement of Joint and Several Liability. Each Loan Party
           ----------------------------------------------
acknowledges that all Loan Parties are jointly and severally liable for all of
the Obligations. Each Loan Party expressly (i) understands, agrees and
acknowledges that Loan Parties are all affiliated entities by common ownership,
(ii) understands, agrees and acknowledges that Purchaser will be lending
against, and relying on a Lien upon, all of the Loan Parties' assets even though
the proceeds from the sale of the Notes may not be advanced directly to a
particular Loan Party, (iii) understands, agrees and acknowledges that each Loan
Party will nonetheless benefit by the Transactions, and (iv) understands, agrees
and acknowledges that all of the representations, warranties, covenants,
obligations, conditions, agreements and other terms contained in the Purchase
Documents shall be applicable to and binding upon each Loan Party.

     10.30 Seal and Effective Date. This Agreement is an instrument executed
           -----------------------
under seal and is to be considered effective and enforceable as of the date set
forth on the first page hereof, independent of the date of actual execution.

                      [SIGNATURES APPEAR ON FOLLOWING PAGE]

                                      * * *

                                       -77-

<PAGE>

                                SIGNATURE PAGE TO
                       NOTE AND EQUITY PURCHASE AGREEMENT

IN WITNESS WHEREOF, the parties hereto have executed this Note and Equity
Purchase Agreement as of the day and year first above written.

                          LOAN PARTIES:

                          ENCORE MEDICAL CORPORATION

                          By: /s/ Harry Zimmerman
                              --------------------------------------------------
                              Name:
                              Title:

                          ENCORE MEDICAL ASSET CORPORATION

                          By: /s/ Harry Zimmerman
                              --------------------------------------------------
                              Name:
                              Title:

                          ENCORE MEDICAL GP, INC.

                          By: /s/ Harry Zimmerman
                              --------------------------------------------------
                              Name:
                              Title:

                          ENCORE MEDICAL, L.P.
                          By: Encore Medical GP, Inc., its sole General Partner

                          By: /s/ Harry Zimmerman
                              --------------------------------------------------
                              Name:
                              Title:

                          CHATTANOOGA GROUP, INC.

                         By: /s/ Harry Zimmerman
                             ---------------------------------------------------
                             Name:
                             Title:

                                       -78-

<PAGE>

                          PURCHASER/AGENT:

                          CAPITALSOURCE FINANCE LLC

                          By: /s/ Steven A. Museles
                              -------------------------------------------
                              Name: Steven A. Museles
                              Title: Sr. Vice President

                                       -79-

<PAGE>

                                    EXHIBIT A
                                    ---------

                                  Form of Note

                                 (see attached)

<PAGE>
                                     ANNEX A
                                     -------

                        INFORMATION RELATING TO PURCHASER

Name and Address of Purchaser
----------------------------

CAPITALSOURCE FINANCE LLC
4445 Willard Avenue, 12/th/ Floor
Chevy Chase, MD 20815
Attention:  Corporate Finance Group, Portfolio Manager
Telephone:  (301) 841-2700
FAX:  (301) 841-2360
E-Mail: rdailey@capitalsource.com

          All payments to be by wire:

               Bank: Bank of America, Baltimore, MD
               ABA #: 052001633
               Account #: 003930559738
               Account Name: CapitalSource Funding, LLC
               Reference: Encore

<PAGE>
                              POST-CLOSING SCHEDULE
                              ---------------------

     The following conditions required by the terms of this Agreement which will
not be completed by the Closing Date. Performance of the following conditions
shall be completed within the time frames set forth below.

        (i)   Within thirty (30) days from the date hereof, Loan Parties shall
use reasonable efforts to deliver to Agent, the Junior Subordination Agreements,
in form and substance satisfactory to Agent, but failure to obtain such Junior
Subordination Agreements after such efforts shall not be an Event of Default
under this Agreement;

        (ii)  Within sixty (60) days from the date hereof, Loan Parties shall
deliver to Agent executed copies of (A) the Landlord Subordination and Consent
Agreement from the Sublessor of the Rutland Drive, Austin, Texas warehouse; (B)
the Bailee Waivers and Agreements; and (C) the Consent and Acknowledgments of
Assignments from those parties who executed such Consent and Acknowledgments of
Assignment in favor of the Senior Agent, in each case in form and substance
satisfactory to Agent;

        (iii) Within sixty (60) days from the date hereof, Loan Parties shall
deliver to Agent evidence of the Life Insurance on Kenneth W. Davidson in the
amount of $3,000,000;

        (iv)  Within forty-five (45) days from the date hereof (or 120 days in
the case of lock-box accounts), Loan Parties shall either deliver to Agent
letter agreements, in form and substance satisfactory to Agent, accepted and
executed by each of the banks or savings institutions at which Loan Parties
maintains deposit accounts or lock-box accounts, acknowledging Agent's security
interest in all of Loan Parties's deposit accounts or lock-box accounts or close
any such deposit accounts or lock-box accounts and transfer any moneys on
deposit therein to an account for which a letter agreement has been delivered;
and

        (v)   Within five (5) days of the Closing, deliver executed mortgages,
in form and substance satisfactory to Agent, for the Real Estate owned by Loan
Parties.

     The failure by Loan Parties to provide any of the foregoing within the time
frames specified shall constitute an Event of Default under this Agreement.

<PAGE>

                                  Schedule 1.1

                          Stock Option Plans and Grants
                          -----------------------------

1992 Stock Option Plan
1993 Surgeon Advisory Panel Stock Option Plan
1993 Distributor Stock Option Plan
1996 Incentive Stock Plan
1997 Surgeon Advisory Panel Stock Option Plan
1997 Distributor Stock Option Plan
2000 Non-Employee Directors Stock Option Plan
Stock Options issued to the following Designing Surgeons: Gary Ferguson, William
         Kennedy, Joe Longo, Richard Friedman (in the name of Riviler LP), David
         Mauerhan (in the name of Aus/Ch L.P.)
Stock Options issued to Directors of Encore Orthopedics, Inc. or Encore Medical
         Corporation prior to the implementation of the 2000 Non-Employee
         Directors Stock Option Plan
Options issued to Leon Lapidus and Morton Certilman
Stock Option issued to Galen Associates dated February 8, 2002
$5 Warrants issued in connection with the initial public offering of Encore
         Medical Corporation which expire on March 8, 2003

<PAGE>

                                  Schedule 1.2

                                     EBITDA
                                     ------

Quarter Ended June 29, 2001           $3,728,000

Quarter Ended September 29, 2001      $4,549,000

Quarter Ended December 31, 2001       $4,197,000

<PAGE>

                                 Schedule 5.1(c)

                  Business; Corporate Name; Prior Transactions
                  --------------------------------------------

                           Encore Medical Corporation
                           --------------------------
1.   Acquisition of orthopedic soft goods, patient safety devices and pressure
     care product lines from Kimberly-Clark Corporation, July, 2001
2.   Acquisition of stock of Biodynamic Technologies, Inc., March, 1999
3.   Name change from Healthcare Acquisition Corp. to Encore Medical
     Corporation, March, 1997

Encore Medical, L.P.
1.   Merger with Healthcare Acquisition, Inc., a wholly-owned subsidiary of
     Healthcare Acquisition Corp., March, 1997
2.   Conversion into a Delaware limited partnership with attendant name change
     to Encore Medical, L.P., February, 2002
3.   Acquisition of assets of Applied Osteo Systems, Inc., May, 1996
4.   Has used assumed name "Encore Orthopedics"

Chattanooga Group, Inc.
1.   Acquisition of the assets of Henley Healthcare from Znetix Acquisition,
     L.P., May 11, 2001
2.   Chattanooga Group, Inc. has operated under the assumed name "Chattanooga
     Corporation"

<PAGE>

                                 Schedule 5.1(d)

                          Capitalization; Subsidiaries
                          ----------------------------

<TABLE>
<S>                                                  <C>
PARENT
Name                                                 Encore Medical Corporation
State of organization / type of entity               Delaware corporation
Chief Executive Office                               9800 Metric Boulevard
                                                     Austin, Texas  78758
Capital Stock Authorized                             36,000,000 total shares authorized
                                                     35,000,000 common shares
                                                     255,000 Series A preferred
                                                     shares 745,000 preferred
                                                     shares Par value $0.001
Owners of 5% or more of Capital Stock                CF Holdings, Ltd, 1,453,037 shares
(on an as converted basis)                           John Abeles, 394,931 shares
                                                     Kenneth W. Davidson, 814,100 shares
                                                     Galen Partners III, L.P., 11,176,691 shares*
                                                     Galen Partners Int'l III, L.P., 1,011,633 shares*
                                                     Galen Employee Fund III, L.P., 46,189 shares*
</TABLE>

* includes common shares plus number of common shares into which the Series A
Preferred shares are convertible

<TABLE>
<S>                                                  <C>
SUBSIDIARIES
Name                                                 Encore Medical, L.P.
State of organization / type of entity               Delaware limited partnership
Chief Executive Office                               9800 Metric Boulevard
                                                     Austin, Texas  78758
General Partner                                      Encore Medical GP, Inc., 1%
Limited Partner                                      Encore Medical Asset Corporation, 99%
Qualified to do Business                             Texas

Name                                                 Encore Medical Asset Corporation
State of organization / type of entity               Nevada corporation
Chief Executive Office                               2920 North Green Valley Parkway
                                                     Building 3, Suite 321
                                                     Henderson, Nevada 89014
Capital Stock authorized                             50,000 common shares, par value $.001
Sole Stockholder                                     Encore Medical Corporation, 1,000 shares

Name                                                 Encore Medical GP, Inc.
State of organization / type of entity               Nevada corporation
Chief Executive Office                               9800 Metric Boulevard
                                                     Austin, Texas  78758
Capital Stock authorized                             50,000 common shares, par value $.001
Sole Stockholder                                     Encore Medical Corporation, 1,000 shares
Qualified to do business in                          Texas
</TABLE>

<PAGE>

<TABLE>
<S>                                                        <C>
Name                                                       Chattanooga Group, Inc.
State of organization / type of entity                     Delaware corporation
Chief Executive Office                                     9800 Metric Boulevard
                                                           Austin, Texas 78758
Capital Stock authorized                                   4,000,000 total shares, par value $.25
                                                           3,900,000 Class B Nonvoting shares
                                                             100,000 Class A Voting shares
Sole Stockholder                                           Encore Medical Corporation
Qualified to do business in                                California, Delaware, District of Columbia,
                                                           Florida, Georgia, Illinois, Kansas,
                                                           Maryland, Michigan, Minnesota, Missouri,
                                                           New Hampshire, New Jersey, New York,
                                                           North Carolina, North  Dakota, Ohio,
                                                           Pennsylvania, South Carolina, Tennessee,
                                                           Texas, Virginia, Washington, Wisconsin

Name                                                       Chattanooga Europe, B.V.B.A.
State of organization / type of entity                     Belgium company
Chief Executive Office                                     9800 Metric Boulevard
                                                           Austin, Texas 78758
Capital Stock Authorized                                   35,000 authorized shares, no par value
Sole shareholder                                           Chattanooga Group, Inc., 1,000 shares

Name                                                       Encore Orthopedics FSC Limited
State of organization / type of entity                     Jamaica company
Chief Executive Office                                     c/o Encore Medical, L.P. (fka Encore Orthopedics, Inc.)
                                                           9800 Metric Boulevard
                                                           Austin, Texas  78758
Capital Stock authorized                                   100 common shares, par value $1.00
Only Stockholders                                          Encore Medical, L.P. (fka Encore Orthopedics, Inc.), 99 shares
                                                           August Faske, as nominee, 1 share

Name                                                       Chattanooga Group Limited
State of organization / type of entity                     English company
Note: This company is in the process of being dissolved.

Name                                                       Chattanooga Pacific PTY Ltd.
State of organization / type of entity                     Australia company
Note: This company is in the process of being dissolved.
</TABLE>

The following options or rights to subscribe for or to purchase shares of Encore
Medical Corporation are outstanding:

Options or warrants granted under the following options plans or arrangements -

<PAGE>

1992 Stock Option Plan
1993 Surgeon Advisory Panel Stock Option Plan
1993 Distributor Stock Option Plan
1996 Incentive Stock Plan
1997 Surgeon Advisory Panel Stock Option Plan
1997 Distributor Stock Option Plan
2000 Non-Employee Directors Stock Option Plan
Stock Options issued to the following Designing Surgeons: Gary Ferguson, William
         Kennedy, Joe Longo, Richard Friedman (in the name of Riviler LP), David
         Mauerhan (in the name of Aus/Ch L.P.)
Stock Options issued to Directors of Encore Orthopedics,  Inc. or Encore Medical
         Corporation prior to the implementation of the 2000 Non-Employee
         Directors Stock Option Plan
Options issued to Leon Lapidus and Morton Certilman
Stock Option issued to Galen Associates dated February 8, 2002
$5 Warrants issued in connection with the initial public offering of Encore
         Medical Corporation which expire on March 8, 2003

Agreements among the Loan Parties' stockholders with respect to the voting or
transfer of Encore Medical Corporation capital stock:

Investor Rights Agreement between the holders of the Series A Preferred Stock
and Encore Medical Corporation dated June 12, 2001, as amended

Rights to Acquire Stock of Encore Medical Corporation:

1.  Galen Advisors LLC will be issued $200,000 worth of Common Stock on February
15, 2002 in connection with a Financial Services Advisory Fee Agreement. The
minimum fair market value of each share issued will be $3.15.
2.  Cleary & Oxford will be issued Common Stock for one-half of its initial
brokerage fee and all of its fee related to the Adjustment Amount (as defined in
the Acquisition Agreement). The minimum fair market value of each share issued
will be $3.15.

<PAGE>

                                 Schedule 5.1(i)

                               Real Estate; Leases
                               -------------------

Encore Medical, L.P.
Lease of 9800 Metric Boulevard, Austin, Texas 78758
Landlord/Lessor:           Met 94, Ltd.
Tenant/Lessee:             Encore Medical, L.P.
Date:                      April 1, 1997

Lease of 9715-B Burnet Road, Austin, Texas 78758
Landlord/Lessor:           Met Phase I 95, Ltd.
Tenant/Lessee:             Encore Medical, L.P.
Date:                      September 28, 2001

Lease of 2209-A Rutland Drive, Austin, Texas 78758
Master Landlord:           CGH-Rut 16, Ltd.
Sublandlord/Sublessor:     TN Master Tile, L.P.
Subtenant/Sublessee:       Encore Medical, L.P.
Date:                      January 28, 2002

Lease of Rockford Business Interiors office furniture
Lessor:                    Steelcase Financial Services, Inc.
Lessee:                    Encore Medical, L.P.
Date:                      Master Lease Agreement dated January 3, 1997;
                           Schedule 1 dated April 18, 1997; Schedule 2 dated
                           November 3, 1997; Schedule 3 dated January 26, 1998

Lease of computer equipment and software
Lessor:                    Winthrop Resources Corporation
Lessee:                    Encore Medical, L.P.
Date:                      Lease Agreement dated August 1, 1998

Lease of Mori Seiki Chip Conveyor and Charmilles Technologies Brother 3600AWT
Wire Cut Machine w/ chiller
Lessor:                    Wells Fargo Equipment Finance, Inc.
Lessee:                    Encore Medical, L.P.
Date:                      Master Lease Agreement dated August 1, 1997; Schedule
                           1 dated March 4, 1998; Schedule 2 dated January 28,
                           1999

Lease of IBM RS/6000 Deskside Server SMP, STAR SR20 CNC Swiss Type Automatic
Lathe, Rockford Business Interiors office furniture and equipment
Lessor:                    Wells Fargo Equipment Finance, Inc.
Lessee:                    Encore Medical, L.P.
Date:                      Master Lease Agreement dated June 24, 1999;
                           Supplement dated June 24, 1999; Supplement dated
                           October 13, 1999; Supplement dated April 24, 2000;
                           Supplement dated December 13, 2000

<PAGE>

                                 Schedule 5.1(i)

                           Real Estate; Leases (cont.)
                           ---------------------------

Lease of medical instruments to AMICO, Saudi Arabian distributor
Lessor:                    Encore Medical, L.P.
Lessee:                    Al Amin Medical Instruments Co. Ltd
Date:                      Master Lease Agreement dated January 24, 2000;
                           Equipment Supplement 001 dated January 26, 2000

Encore Medical Asset Corporation
Sublease of office space
Lessor:                    Griffin Corporate Services, Inc.
Lessee:                    Encore Medical Asset Corporation
Date:                      Sublease Agreement dated February 1, 2002

Chattanooga Group, Inc.
Real Estate owned
-----------------
4717 Adams Road (a/k/a 2735 Kanasita Drive), Hixson, TN  37343
101 Memorial Drive, Red Bank, TN  37415

Leases in effect
----------------
Lease of Biezenhoed 103, 2450 Meerhout, BELGIUM
Landlord/Lessor:           Herman Swannet, Hakenrode 3, 2450 Meerhout, BELGIUM
Tenant/Lessee:             Chattanooga Europe, B.V.B.A.
Date:                      March 1, 2001

Lease of Unit 6/2 Garden Boulevard, Dingley, AUSTRALIA  3172
Landlord/Lessor:           Leslie William Goodridge
                           C/- Nixon Management Services
                           942 Nepean Highway, Moorabbin
Tenant/Lessee:             Chattanooga Pacific Pty. Ltd.
                           2 Hasp Street, Seventeen Miles Rocks, Queensland,
                           4073
Date:                      March 23, 1999

Lease of AS/400 9406/720 Computer, Lotus Domino Software Server
Lessor:                    IBM Credit Corporation
Lessee:                    Chattanooga Group, Inc
Date:                      May 10, 2000

<PAGE>

                                 Schedule 5.1(j)

                               Proprietary Rights
                               ------------------

See attached:

List of Encore Medical Corporation patents
List of Encore Medical Corporation trademarks
List of Chattanooga Group, Inc. patents
List of Chattanooga Group, Inc. trademarks
List of Chattanooga Group, Inc. copyrights
List of licensing agreements related to any proprietary rights

<PAGE>

                                 Schedule 5.1(k)

                                   Trade Names
                                   -----------

Encore
Encore Orthopedics
Encore Spine
Chattanooga Group
Chattanooga Corporation
Encore Medical
Encore Medical OSG

<PAGE>

                                 Schedule 5.1(w)

                               Material Agreements
                               -------------------

None

<PAGE>

                                 Schedule 5.1(z)

                               Investment Property
                               -------------------

Encore Medical Corporation
--------------------------

1,000 shares common stock, Encore Medical Asset Corporation
1,000 shares common stock, Encore Medical GP, Inc.
635,446 shares common stock (treasury stock), Encore Medical Corporation
56,269 shares Class A common stock, Chattanooga Group, Inc.
2,296,307 shares Class B common stock, Chattanooga Group, Inc.

Encore Medical, L.P.
--------------------

99 shares common stock, Encore Orthopedics FSC Limited

Encore Medical Asset Corporation
--------------------------------

99 % limited partnership interest in Encore Medical, L.P.

Encore Medical GP, Inc.
-----------------------

1% general partnership interest in Encore Medical, L.P.

Chattanooga Group, Inc.
-----------------------

1,000 shares in Chattanooga Europe, B.V.B.A.

<PAGE>

                                Schedule 5.1(ee)

                                     Brokers
                                     -------

Encore Medical Corporation
--------------------------

Cleary & Oxford Associates - Fee in connection with the acquisition of
      Chattanooga Group, Inc.

Bank of America Securites - Fee in connection with the placing of the Senior
      Subordinated Notes

<PAGE>

                                Schedule 5.1(ff)

                             Affiliate Transactions
                             ----------------------

Encore Medical Corporation
--------------------------

Employment Agreements between the Company and each of Kenneth W. Davidson, Jack
Cahill, Craig L. Smith, August Faske and Harry L. Zimmerman

Restricted Stock Agreements between the Company and each of Kenneth W. Davidson,
Jack Cahill, Craig L. Smith, August Faske, Harry L. Zimmerman, Jess Jackson,
Greg Kaseeska, Kathy Wiederkehr, and J.D. Webb

Consulting Agreement between the Company and Nick Cindrich

Advisory Services Fee Agreement between the Company and Galen Associates

Chattanooga Group, Inc.
-----------------------

Employment Agreements between the Company and each of Paul Chapman, Scott
Klosterman, Charles M. Thomas, and David C. Linville

<PAGE>

                                 Schedule 7.2(i)

                              Permitted Investments
                              ---------------------

Encore Medical Corporation
--------------------------

1,000 shares common stock, Encore Medical Asset Corporation
1,000 shares common stock, Encore Medical GP, Inc.
635,446 shares common stock (treasury stock), Encore Medical Corporation
56,269 shares Class A common stock, Chattanooga Group, Inc.
2,296,307 shares Class B common stock, Chattanooga Group, Inc.

Encore Medical, L.P.
--------------------

99 shares common stock, Encore Orthopedics FSC Limited

Encore Medical Asset Corporation
--------------------------------

99 % limited partnership interest in Encore Medical, L.P.

Encore Medical GP, INC.
-----------------------

1% general partnership interest in Encore Medical, L.P.

Chattanooga Group, Inc.
-----------------------

1,000 shares in Chattanooga Europe, B.V.B.A.

<PAGE>

                                 Schedule 7.2(r)
                                 ---------------

                           Name and Location Schedule
                           --------------------------

Encore Medical Corporation
9800 Metric Boulevard
Austin, Texas 78758

Encore Medical Corporation
9715 Burnet Road
Austin, Texas 78758

Encore Medical Corporation
2209-A Rutland Drive
Austin, Texas 78758

Encore Medical, L.P.
9800 Metric Boulevard
Austin, Texas 78758

Encore Medical Asset Corporation
2920 North Green Valley Parkway
Building 3, Suite 321
Henderson, Nevada 89014

Encore Medical GP, Inc.
9800 Metric Boulevard
Austin, Texas 78758

Chattanooga Group, Inc.
4717 Adams Road (also known as 2735
Kanasita Drive)
Hixson, TN 37343

Chattanooga Group, Inc.
101 Memorial Drive
Red Bank, TN 37415

Chattanooga Europe, B.V.B.A.
Biezenhoed 103
2450 Meerhout
BELGIUM

Chattanooga Pacific Pty, Ltd.
Unit 6/2 Garden Boulevard, Dingley
AUSTRALIA 3172

Border Opportunity Saver Systems
10 Finegan Drive
Del Rio, Texas 78741-1407

Maquiladora de Coahuila, SA de CV
Carretera Presa la Amistad, KM 1.5
Cuidad Acuna, Coahuila, 22630
MEXICO

Encore of Michigan
550 Peninsular
Cement City, MI 49233

Hi-Tech Orthopedic, Inc.
31 Longell Drive
Wayne, NJ 07470

Encore - Northeastern PA
7017 Elm Tree Drive
Slatington, PA 18080

GRL Corporation
8859 Silverline Drive
Fairfax Station, VA 22039

MedSource, Inc.
66 Girard Avenue #320
Newport, RI 02840

MedTech, Inc.
10114 Bredgewater Pkwy.
Woodbury, MN 55129

Mike McGann
98 Orchard Street, Apt. 3D
New York, NY 10002

Futurtek, Inc.
2915 North Classen Blvd., Suite 319
Oklahoma City, OK 73106

<PAGE>

Med-Pro Technologies, Inc.
2106 West Pioneer Parkway, Suite 125
Arlington, TX 76013

Toedtmann Enterprises, Inc.
1603 Birmingham Court
Colombia, MO 65203

Spectrum Surgical
1915 Leather Stem
Kingwood, TX 77345

KRB Enterprises, Inc.
800 End-O Trail
Harker Keights, TX 76548

Surgical Resources of North Texas, Inc.
2800 Stanford Drive
Flower Mound, TX 75022

Orthopedic Sales and Services, L.L.C.
2313 Newfield Lane
Austin, TX 78703

Orthosource, Inc.
4500 140/th/ Avenue North, Suite 202
Clearwater, FL 33762

Osteo-Encore, Inc.
1425 East Newport Center Drive
Deerfield Beach, FL 33442

Georgia Orthopedic Distributors
3040 St. Andrews Drive
Duluth, GA 30136

Superior Surgical Technologies
9036 Saint Thomas Lane
Charlotte, NC 28277

Southern Surgical, Inc.
1908 Church Street
Nashville, TN 37203

Midsouth Surgical, Inc.
3033 Woodlawn
Nashville, TN 37215

S.J. Enterprises
300 West Road #1
Portsmouth, VA 23707

G&S Inc.
2407 Sunset Hills Terrace
Richmond, VA 23236

Richardson Medical
4161 Hambrick Way
Stone Mountain, GA 30083

Encore-Southern California
1787 Pomona Road, Suite J
Corona, CA 92880

Encore - Montana
7235 Old Grant Creek Road
Missoula, MT 59802

MDS
425 Everston Circle
Las Vegas, NV 89123

SurgiSystems, Inc.
558 West Monte Avenue
Mesa, AZ 85210

Encore - San Diego
7293 Aquamarine Road
San Diego, CA 92114

CCS Medical
6903 N. Frontier Drive
Mt. Green, UT 84050

Presidio Surgical, Inc.
2763 Bush Street, Suite A
San Francisco, CA 94115

<PAGE>

Pacific Biosystems Corporation, Ltd.
5707 Lacey Blvd. SE, Suite 104
Lacey, WA  98503

Guthrie Orthopedic Products
1039 Kings View Court
Henderson, NV  89015

Applied Medical Services, Inc.
549A North Judd Street
Honolulu, HI  96817

Lawrence Hospital
55 Palmer Avenue
Bronxville, NY  10708

Westchester County Med Center
98 Orchard Street Apt. 3d
New York, NY  10002

Orthopedics PRN
3105 Lake Highland Lane
Birmingham, AL 35242

Kennestone Hospital
PO Box 725533
Atlanta, GA  31139

Norton Healthcare
PO Box 35070
Louisville, KY  40232

Providence Health System
8205 East Martin Way NE, PMB 103
Olympia, WA  98516<PAGE>

                                                                    EXHIBIT 10.4

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR APPLICABLE SECURITIES LAWS. THIS NOTE MAY NOT BE OFFERED, SOLD, ASSIGNED,
TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN
EFFECTIVE REGISTRATION STATEMENT OF THE NOTE UNDER SUCH ACT AND UNDER ANY
APPLICABLE STATE SECURITIES LAWS, UNLESS THE ISSUER HEREOF IS SATISFIED THAT
SUCH REGISTRATION IS NOT REQUIRED AS TO SUCH SALE OR OFFER.

THIS NOTE IS SUBJECT TO THE TERMS OF A SUBORDINATION PROVISIONS SET FORTH IN
THAT CERTAIN SUBORDINATION AND INTERCREDITOR AGREEMENT DATED AS OF THE DATE
HEREOF, AMONG EACH OF ENCORE MEDICAL CORPORATION, ENCORE MEDICAL, L.P., ENCORE
MEDICAL GP, INC., ENCORE MEDICAL ASSET CORPORATION AND CHATTANOOGA GROUP, INC.,
BANK OF AMERICA, NATIONAL ASSOCIATION, AS AGENT, AND CERTAIN OTHER PARTIES
SIGNATORY THERETO (INCLUDING EACH SUCH PARTY'S SUCCESSORS AND ASSIGNS). A COPY
OF THIS AGREEMENT IS ON FILE AT THE OFFICE OF ENCORE MEDICAL CORPORATION AND IS
AVAILABLE FOR INSPECTION AT SUCH OFFICE.

                            SENIOR SUBORDINATED NOTE

$3,000,000.00                                                   February 8, 2002

          FOR VALUE RECEIVED, the undersigned, ENCORE MEDICAL CORPORATION, a
Delaware corporation (the "Parent"), ENCORE MEDICAL, L.P., a Delaware limited
partnership, ENCORE MEDICAL GP, INC., a Nevada corporation, ENCORE MEDICAL ASSET
CORPORATION, a Nevada corporation, and CHATTANOOGA GROUP, INC., a Delaware
corporation (together with their respective successors and assigns, each a "Loan
Party" and collectively, the "Loan Parties") jointly and severally promise to
pay to the order of CAPITALSOURCE FINANCE LLC, a Delaware limited liability
company (the "Holder"), the principal sum of THREE MILLION DOLLARS
($3,000,000.00), together with interest thereon as set forth below, at its
offices or such other place as the Holder may designate in writing.

     1.   Purchase Agreement. This Senior Subordinated Note (the "Note") is
          ------------------
executed and delivered by the Loan Parties at the Closing in connection with an
investment (the "Investment") being made by the Holder in the Loan Parties,
pursuant to the terms and conditions of a Note and Equity Purchase Agreement by
and among the Loan Parties and the Holder dated of even date herewith (the
"Purchase Agreement"). This Note and the other notes evidencing the Investment
(the "Other Notes") are each subject to the terms and conditions of the Purchase
Agreement. A copy of the Purchase Agreement may be examined during normal
business hours at the offices of the Parent. Any capitalized term used herein
and not otherwise defined herein shall have the meaning assigned to it in the
Purchase Agreement.

                                       -1-

<PAGE>

     2.   Interest Rate Provisions.
          ------------------------

          2.1  Accrual and Pay Rates. Except as provided in Section 2.3 hereof,
               ---------------------
from the date hereof and thereafter until the repayment of this Note in full,
interest shall accrue on the principal balance of this Note outstanding from
time to time at the Accrual Rate (as hereinafter defined), compounded monthly,
and shall be paid in cash on a monthly basis at the Pay Rate (as hereinafter
defined). For the purposes of this Note, "Accrual Rate" means (i) the Pay Rate
plus (ii) two and three-fourths percent (2.75%), and "Pay Rate" means the
greater of (i) thirteen percent (13%) and (ii) the Prime Rate plus four percent
(4%), subject to a maximum cap of fifteen percent (15%).

          2.2  PIK Amounts. On each Payment Date (as defined in Section 3.1
               -----------
hereof), the then outstanding principal balance of this Note shall be increased
by an amount (the "PIK Amount") equal to the difference between (i) interest
accruing at the Accrual Rate on the principal balance of this Note outstanding
at the end of the preceding month period and (ii) interest payable at the Pay
Rate on the principal balance of this Note outstanding at the end of the
preceding month period.

          2.3  Default Interest Rate. Following the occurrence and during the
               ---------------------
continuance of any Event of Default, the Accrual Rate and the Pay Rate shall
each increase 300 basis points.

          2.4  Calculation of Interest. Interest shall be calculated on the
               -----------------------
basis of a year of 360 days, composed of twelve 30-day months, and the actual
number of days elapsed.

     3.   Payment Provisions.
          ------------------

          3.1  Interest Payments. Commencing on March 1, 2002, and continuing on
               -----------------
the first day of each succeeding month thereafter, up to and including February
8, 2007 ("the Maturity Date") (each such date, a "Payment Date"), the Borrower
shall pay in cash to the Holder monthly installments of interest only (in
arrears) at the applicable Pay Rate on the then outstanding principal balance
under this Note.

          3.2  Principal Payments and Payment at Maturity. On the Maturity Date,
               ------------------------------------------
the entire then outstanding principal balance of this Note, together with all
accrued but unpaid interest, and all other sums owed hereunder shall be due and
payable in full in cash without further notice or demand.

          3.3  Prepayments; Application of Payments. The Loan Parties may prepay
               ------------------------------------
the then outstanding principal amount of this Note in full in accordance with
the terms of Section 3.3 of the Purchase Agreement. In addition, the Loan
             -----------
Parties shall prepay the then outstanding principal amount of this Note in
accordance with the terms of Section 3.5 of the Purchase Agreement. Each
                             -----------
prepayment shall be applied in the following order of priority: (i) first, to
any prepayment fees due pursuant to the Purchase Agreement; (ii) second, to
accrued, but unpaid, interest at the applicable rate; (iii) third, to any PIK
Amount prior to the time such PIK Amount has been added to the then outstanding
principal balance pursuant to the terms hereof and (iv)

                                       -2-

<PAGE>

finally, to the then outstanding principal balance of the Note (including any
PIK Amounts that have been added to the principal balance pursuant to Section
                                                                      -------
2.2 hereof).
---

     4.   Subordination. The indebtedness represented by this Note is
          -------------
subordinate to the Senior Debt of the Loan Parties in accordance with the terms
of the Subordination Agreement and as specified in the Purchase Agreement.

     5.   Assignment. This Note and the obligations hereunder may not be
          ----------
assigned by the Loan Parties without the prior written consent of the Holder.

     6.   Default and Remedies. The occurrence of an Event of Default under the
          --------------------
Purchase Agreement shall constitute a default hereunder and shall entitle the
Holder to exercise the rights and remedies specified in the Purchase Agreement,
as well as those available at law or in equity.

     7.   Waivers. Each Loan Party hereby waive presentment, demand, protest, or
          -------
further notice of any kind (except such notices as may be specifically required
by the express terms of the Purchase Agreement).

     8.   Controlling Law. This Note and all matters related hereto shall be
          ---------------
governed, construed and interpreted strictly in accordance with the laws of the
State of Maryland, without regard to its principles of conflicts of law.

     9.   No Usury. This Note is subject to the express condition that at no
          --------
time shall the Borrower be obligated or required to pay interest hereunder at a
rate which could subject the Holder to either civil or criminal liability as a
result of being in excess of the maximum rate which the Borrower is permitted by
law to contract or agree to pay. If, by the terms of this Note, the Borrower is
at any time required or obligated to pay interest at a rate in excess of such
maximum rate, the rate of interest under this Note shall be deemed to be
immediately reduced to such maximum rate and interest payable hereunder shall be
computed at such maximum rate and the portion of all prior interest payments in
excess of such maximum rate shall be applied and shall be deemed to have been
payments in reduction of the principal balance of this Note.

     10.  Automatic Conversion. In the event that the Holder sells or otherwise
          --------------------
transfers the portion of this Note equal to the original principal amount of
this Note to Galen Associates pursuant to the terms of the Galen Agreement, (a)
this Note shall automatically be converted into the number of shares of Series A
Preferred Stock of the Parent determined by dividing the principal amount of
this Note so converted by the lesser of (i) $150 and (ii) 50 times the greater
of $1 and the average of the closing prices of the Company's Common Stock as
quoted in the Nasdaq National Market or the principal exchange on which the
Common Stock is listed for 10 trading days prior to the date of conversion,
provided, however, that without the approval of the stockholders of Parent, this
Note shall not be convertible into shares of Series A Preferred Stock
representing more than nineteen and ninety-nine one hundredths percent (19.99%)
of the voting power of the Parent or nineteen and ninety-nine one hundredths
percent (19.99%) of the outstanding Common Stock of the Parent, and (b) the
Company shall immediately issue to the Holder a new Note in an original
principal amount equal to all PIK Interest and all accrued and unpaid interest
to the date of conversion that is unpaid on this Note. The conversion of this
Note

                                       -3-

<PAGE>

shall be effective automatically, without any further action by the Holder or
Galen Associates and whether or not this Note is surrendered to the Parent;
provided that the Parent shall not be obligated to issue to Galen Associates
certificates evidencing shares of Series A Preferred Stock issuable upon such
conversion unless this Note is delivered to the Parent. From and after the date
of conversion, this Note shall be deemed to have been paid in full and shall be
canceled.

                            [Signatures on next page]

                                       -4-

<PAGE>

     IN WITNESS WHEREOF, the undersigned has caused this Note to be executed and
its seal affixed on the day and year first above written.

WITNESS                                  ENCORE MEDICAL CORPORATION,
                                              a Delaware corporation

/s/ Harry Zimmerman                      By: /s/ Kenneth W. Davidson
-------------------                          -----------------------
                                         Name:
                                         Title:

WITNESS                                  ENCORE MEDICAL ASSET CORPORATION,
                                              a Nevada corporation

/s/ Harry Zimmerman                      By: /s/ Kenneth W. Davidson
-------------------                          -----------------------
                                         Name:
                                         Title:

WITNESS                                  ENCORE MEDICAL GP, INC.
                                              a Nevada corporation

/s/ Harry Zimmerman                      By: /s/ Kenneth W. Davidson
-------------------                          -----------------------
                                         Name:
                                         Title:

WITNESS                                  ENCORE MEDICAL, L.P.
                                              a Delaware limited partnership
                                         By: Encore Medical GP, Inc.,
                                              its sole General Partner

/s/ Harry Zimmerman                      By: /s/ Kenneth W. Davidson
-------------------                          -----------------------
                                         Name:
                                         Title:

WITNESS                                  CHATTANOOGA GROUP, INC.,
                                              a Delaware corporation

/s/ Harry Zimmerman                      By: /s/ Kenneth W. Davidson
-------------------                          -----------------------
                                         Name:
                                         Title:

                                       -5-

<PAGE>

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR APPLICABLE SECURITIES LAWS. THIS NOTE MAY NOT BE OFFERED, SOLD, ASSIGNED,
TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN
EFFECTIVE REGISTRATION STATEMENT OF THE NOTE UNDER SUCH ACT AND UNDER ANY
APPLICABLE STATE SECURITIES LAWS, UNLESS THE ISSUER HEREOF IS SATISFIED THAT
SUCH REGISTRATION IS NOT REQUIRED AS TO SUCH SALE OR OFFER.

THIS NOTE IS SUBJECT TO THE TERMS OF A SUBORDINATION PROVISIONS SET FORTH IN
THAT CERTAIN SUBORDINATION AND INTERCREDITOR AGREEMENT DATED AS OF THE DATE
HEREOF, AMONG EACH OF ENCORE MEDICAL CORPORATION, ENCORE MEDICAL, L.P., ENCORE
MEDICAL GP, INC., ENCORE MEDICAL ASSET CORPORATION AND CHATTANOOGA GROUP, INC.,
BANK OF AMERICA, NATIONAL ASSOCIATION, AS AGENT, AND CERTAIN OTHER PARTIES
SIGNATORY THERETO (INCLUDING EACH SUCH PARTY'S SUCCESSORS AND ASSIGNS). A COPY
OF THIS AGREEMENT IS ON FILE AT THE OFFICE OF ENCORE MEDICAL CORPORATION AND IS
AVAILABLE FOR INSPECTION AT SUCH OFFICE.

                            SENIOR SUBORDINATED NOTE

$3,000,000.00                                                   February 8, 2002

          FOR VALUE RECEIVED, the undersigned, ENCORE MEDICAL CORPORATION, a
Delaware corporation (the "Parent"), ENCORE MEDICAL, L.P., a Delaware limited
partnership, ENCORE MEDICAL GP, INC., a Nevada corporation, ENCORE MEDICAL ASSET
CORPORATION, a Nevada corporation, and CHATTANOOGA GROUP, INC., a Delaware
corporation (together with their respective successors and assigns, each a "Loan
Party" and collectively, the "Loan Parties") jointly and severally promise to
pay to the order of CAPITALSOURCE FINANCE LLC, a Delaware limited liability
company (the "Holder"), the principal sum of THREE MILLION DOLLARS
($3,000,000.00), together with interest thereon as set forth below, at its
offices or such other place as the Holder may designate in writing.

     1.   Purchase Agreement. This Senior Subordinated Note (the "Note") is
          ------------------
executed and delivered by the Loan Parties at the Closing in connection with an
investment (the "Investment") being made by the Holder in the Loan Parties,
pursuant to the terms and conditions of a Note and Equity Purchase Agreement by
and among the Loan Parties and the Holder dated of even date herewith (the
"Purchase Agreement"). This Note and the other notes evidencing the Investment
(the "Other Notes") are each subject to the terms and conditions of the Purchase
Agreement. A copy of the Purchase Agreement may be examined during normal
business hours at the offices of the Parent. Any capitalized term used herein
and not otherwise defined herein shall have the meaning assigned to it in the
Purchase Agreement.

                                      -1-

<PAGE>

     2.   Interest Rate Provisions.
          ------------------------

          2.1  Accrual and Pay Rates. Except as provided in Section 2.3 hereof,
               ---------------------
from the date hereof and thereafter until the repayment of this Note in full,
interest shall accrue on the principal balance of this Note outstanding from
time to time at the Accrual Rate (as hereinafter defined), compounded monthly,
and shall be paid in cash on a monthly basis at the Pay Rate (as hereinafter
defined). For the purposes of this Note, "Accrual Rate" means (i) the Pay Rate
plus (ii) two and three-fourths percent (2.75%), and "Pay Rate" means the
greater of (i) thirteen percent (13%) and (ii) the Prime Rate plus four percent
(4%), subject to a maximum cap of fifteen percent (15%).

          2.2  PIK Amounts. On each Payment Date (as defined in Section 3.1
               -----------
hereof), the then outstanding principal balance of this Note shall be increased
by an amount (the "PIK Amount") equal to the difference between (i) interest
accruing at the Accrual Rate on the principal balance of this Note outstanding
at the end of the preceding month period and (ii) interest payable at the Pay
Rate on the principal balance of this Note outstanding at the end of the
preceding month period.

          2.3  Default Interest Rate. Following the occurrence and during the
               ---------------------
continuance of any Event of Default, the Accrual Rate and the Pay Rate shall
each increase 300 basis points.

          2.4  Calculation of Interest. Interest shall be calculated on the
               -----------------------
basis of a year of 360 days, composed of twelve 30-day months, and the actual
number of days elapsed.

     3.   Payment Provisions.
          ------------------

          3.1  Interest Payments. Commencing on March 1, 2002, and continuing on
               -----------------
the first day of each succeeding month thereafter, up to and including February
8, 2007 ("the Maturity Date") (each such date, a "Payment Date"), the Borrower
shall pay in cash to the Holder monthly installments of interest only (in
arrears) at the applicable Pay Rate on the then outstanding principal balance
under this Note.

          3.2  Principal Payments and Payment at Maturity. On the Maturity Date,
               ------------------------------------------
the entire then outstanding principal balance of this Note, together with all
accrued but unpaid interest, and all other sums owed hereunder shall be due and
payable in full in cash without further notice or demand.

          3.3  Prepayments; Application of Payments. The Loan Parties may prepay
               ------------------------------------
the then outstanding principal amount of this Note in full in accordance with
the terms of Section 3.3 of the Purchase Agreement. In addition, the Loan
             -----------
Parties shall prepay the then outstanding principal amount of this Note in
accordance with the terms of Section 3.5 of the Purchase Agreement. Each
                             -----------
prepayment shall be applied in the following order of priority: (i) first, to
any prepayment fees due pursuant to the Purchase Agreement; (ii) second, to
accrued, but unpaid, interest at the applicable rate; (iii) third, to any PIK
Amount prior to the time such PIK Amount has been added to the then outstanding
principal balance pursuant to the terms hereof and (iv)

                                      -2-

<PAGE>

finally, to the then outstanding principal balance of the Note (including any
PIK Amounts that have been added to the principal balance pursuant to Section
                                                                      -------
2.2 hereof).
---

     4.   Subordination. The indebtedness represented by this Note is
          -------------
subordinate to the Senior Debt of the Loan Parties in accordance with the terms
of the Subordination Agreement and as specified in the Purchase Agreement.

     5.   Assignment. This Note and the obligations hereunder may not be
          ----------
assigned by the Loan Parties without the prior written consent of the Holder.

     6.   Default and Remedies. The occurrence of an Event of Default under the
          --------------------
Purchase Agreement shall constitute a default hereunder and shall entitle the
Holder to exercise the rights and remedies specified in the Purchase Agreement,
as well as those available at law or in equity.

     7.   Waivers. Each Loan Party hereby waive presentment, demand, protest, or
          -------
further notice of any kind (except such notices as may be specifically required
by the express terms of the Purchase Agreement).

     8.   Controlling Law. This Note and all matters related hereto shall be
          ---------------
governed, construed and interpreted strictly in accordance with the laws of the
State of Maryland, without regard to its principles of conflicts of law.

     9.   No Usury. This Note is subject to the express condition that at no
          --------
time shall the Borrower be obligated or required to pay interest hereunder at a
rate which could subject the Holder to either civil or criminal liability as a
result of being in excess of the maximum rate which the Borrower is permitted by
law to contract or agree to pay. If, by the terms of this Note, the Borrower is
at any time required or obligated to pay interest at a rate in excess of such
maximum rate, the rate of interest under this Note shall be deemed to be
immediately reduced to such maximum rate and interest payable hereunder shall be
computed at such maximum rate and the portion of all prior interest payments in
excess of such maximum rate shall be applied and shall be deemed to have been
payments in reduction of the principal balance of this Note.

     10.  Automatic Conversion. In the event that the Holder sells or otherwise
          --------------------
transfers the portion of this Note equal to the original principal amount of
this Note to Galen Associates pursuant to the terms of the Galen Agreement, (a)
this Note shall automatically be converted into the number of shares of Series A
Preferred Stock of the Parent determined by dividing the principal amount of
this Note so converted by the lesser of (i) $150 and (ii) 50 times the greater
of $1 and the average of the closing prices of the Company's Common Stock as
quoted in the Nasdaq National Market or the principal exchange on which the
Common Stock is listed for 10 trading days prior to the date of conversion,
provided, however, that without the approval of the stockholders of Parent, this
Note shall not be convertible into shares of Series A Preferred Stock
representing more than nineteen and ninety-nine one hundredths percent (19.99%)
of the voting power of the Parent or nineteen and ninety-nine one hundredths
percent (19.99%) of the outstanding Common Stock of the Parent, and (b) the
Company shall immediately issue to the Holder a new Note in an original
principal amount equal to all PIK Interest and all accrued and unpaid interest
to the date of conversion that is unpaid on this Note. The conversion of this
Note

                                      -3-

<PAGE>

shall be effective automatically, without any further action by the Holder or
Galen Associates and whether or not this Note is surrendered to the Parent;
provided that the Parent shall not be obligated to issue to Galen Associates
certificates evidencing shares of Series A Preferred Stock issuable upon such
conversion unless this Note is delivered to the Parent. From and after the date
of conversion, this Note shall be deemed to have been paid in full and shall be
canceled.

                            [Signatures on next page]

                                      -4-

<PAGE>

     IN WITNESS WHEREOF, the undersigned has caused this Note to be executed and
its seal affixed on the day and year first above written.

WITNESS                                   ENCORE MEDICAL CORPORATION,
                                               a Delaware corporation

/s/ Harry Zimmerman                       By: /s/ Kenneth W. Davidson
-------------------                           -----------------------
                                          Name:
                                          Title:

WITNESS                                   ENCORE MEDICAL ASSET CORPORATION,
                                               a Nevada corporation

/s/ Harry Zimmerman                       By:  /s/ Kenneth W. Davidson
--------------------                           -----------------------
                                          Name:
                                          Title:

WITNESS                                   ENCORE MEDICAL GP, INC.
                                               a Nevada corporation

/s/ Harry Zimmerman                       By: /s/ Kenneth W. Davidson
-------------------                           -----------------------
                                          Name:
                                          Title:

WITNESS                                   ENCORE MEDICAL, L.P.
                                               a Delaware limited partnership
                                          By: Encore Medical GP, Inc.,
                                               its sole General Partner

/s/ Harry Zimmerman                       By: /s/ Kenneth W. Davidson
-------------------                           -----------------------
                                          Name:
                                          Title:

WITNESS                                   CHATTANOOGA GROUP, INC.,
                                               a Delaware corporation

/s/ Harry Zimmerman                       By: /s/ Kenneth W. Davidson
-------------------                           -----------------------
                                          Name:
                                          Title:

                                      -5-

<PAGE>

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR APPLICABLE SECURITIES LAWS. THIS NOTE MAY NOT BE OFFERED, SOLD, ASSIGNED,
TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN
EFFECTIVE REGISTRATION STATEMENT OF THE NOTE UNDER SUCH ACT AND UNDER ANY
APPLICABLE STATE SECURITIES LAWS, UNLESS THE ISSUER HEREOF IS SATISFIED THAT
SUCH REGISTRATION IS NOT REQUIRED AS TO SUCH SALE OR OFFER.

THIS NOTE IS SUBJECT TO THE TERMS OF A SUBORDINATION PROVISIONS SET FORTH IN
THAT CERTAIN SUBORDINATION AND INTERCREDITOR AGREEMENT DATED AS OF THE DATE
HEREOF, AMONG EACH OF ENCORE MEDICAL CORPORATION, ENCORE MEDICAL, L.P., ENCORE
MEDICAL GP, INC., ENCORE MEDICAL ASSET CORPORATION AND CHATTANOOGA GROUP, INC.,
BANK OF AMERICA, NATIONAL ASSOCIATION, AS AGENT, AND CERTAIN OTHER PARTIES
SIGNATORY THERETO (INCLUDING EACH SUCH PARTY'S SUCCESSORS AND ASSIGNS). A COPY
OF THIS AGREEMENT IS ON FILE AT THE OFFICE OF ENCORE MEDICAL CORPORATION AND IS
AVAILABLE FOR INSPECTION AT SUCH OFFICE.

                            SENIOR SUBORDINATED NOTE

$8,000,000.00                                                   February 8, 2002

          FOR VALUE RECEIVED, the undersigned, ENCORE MEDICAL CORPORATION, a
Delaware corporation (the "Parent"), ENCORE MEDICAL, L.P., a Delaware limited
partnership, ENCORE MEDICAL GP, INC., a Nevada corporation, ENCORE MEDICAL ASSET
CORPORATION, a Nevada corporation, and CHATTANOOGA GROUP, INC., a Delaware
corporation (together with their respective successors and assigns, each a "Loan
Party" and collectively, the "Loan Parties") jointly and severally promise to
pay to the order of CAPITALSOURCE FINANCE LLC, a Delaware limited liability
company (the "Holder"), the principal sum of EIGHT MILLION DOLLARS
($8,000,000.00), together with interest thereon as set forth below, at its
offices or such other place as the Holder may designate in writing.

     1.   Purchase Agreement. This Senior Subordinated Note (the "Note") is
          ------------------
executed and delivered by the Loan Parties at the Closing in connection with an
investment (the "Investment") being made by the Holder in the Loan Parties,
pursuant to the terms and conditions of a Note and Equity Purchase Agreement by
and among the Loan Parties and the Holder dated of even date herewith (the
"Purchase Agreement"). This Note and the other notes evidencing the Investment
(the "Other Notes") are each subject to the terms and conditions of the Purchase
Agreement. A copy of the Purchase Agreement may be examined during normal
business hours at the offices of the Parent. Any capitalized term used herein
and not otherwise defined herein shall have the meaning assigned to it in the
Purchase Agreement.

                                      -1-

<PAGE>

     2.   Interest Rate Provisions.
          ------------------------

          2.1  Accrual and Pay Rates. Except as provided in Section 2.3 hereof,
               ---------------------
from the date hereof and thereafter until the repayment of this Note in full,
interest shall accrue on the principal balance of this Note outstanding from
time to time at the Accrual Rate (as hereinafter defined), compounded monthly,
and shall be paid in cash on a monthly basis at the Pay Rate (as hereinafter
defined). For the purposes of this Note, "Accrual Rate" means (i) the Pay Rate
plus (ii) two and three-fourths percent (2.75%), and "Pay Rate" means the
greater of (i) thirteen percent (13%) and (ii) the Prime Rate plus four percent
(4%), subject to a maximum cap of fifteen percent (15%).

          2.2  PIK Amounts. On each Payment Date (as defined in Section 3.1
               -----------
hereof), the then outstanding principal balance of this Note shall be increased
by an amount (the "PIK Amount") equal to the difference between (i) interest
accruing at the Accrual Rate on the principal balance of this Note outstanding
at the end of the preceding month period and (ii) interest payable at the Pay
Rate on the principal balance of this Note outstanding at the end of the
preceding month period.

          2.3  Default Interest Rate. Following the occurrence and during the
               ---------------------
continuance of any Event of Default, the Accrual Rate and the Pay Rate shall
each increase 300 basis points.

          2.4  Calculation of Interest. Interest shall be calculated on the
               -----------------------
basis of a year of 360 days, composed of twelve 30-day months, and the actual
number of days elapsed.

     3.   Payment Provisions.
          ------------------

          3.1  Interest Payments. Commencing on March 1, 2002, and continuing on
               -----------------
the first day of each succeeding month thereafter, up to and including February
8, 2007 ("the Maturity Date") (each such date, a "Payment Date"), the Borrower
shall pay in cash to the Holder monthly installments of interest only (in
arrears) at the applicable Pay Rate on the then outstanding principal balance
under this Note.

          3.2  Principal Payments and Payment at Maturity. On the Maturity Date,
               ------------------------------------------
the entire then outstanding principal balance of this Note, together with all
accrued but unpaid interest, and all other sums owed hereunder shall be due and
payable in full in cash without further notice or demand.

          3.3  Prepayments; Application of Payments. The Loan Parties may prepay
               ------------------------------------
the then outstanding principal amount of this Note in full in accordance with
the terms of Section 3.3 of the Purchase Agreement. In addition, the Loan
             -----------
Parties shall prepay the then outstanding principal amount of this Note in
accordance with the terms of Section 3.5 of the Purchase Agreement. Each
                             -----------
prepayment shall be applied in the following order of priority: (i) first, to
any prepayment fees due pursuant to the Purchase Agreement; (ii) second, to
accrued, but unpaid, interest at the applicable rate; (iii) third, to any PIK
Amount prior to the time such PIK Amount has been added to the then outstanding
principal balance pursuant to the terms hereof and (iv)

                                      -2-

<PAGE>

finally, to the then outstanding principal balance of the Note (including any
PIK Amounts that have been added to the principal balance pursuant to Section
                                                                      -------
2.2 hereof).
---

     4.   Subordination. The indebtedness represented by this Note is
          -------------
subordinate to the Senior Debt of the Loan Parties in accordance with the terms
of the Subordination Agreement and as specified in the Purchase Agreement.

     5.   Assignment. This Note and the obligations hereunder may not be
          ----------
assigned by the Loan Parties without the prior written consent of the Holder.

     6.   Default and Remedies. The occurrence of an Event of Default under the
          --------------------
Purchase Agreement shall constitute a default hereunder and shall entitle the
Holder to exercise the rights and remedies specified in the Purchase Agreement,
as well as those available at law or in equity.

     7.   Waivers. Each Loan Party hereby waive presentment, demand, protest, or
          -------
further notice of any kind (except such notices as may be specifically required
by the express terms of the Purchase Agreement).

     8.   Controlling Law. This Note and all matters related hereto shall be
          ---------------
governed, construed and interpreted strictly in accordance with the laws of the
State of Maryland, without regard to its principles of conflicts of law.

     9.   No Usury. This Note is subject to the express condition that at no
          --------
time shall the Borrower be obligated or required to pay interest hereunder at a
rate which could subject the Holder to either civil or criminal liability as a
result of being in excess of the maximum rate which the Borrower is permitted by
law to contract or agree to pay. If, by the terms of this Note, the Borrower is
at any time required or obligated to pay interest at a rate in excess of such
maximum rate, the rate of interest under this Note shall be deemed to be
immediately reduced to such maximum rate and interest payable hereunder shall be
computed at such maximum rate and the portion of all prior interest payments in
excess of such maximum rate shall be applied and shall be deemed to have been
payments in reduction of the principal balance of this Note.

                            [Signatures on next page]

                                      -3-

<PAGE>

     IN WITNESS WHEREOF, the undersigned has caused this Note to be executed and
its seal affixed on the day and year first above written.

WITNESS                                   ENCORE MEDICAL CORPORATION,
                                               a Delaware corporation

/s/ Harry Zimmerman                       By: /s/ Kenneth W. Davidson
-------------------                          ------------------------
                                          Name:
                                          Title:

WITNESS                                   ENCORE MEDICAL ASSET CORPORATION,
                                               a Nevada corporation

/s/ Harry Zimmerman                       By: /s/ Kenneth W. Davidson
-------------------                           -----------------------
                                          Name:
                                          Title:

WITNESS                                   ENCORE MEDICAL GP, INC.
                                               a Nevada corporation

/s/ Harry Zimmerman                       By: /s/ Kenneth W. Davidson
-------------------                           -----------------------
                                          Name:
                                          Title:

WITNESS                                   ENCORE MEDICAL, L.P.
                                               a Delaware limited partnership
                                          By: Encore Medical GP, Inc.,
                                               its sole General Partner

/s/ Harry Zimmerman                       By: /s/ Kenneth W. Davidson
-------------------                           -----------------------
                                          Name:
                                          Title:

WITNESS                                   CHATTANOOGA GROUP, INC.,
                                               a Delaware corporation

/s/ Harry Zimmerman                       By: /s/ Kenneth W. Davidson
-------------------                           -----------------------
                                          Name:
                                          Title:

                                      -4-

<PAGE>

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR APPLICABLE SECURITIES LAWS. THIS NOTE MAY NOT BE OFFERED, SOLD, ASSIGNED,
TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN
EFFECTIVE REGISTRATION STATEMENT OF THE NOTE UNDER SUCH ACT AND UNDER ANY
APPLICABLE STATE SECURITIES LAWS, UNLESS THE ISSUER HEREOF IS SATISFIED THAT
SUCH REGISTRATION IS NOT REQUIRED AS TO SUCH SALE OR OFFER.

THIS NOTE IS SUBJECT TO THE TERMS OF A SUBORDINATION PROVISIONS SET FORTH IN
THAT CERTAIN SUBORDINATION AND INTERCREDITOR AGREEMENT DATED AS OF THE DATE
HEREOF, AMONG EACH OF ENCORE MEDICAL CORPORATION, ENCORE MEDICAL, L.P., ENCORE
MEDICAL GP, INC., ENCORE MEDICAL ASSET CORPORATION AND CHATTANOOGA GROUP, INC.,
BANK OF AMERICA, NATIONAL ASSOCIATION, AS AGENT, AND CERTAIN OTHER PARTIES
SIGNATORY THERETO (INCLUDING EACH SUCH PARTY'S SUCCESSORS AND ASSIGNS). A COPY
OF THIS AGREEMENT IS ON FILE AT THE OFFICE OF ENCORE MEDICAL CORPORATION AND IS
AVAILABLE FOR INSPECTION AT SUCH OFFICE.

                            SENIOR SUBORDINATED NOTE

$10,000,000.00                                                February 8, 2002

          FOR VALUE RECEIVED, the undersigned, ENCORE MEDICAL CORPORATION, a
Delaware corporation (the "Parent"), ENCORE MEDICAL, L.P., a Delaware limited
partnership, ENCORE MEDICAL GP, INC., a Nevada corporation, ENCORE MEDICAL ASSET
CORPORATION, a Nevada corporation, and CHATTANOOGA GROUP, INC., a Delaware
corporation (together with their respective successors and assigns, each a "Loan
Party" and collectively, the "Loan Parties") jointly and severally promise to
pay to the order of CAPITALSOURCE FINANCE LLC, a Delaware limited liability
company (the "Holder"), the principal sum of TEN MILLION DOLLARS
($10,000,000.00), together with interest thereon as set forth below, at its
offices or such other place as the Holder may designate in writing.

     1.   Purchase Agreement. This Senior Subordinated Note (the "Note") is
          ------------------
executed and delivered by the Loan Parties at the Closing in connection with an
investment (the "Investment") being made by the Holder in the Loan Parties,
pursuant to the terms and conditions of a Note and Equity Purchase Agreement by
and among the Loan Parties and the Holder dated of even date herewith (the
"Purchase Agreement"). This Note and the other notes evidencing the Investment
(the "Other Notes") are each subject to the terms and conditions of the Purchase
Agreement. A copy of the Purchase Agreement may be examined during normal
business hours at the offices of the Parent. Any capitalized term used herein
and not otherwise defined herein shall have the meaning assigned to it in the
Purchase Agreement.

                                      -1-

<PAGE>

     2.   Interest Rate Provisions.
          ------------------------

          2.1  Accrual and Pay Rates. Except as provided in Section 2.3 hereof,
               ---------------------
from the date hereof and thereafter until the repayment of this Note in full,
interest shall accrue on the principal balance of this Note outstanding from
time to time at the Accrual Rate (as hereinafter defined), compounded monthly,
and shall be paid in cash on a monthly basis at the Pay Rate (as hereinafter
defined). For the purposes of this Note, "Accrual Rate" means (i) the Pay Rate
plus (ii) two and three-fourths percent (2.75%), and "Pay Rate" means the
greater of (i) thirteen percent (13%) and (ii) the Prime Rate plus four percent
(4%), subject to a maximum cap of fifteen percent (15%).

          2.2  PIK Amounts. On each Payment Date (as defined in Section 3.1
               -----------
hereof), the then outstanding principal balance of this Note shall be increased
by an amount (the "PIK Amount") equal to the difference between (i) interest
accruing at the Accrual Rate on the principal balance of this Note outstanding
at the end of the preceding month period and (ii) interest payable at the Pay
Rate on the principal balance of this Note outstanding at the end of the
preceding month period.

          2.3  Default Interest Rate. Following the occurrence and during the
               ---------------------
continuance of any Event of Default, the Accrual Rate and the Pay Rate shall
each increase 300 basis points.

          2.4  Calculation of Interest. Interest shall be calculated on the
               -----------------------
basis of a year of 360 days, composed of twelve 30-day months, and the actual
number of days elapsed.

     3.   Payment Provisions.
          ------------------

          3.1  Interest Payments. Commencing on March 1, 2002, and continuing on
               -----------------
the first day of each succeeding month thereafter, up to and including February
8, 2007 ("the Maturity Date") (each such date, a "Payment Date"), the Borrower
shall pay in cash to the Holder monthly installments of interest only (in
arrears) at the applicable Pay Rate on the then outstanding principal balance
under this Note.

          3.2  Principal Payments and Payment at Maturity. On the Maturity Date,
               ------------------------------------------
the entire then outstanding principal balance of this Note, together with all
accrued but unpaid interest, and all other sums owed hereunder shall be due and
payable in full in cash without further notice or demand.

          3.3  Prepayments; Application of Payments. The Loan Parties may prepay
               ------------------------------------
the then outstanding principal amount of this Note in full in accordance with
the terms of Section 3.3 of the Purchase Agreement. In addition, the Loan
             -----------
Parties shall prepay the then outstanding principal amount of this Note in
accordance with the terms of Section 3.5 of the Purchase Agreement. Each
                             -----------
prepayment shall be applied in the following order of priority: (i) first, to
any prepayment fees due pursuant to the Purchase Agreement; (ii) second, to
accrued, but unpaid, interest at the applicable rate; (iii) third, to any PIK
Amount prior to the time such PIK Amount has been added to the then outstanding
principal balance pursuant to the terms hereof and (iv)

                                      -2-

<PAGE>

finally, to the then outstanding principal balance of the Note (including any
PIK Amounts that have been added to the principal balance pursuant to Section
                                                                      -------
2.2 hereof).
---

     4.   Subordination. The indebtedness represented by this Note is
          -------------
subordinate to the Senior Debt of the Loan Parties in accordance with the terms
of the Subordination Agreement and as specified in the Purchase Agreement.

     5.   Assignment. This Note and the obligations hereunder may not be
          ----------
assigned by the Loan Parties without the prior written consent of the Holder.

     6.   Default and Remedies. The occurrence of an Event of Default under the
          --------------------
Purchase Agreement shall constitute a default hereunder and shall entitle the
Holder to exercise the rights and remedies specified in the Purchase Agreement,
as well as those available at law or in equity.

     7.   Waivers. Each Loan Party hereby waive presentment, demand, protest, or
          -------
further notice of any kind (except such notices as may be specifically required
by the express terms of the Purchase Agreement).

     8.   Controlling Law. This Note and all matters related hereto shall be
          ---------------
governed, construed and interpreted strictly in accordance with the laws of the
State of Maryland, without regard to its principles of conflicts of law.

     9.   No Usury. This Note is subject to the express condition that at no
          --------
time shall the Borrower be obligated or required to pay interest hereunder at a
rate which could subject the Holder to either civil or criminal liability as a
result of being in excess of the maximum rate which the Borrower is permitted by
law to contract or agree to pay. If, by the terms of this Note, the Borrower is
at any time required or obligated to pay interest at a rate in excess of such
maximum rate, the rate of interest under this Note shall be deemed to be
immediately reduced to such maximum rate and interest payable hereunder shall be
computed at such maximum rate and the portion of all prior interest payments in
excess of such maximum rate shall be applied and shall be deemed to have been
payments in reduction of the principal balance of this Note.

                            [Signature on next page]

                                      -3-

<PAGE>

     IN WITNESS WHEREOF, the undersigned has caused this Note to be executed and
its seal affixed on the day and year first above written.

WITNESS                                  ENCORE MEDICAL CORPORATION,
                                              a Delaware corporation

/s/ Harry Zimmerman                      By:/s/ Kenneth W. Davidson
-------------------                         -----------------------
                                         Name:
                                         Title:

WITNESS                                  ENCORE MEDICAL ASSET CORPORATION,
                                              a Nevada corporation

/s/ Harry Zimmerman                      By:/s/ Kenneth W. Davidson
-------------------                         -----------------------
                                         Name:
                                         Title:

WITNESS                                  ENCORE MEDICAL GP, INC.
                                              a Nevada corporation

/s/ Harry Zimmerman                      By:/s/ Kenneth W. Davidson
-------------------                         -----------------------
                                         Name:
                                         Title:

WITNESS                                  ENCORE MEDICAL, L.P.
                                              a Delaware limited partnership
                                         By: Encore Medical GP, Inc.,
                                              its sole General Partner

/s/ Harry Zimmerman                      By:/s/ Kenneth W. Davidson
-------------------                         -----------------------
                                         Name:
                                         Title:

WITNESS                                  CHATTANOOGA GROUP, INC.,
                                              a Delaware corporation

/s/ Harry Zimmerman                      By:/s/ Kenneth W. Davidson
-------------------                         -----------------------
                                         Name:
                                         Title:

                                      -4-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00034-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00034-of-00352.parquet"}]]